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Abstract
The related Syk and Zap70 tyrosine kinases play an important role in lymphocyte 
development and signalling. Gene targeted mutant mice revealed that Syk plays a 
significant role in B cell development. Syk'1' mice show a partial block in B cell 
development at the pro-B to pre-B cell transition and a complete block at the immature 
to mature B cell transition. In contrast, mice deficient for Zap70 were reported to have 
normal numbers of B cells, but no T cells due to a block in thymic positive selection. 
Unexpectedly, mice deficient for both Syk and Zap70 show a complete block in B cell 
development at the pro-B to pre-B cell transition, indicating that Zap70 plays a role in 
the B cell lineage as well.
I have now further explored the role of Zap70 in B cell development and function. I 
found that Zap70 is expressed in all developing and mature B cell subsets, although pro- 
B cells express higher levels of Zap70 than other populations. Analysis of B cell 
development showed an increase in Bib and marginal zone B cells in Zap7(y'~ mice, 
which was due to the lack of Zap70 in the B cell lineage. In contrast, Zap70-deficient B 
cells were able to mount normal T-dependent and T-independent immune responses and 
had unaffected BCR-induced calcium release.
Furthermore, I asked whether the distinct effects of Syk and Zap70 mutations on B cell 
development were due to intrinsic differences in the function of the two kinases, or 
rather reflected differences in levels of expression. I found that overexpression of Zap70 
in Syk'1' mice completely rescued B cell development, arguing that the two kinases are 
able to perform the same function during B cell development, and that the distinct B cell
3
phenotypes of Syk'1' and Zap 7O'1' mice are caused mainly by differences in levels of 
expression.
Finally, to be able to address the role of Syk in mature B cells, I set up a system where I 
made Syk inducible by fusing the protein to the hormone-binding domain of the estrogen 
receptor (ER-HBD). Three different Syk-ER fusion constructs were expressed in Syk'1' 
DT40 cells and one of these was found to restore BCR-induced calcium fluxes in a 
hormone-dependent manner.
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1. Introduction
1.1 Innate and adaptive immune system
Defence against microbes is mediated by the early reactions of the innate immune 
system and the later responses of the adaptive immune system. Innate immunity consists 
of mechanisms that exist before infection, are capable of rapid responses to microbes, 
and react in essentially the same way to repeated infections. The principal components 
of innate immunity are physical and chemical barriers, phagocytic cells and natural killer 
cells, blood proteins and cytokines (Medzhitov and Janeway, 1997).
In contrast to innate immunity, adaptive immunity refers to antigen-specific immune 
responses. This type of immunity develops as a response to infection and adapts to the 
infection. One of the most important features of adaptive immunity is that it leads to 
long-lasting memory of specific antigens (Janeway, 2001).
There are two types of adaptive immunity, called humoral immunity and cellular 
immunity, which are mediated with different components of the immune system and 
function to eliminate different types of microbes. Humoral immunity is mediated by 
antibodies, which are produced by B lymphocytes or B cells and functions in defence 
against extracellular microbes. Cellular immunity is mediated by T lymphocytes and 
their products, such as cytokines. T cells destroy intracellular pathogens by killing 
infected cells and by activating macrophages, but they also have a central role in the 
destruction of extracellular pathogens by activating B cells (Abbas, 2000).
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The macrophages and neutrophils of the innate immune system provide a first line of 
defence against many common microorganisms and are essential for the control of 
common bacterial infections. However, they cannot always eliminate infectious 
organisms, and there are some pathogens that they cannot recognise. The lymphocytes 
of the adaptive immune system have evolved to provide various means of defence, 
which in addition provides increased protection against subsequent re-infection with the 
same pathogen.
The cells of the innate immune system, however, play a crucial part in the initiation and 
subsequent direction of adaptive immune responses, as well as participating in the 
removal of pathogens that have been targeted by an adaptive immune response. 
Furthermore, because there is a delay of 4 to 7 days before the initial adaptive immune 
response takes effect, the innate immune response has a critical role in controlling 
infections during this period.
1.1.1 Humoral immunity
As mentioned before, humoral immunity is mediated by antibodies, which are produced 
by B cells. The simplest way in which antibodies can protect from pathogens such as 
viruses or bacterial toxins is by binding to them and thereby blocking their access to 
cells that they might infect or destroy. This process is known as Neutralisation.
Binding by antibodies, however, is not sufficient on its own to arrest the replication of 
bacteria that multiply outside cells. In this case, antibodies can coat pathogens and this
18
coating enables a phagocytic cell to ingest and destroy the bacterium. This coating of the 
bacterium by antibodies is known as Opsonization.
Antibodies also have the function to activate the complement system, which in some 
cases can form pores that directly destroy bacteria. However the main function of 
complement is to coat the surface of pathogens, like antibodies do themselves, and 
enable phagocytes to engulf and destroy the bacteria that they would otherwise not 
recognise.
1.2 Cellular immunity
Some bacterial pathogens and parasites and all viruses, replicate inside the cell where 
they cannot be detected by antibodies. The destruction of these invaders is the function 
of T cells. Cellular immunity or cell-mediated immune responses are dependent on the 
direct interactions between the T cell and the cell bearing the antigen that the T cell 
recognises. Cytotoxic T cells (or CD8+ T cells) can recognise e.g. antigens derived from 
replicating viruses displayed on the surface of infected cells. These cells control the 
infection by directly killing the infected cell before viral replication is complete and 
viruses are released. T helper cells (CD4+ T cells) activate the cell they recognise. TH1 
(T helper 1) cells are important for controlling intracellular bacterial infections, by e.g. 
activating macrophages. TH2 cells have a central role in the destruction of extracellular 
pathogens by activating B cells.
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In all cases, T cells recognise their targets by detecting peptide fragments derived from 
the foreign proteins, after these peptides have been captured and by the host cell and 
displayed by them at the cell surcface. The molecules that display peptide antigen to the 
T cells are membrane glycoproteins encoded in a cluster of genes, called the major 
histocompatibility complex (MHC). There are two types of MHC molecules, called 
MHC class I and MHC class II. MHC class I molecules bearing viral peptides are 
recogised by cytotoxic T cells, which then kill the infected cell. MHC class II molecules 
bearing peptides derived from pathogens taken up into vesicle are recognised by TH1 or 
Th2 cells (Janeway, 2001). The antigen-specific activation of these T cells is aided by 
co-receptors that distinguish between the two classes of MHC molecules. Cytotoxic T 
cells express CD8 co-receptor, which bind MHC class I molecules and TH1 or TH2 cells 
express CD4 co-receptor with specificity for MHC class II molecules. Maintaining the 
proper number and proportion of CD4+ and CD8+ T cells is essential for optimal host 
defence.
1.2.1 T cell development
Committed lymphoid progenitors arise in the bone marrow and migrate to the thymus. 
Early committed T cells lack expression of T cell receptor (TCR), CD4 and CD8 and are 
termed double-negative (DN) thymocytes. These cells can give rise to the major 
population of ap  T cells and the minor population of y6 T cells. y6 T cells are involved 
in immunoregulation and tumour surveillance, and have been implicated in wound 
healing
20
DN thymocytes are further subdivided into four stages of differentiation according to 
their cell surface marker expression: DN1, CD44+CD25'; DN2, CD44+CD25+; DN3, 
CD44'CD25+; DN4, CD44 CD25' (Godfrey et al., 1993). The precise DN stage at which 
yb lineage commitment occurs is currently unclear. Subsequent expression of TCRyb in 
yb committed progenitors selects those cells for yb T cell maturation, whereas expression 
of the pre-T cell antigen receptor (pre-TCR) in ap  committed cells selects for ap  T cell 
maturation (Pennington et al., 2005). As cells progress through DN2 to DN4 stages, they 
express the pre-TCR, which is composed of the non-rearranging pre-Tex chain and a 
rearranged TCR-p chain. Successful pre-TCR expression leads to substantial cell 
proliferation and differentiation into DN4 and CD4+CD8+ double-positive (DP) cells. 
Successful rearrangement of TCRa genes leads to the expression of a complete ap  TCR. 
The ap-TCR+CD4+CD8+ (DP) thymocytes then interact with cortical epithelial cells that 
express a high density of MHC class I and MHC class II molecules associated with self­
peptides. The fate of the DP thymocytes depends on signalling that is mediated by 
interaction of the TCR with these self-peptide MHC-ligands (Robey and Fowlkes, 
1994). The appropriate, intermediate level of TCR signalling initiates effective 
maturation (positive selection). Thymocytes that express TCRs that bind self-peptide- 
MHC-class I complexes become CD8+ single posititive (SP) T cells, whereas those that 
express TCRs that bind self-peptide-MHC class II ligands become become CD4+ T cells. 
These cells are then ready to be exported from thymus to peripheral lymphoid sites 
(Germain, 2002).
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1.2.2 The role o f B cells in adaptive immunity
B cells are small (6-10 pm  in diameter) and have a dense nucleus and little cytoplasm. 
Early DNA-labelling studies of bone marrow, using 3H-thymidine and autoradiography, 
demonstrated a large-scale local production and emigration of small lymphocytes that 
expressed surface IgM molecules and other B-cell-related receptors and were thus 
identified as “B-lymphocytes” (Osmond and Everett, 1964; Osmond and Nossal, 1974; 
Osmond et al., 1998; Yang et al., 1978). B cells develop in the fetal liver, the bone 
marrow, and in a specialised organ called bursa of Fabricius in birds. B cells take their 
name from “bursa”, which has been widely used as a model system (Glick, 1991).
Each B cell carries a unique receptor (B cell antigen receptor, BCR), in the form of 
surface-bound immunoglobulin M (IgM) that determines the antigen specificity of a 
given B cell. Each BCR contains heavy and light chains, both of which are composed of 
variable V and constant C portions. The need for a large repertoire of antigen-specific B 
cells carrying distinct receptors is served by the mechanism of gene rearrangement that 
during development brings together gene segments coding for different parts of the 
receptor proteins. The great diversity stems partly from the possibility of different gene- 
segment combinations and partly from the variability of the junctions, including the non­
exact positions of crossovers and the addition of extra, non-germline-encoded 
nucleotides. Ontogenically the first step is the recombination of a given DH (diversity 
gene of the heavy chain locus) segment with one of the four JH (joining) segments. The 
rearrangement process only becomes entirely B lineage specific at the next step, when a 
VH (variable) segment is chosen to join a DJH pair. If the assembly happens in the correct
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reading frame, a heavy chain protein can be synthesised and tested. Light chain 
generation follows that of heavy chain, by a similar mechanism involving joining of VL 
and JL segments (Max, 1993). VH segments in the mouse have been grouped into 14 
families, altogether consisting of potentially more than 1000 genes, followed by 13 DH 
genes in three families and 4 JH segments. There are two light chain genes: k  and X. The 
k  locus contains multiple V region families to be recombined with one of the four JK 
segments, whereas the X locus contains only 3 V*. genes with 3 Jx segments.
During development cells are eliminated if they express self-reactive receptors or fail to 
express a functional receptor. Antigen binding is required for the final stages of 
development. Following antigen recognition, B cells become activated with or without T 
cell help. Once activated, B cells proliferate; moreover, following selection, some B 
cells differentiate into antibody-secreting plasma cells and later into memory B cells. 
Two types of genetic changes occur during this differentiation. First, somatic mutations 
change the antigen-binding properties so that B cells can bind antigens more avidly. 
Second, class switching, which results from a change in the heavy chain constant region 
alters the way that immunoglobulins on B cells are recognised by effector cells (for 
example cells from the innate immune system) (Ollila and Vihinen, 2005).
During B cell activation, the cells become enlarged, especially their cytoplasm. 
Subsequent cell division leads to the expansion of specific clonal lineages. Terminally 
differentiated B cells, the antibody-producing plasma cells, have a very large rough 
endoplasmic reticulum and Golgi apparatus, which are necessary for the production and 
secretion of immunoglobulins. The expression of immunoglobulin mRNAs increases 6-
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12 fold while the expression of surface immunoglobulin decreases, since plasma cells 
produce only soluble antibodies.
1.3 B cell development
In the mouse, B cells are generated throughout life by differentiation from 
haematopoietic stem cells (HSC) in the liver before birth and in the bone marrow of 
adult animals (Hardy, 2003). This differentiation can be viewed as a progression from 
very primitive progenitors with multiple lineage potentials (e.g. B, T, NK, myeloid and 
erythroid) through more restricted progenitors, such as common lymphoid progenitor 
(CLP), finally to a B cell-restricted stage. Lineage-restricted cells execute a programmed 
development, first rearranging immunoglobulin heavy chains at the pro-B cell stage, 
then undergoing multiple rounds of clonal expansion at the pre-B cell stage and finally 
rearranging the light chain to develop into newly formed surface IgM+ B cells.
1.3.1 Early stages o fB  cell development
B cell development can be divided into several stages based on the rearrangement status 
of the immunoglobulin genes and the expression of specific cell surface markers (Fig. 
1.1). Immediately prior to B lineage commitment is a subset of cells called common 
lymphoid progenitors (CLP) (Kondo et al., 1997). While these cells are negative for 
lineage markers (including B220, Mac-1, Terll9 , GR-1), they express c-kit and IL-7
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receptor a  chain. Individual cells with this surface phenotype give rise to mixed B, T 
and NK progeny, but not to other hematopoietic lineages, such as myeloid or erythroid 
cells.
Pre-BC R  BCR
signal signal
Phi l adel phi a A B C  C ’ D  E
■m rtrm rr pro 11 ►    ■ pre m mm , Im m a t—^
_  . Prp RT PreBII Pre-BII ImmatBaSGI smmh pro-B rre-D i
large small
c-kit + + + - - -
SLC + + + + - —
CD43 + + + + - —
HSA — + + ++ ++ ++
BP1 — — + + - —
CD25 - — — + + +
CD2 - - - +/- + +
CD19 — + + + + +
Rag1+2 + + + +/- + —
HC DJ VDJ VDJ V DJ VDJ V DJ
LC G G G G G VJ
Figure 1.1. Early stages of B cell development
The development of B cells proceeds through a number of stages marked by the 
rearrangement of the immunoglobulin genes and expression of specific cell surface 
markers. Currently two nomenclatures are used, the Philadelphia and Basel 
nomenclature (Hardy and Hayakawa, 2001; Martensson et al., 2002; Osmond et al., 
1998). SCL, surrogate light chain; HC, Immunoglobulin heavy chain; LC, 
Immunoglobulin light chain; G, germline; D, diversity; J, joining; V, variable; immat, 
immature; HC and LC rows show heavy chain and light chain rearrangement status in 
different B cell subsets.
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Immediately following the CLP stage, B lineage restriction can be recognised by 
expression of the tyrosine phosphatase B220 (an isoform of CD45) (Allman et al., 1999; 
Li et al., 1996) on the surface of pro-B cells. Currently two nomenclatures are used to 
define the various stages of B cell development: the Hardy (Philadelphia) and the 
Rolink/Melchers (Basel) classifications (Alarid et al., 1999; Hardy and Hayakawa, 2001; 
Martensson et al., 2002; Osmond et al., 1998). Here, I will use the Hardy (Philadelphia) 
nomenclature. These earliest B220+ pro-B cells are also CD43+ CD24 (HSA)l0W AA4.1+ 
and is known as Fraction A (Li et al., 1996), whereas the AA4.1' subset consists of non- 
B cell lineage cells. AA4.1+ cells can be further subdivided into half that express low 
levels of CD4 antigen (Fraction At) and half that do not (Fraction A2). Fraction A x is less 
efficient in generating B cells than Fraction A2 (Hardy, 2003; Li et al., 1996). Both 
and A2 cells have little or no immunoglobulin gene rearrangement.
Next, in fractions B and C of the pro-B cell stage, all cells have recombined DH to JH 
gene segments on both Immunoglobulin heavy chain (IgH) gene alleles and have 
upregulated CD19 expression. These cells express the VpreB and X5 genes encoding 
surrogate light chain (SLC) (Abbas, 2000; Karasuyama et al., 1993; Kudo and Melchers, 
1987; Sakaguchi and Melchers, 1986).
Several transcription factors are important for lineage restriction during hematopoiesis 
and early B cell development. PU.l, E2A and early B cell factor (EBF) play critical 
roles in B cell development, as mice lacking PU.l fail to generate B lineage cells at all 
(Scott et al., 1994), while E2A'/‘ and EBF" mice show very early blocks in B cell 
development (Bain et al., 1997; Lin and Grosschedl, 1995). PAX5 is a key transcription 
factor for B cell commitment, as the inactivation of PAX5 allowed the generation of
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multiple hematopoietic cell types from cells that would normally be B lineage restricted 
(Nutt et al., 1999).
1.3.2 The pre-BCR
If the rearrangement of the IgH genes in pro-B cells is successful, the resulting p  heavy 
chain associates with SLC resulting in surface expression of a complex known as the 
pre-BCR. Signals from the pre-BCR induce proliferation and differentiation into pre-B 
cells characterised by a loss of c-kit and CD43 expression, and gain of CD25 and CD2 
expression (Rolink et al., 2000). B cell development in mutant mice unable to generate 
rearranged heavy chains, such as SCID (severe combined immunodeficiency) mice, 
which have a defect in the DNA-PK repair complex and consequently fail to rejoin DNA 
efficiently during Ig H rearrangement is arrested prior to the pre-B cell stage (Reichman- 
Fried et al., 1990). Likewise, targeting of the recombination-activating genes, Rag-1 and 
Rag-2 that are required to generate double strand breaks in DNA during 
immunoglobulin rearrangement result in a similar phenotype (Spanopoulou et al., 1994). 
Analysis of Rag expression in pre-BCR+pro-B cells fraction C’ shows a downregulation 
of both Rag-1 and Rag-2 in this rapidly cycling fraction. In addition to this transient 
downregulation of Rag-1 and Rag-2 genes, terminal deoxynucleotidyl transferase (TdT) 
expression, which is expressed by cells during VH rearrangement, is permanently 
downregulated (Wasserman et al., 1997). TdT adds untemplated nucleotides to protein 
coding segment ends exposed by activity of the Rag-1 and Rag-2 proteins. The level of
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kappa light chain germline transcription, which precedes rearrangement is also 
upregulated in fraction C’ pro-B cells.
The pre-BCR assembles with the imunoglobulin accessory proteins Iga and Igp on the 
surface of the cell and plays a critical role in cell differentiation. In piMT mice, 
generated by a targeted disruption of the pc heavy chain membrane exon, the heavy chain 
locus undergoes rearrangement, but the protein product cannot be inserted into the 
membrane. The result of this is a developmental block at the pro-B cell stage (Kitamura 
et al., 1991). Elimination of other components of the SLC of the pre-BCR complex, X5 
or Vpre-Bl and/or Vpre-B2 also partially blocks development at this stage (Gong and 
Nussenzweig, 1996; Kitamura et al., 1992; Martensson et al., 2002).
Signalling initiated through the pre-BCR induces clonal expansion of pre-B cells, 
whereby interleukin (IL)-7 acts as a crucial pre-B cell specific proliferation factor 
(Hendriks and Middendorp, 2004). As a result, cells from fraction B and C differentiate 
into the next compartment of large, cycling cells of fraction C \ As mentioned above, in 
these cells Rag-1 and Rag-2 are transiently downregulated to terminate further IgH chain 
rearrangement, thus ensuring that only one functional Igp is synthesized, a phenomenon 
referred to as allelic exclusion. After 2-5 rounds of cell division, the large cells from 
fraction C’ stop cycling and differentiate into small, resting pre-B cells (fraction D). This 
transition is associated with reactivation of the rearrangement machinery for the 
initiation of VL and JL rearrangements and significant changes in cell surface marker 
profiles. Cell from fraction D have downregulated CD43 and BP-1 expression but now 
express CD2, CD25 and CD22 on their cell surface.
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After clonal expansion of cells with successful heavy chain rearrangement, pre-B cells 
stop cycling. Rag-1 and Rag-2 and IgK germline transcripts are expressed and pre-B 
cells undergo light chain gene recombination. Successful light chain gene rearrangement 
leads to the assembly of the BCR and replacement of the SLC of the pre-BCR with IgK 
or IgX.
Productive rearrangement at the immunoglobulin light chain (IgL) loci is an important 
event that ultimately allows cell surface immunoglobulin expression and developmental 
progression towards B cell maturity. As metioned above, the light chains exist in two 
forms, k  or X. The k  locus rearranges first and excludes X locus from recombination -  a 
process called isotype exclusion (Corcoran, 2005). If rearrangement of the first k  allele 
is not productive, rearrangement and expression of the second allele occurs. If this 
rearrangement is not productive either, rearrangement and expression of X locus starts. 
In the mouse, Ig?i recombination only occurs in 10% of cells, when rearrangements on 
both k  alleles have been unsuccessful. Unproductive rearrangements on both IgH alleles 
or on all IgL alleles, lead to apoptosis.
1.3.3 Receptor editing
Immature B cells that express unique antigen receptors are tested for reactivity against 
self-antigen, with autoreactive B cells becoming deleted (clonal deletion), anergised or 
modified (Bergman and Cedar, 2004) This latter process occurs mostly through 
continuous rearrangement at the IgL locus, known as receptor editing (Gay et al., 1993).
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During this process, secondary IgL rearrangements replace existing light chains, 
generating receptors with altered specificity.
Immature B cells are the first B lineage cells to express surface BCRs, mainly surface 
IgM. B cells remain in the immature compartment for an average of 3.5 days (Meffre et 
al., 2000; Osmond, 1993). It is in this compartment that self-reactive B cells that fail to 
edit their receptor are deleted or anergised (Sandel and Monroe, 1999).
1.3.4 Clonal deletion
Immature B cells differ from mature B cells in that they are particularly susceptible to 
BCR-induced apoptosis. B cells bearing self-reactive antibodies are efficiently 
eliminated in large numbers (Nemazee and Burki, 1989), and the degree of B cell 
elimination is dependent on the strength of receptor cross-linking. High-affinity 
interactions with membrane-bound antigen result in deletion, whereas lower-affinity 
interactions and soluble antigens allow editing or result in anergy (Hardy and Hayakawa,
2001). Deletion of self-reactive B cells during development is considered to be one way 
of establishing tolerance (Lederberg, 1959; Meffre et al., 2000).
1.3.5 Anergy
Anergy is the third mechanism by which self-tolerance is induced in immature B cells. 
This phenomenon was observed in cultures of developing B cells exposed to different
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concentrations of anti -//. B cells cultured in high concentrations of anti-// did not 
develop and underwent deletion. In contrast, intermediate levels of BCR crosslinking by 
lower concentrations of anti -pi allowed B cells to develop but abrogated normal B cell 
function, as determined by decreased proliferation and antibody production upon 
mitogen exposure (Pike et al., 1982). Anergic B cells are short-lived and have difficulty 
developing from the immature to the long-lived B cell compartment in the spleen.
Anergy preserves the cells, but they are rendered inactive (e.g. do not secrete antibody) 
after they meet their cognate ligand. Using the HEL (hen egg lysozyme) system, where 
anti-HEL BCR transgenic cells meet their cognate ligand in soluble (sHEL) form, IgM 
expression levels are reduced on anergic B cells (while IgD expression is maintained) as 
a sign of previous antigen encounter. The life span of these cells is much shorter (Cyster 
and Goodnow, 1995; Goodnow et al., 1988).
1.4 Late stages o f B cell development
Of the 2xl07 BCR+ (IgM+) B cells that develop in the murine bone marrow daily, only 
around 10% exit to the periphery (Osmond, 1993). Of these cells, about a third 
progresses to the mature B cell pool.
1.4.1 Transitional B cells
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The emigrating immature B cells, now called transitional B cells, retain key phenotypic 
characteristics of their bone marrow counterparts, such as susceptibility to negative 
selection and the expression of defining cell surface markers. All transitional B cells are 
heat-stable antigen (HSA)high when compared to their mature counterparts and express 
AA4.1. Also, their IgM levels are higher than in mature B cells, whereas the surface 
levels of CD22 and B220 are lower (Chung et al., 2003). Although BCR stimulation of 
mature B cells leads to activation and proliferation, the same signals on developing B 
cells lead to arrest in an unresponsive state or cell death (Goodnow et al., 1988; Norvell 
etal.,1995).
On exiting the bone marrow, the early transitional B cells enter the peripheral 
circulation. The open circulation of the spleen leads to the entry of newly emerging 
transitional B cells into the red pulp through the terminal branches of the central 
arterioles. From the red pulp, these B cells penetrate the marginal zone sinuses to reach 
the outer zone of the periarteriolar lymphoid sheath (PALS) (Liu, 1997). Although 
transitional B cells migrate to the spleen, they are excluded from the lymph nodes, 
perhaps lack of surface expression of CD62L (Flaishon et al., 2000; Loder et al., 1999).
Separation of splenic transitional B cells into two distinct populations, termed 
transitional 1 (Tl) and transitional 2 (T2), was first proposed by Loder et al., based on 
their surface phenotype and functional characteristics (Loder et al., 1999). Tl B cells are 
distinguished from the other subsets by their expression of the following surface 
markers: they are IgMhlghIgD'CD21 CD23', whereas T2 B cells retain high levels of 
surface IgM, but are also IgD+CD21+CD23+ (Fig. 1.2). Using the AA4.1 antibody,
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Allman et al. described a third non-proliferating population, termed T3, which resembles 
T2 with the exception of a lower level of surface IgM (Allman et al., 2001).
The transitional B cell subsets differ in their localization within the spleen. Tl B cells 
appear to be limited to the outer PALS, whereas T2 B cells are located in B cell follicles 
(Loder etal., 1999).
MZ B la B i bimmau T l T2 MRF
CD21 - - + + ++ - .
CD23 - - + + - - -
AA4.1 + + + - - - -
IgM ++ ++ ++ + ++ ++ ++
IgD - - 1* + ++ +/- +/- +/-
CD5 - - - - - + -
Mac-1 - ■ - - ■ + +
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Figure 1.2. Late stages of B cell development
Figure shows the late stages of B cell development from the immature to the mature 
stage. Different surface markers expressed on the different cells and their anatomic 
locations are indicated. T l, T2 = transitional 1, 2; MRF = mature recirculating follicular; 
PALS = periarteriolar lymphoid sheath, MZ = marginal zone; PEC = peritoneal cavity; 
LN = lymph nodes; BM = bone marrows;
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Based on reconstitution and adoptive transfer studies, Tl B cells were classified as the 
progenitors of T2 B cells, while T2 B cells were classified as the progenitors of both 
follicular and marginal zone B cells (Srivastava et al., 2005; Su and Rawlings, 2002). 
Although Tl B cells fail to proliferate and instead undergo apoptosis on BCR-cross 
linking, there is disagreement in the literature regarding the response of T2 B cells to the 
same signals. One study indicates that T2 B cells also do not proliferate and are 
susceptible to BCR-induced apoptosis (Allman et al., 2001). However, another study 
suggests that T2 B cells are able to proliferate and are resistant to apoptosis (Loder et al., 
1999).
Only a small percentage of T l B cells proceed to the T2 stage, which indicates that most 
T IB  cells undergo apoptosis. Some of the B cells that are generated in the bone marrow 
might cross-react with self-antigens that are expressed only in peripheral tissues and so 
need to be deleted. In addition, the fact that T l B cells express the pro-apoptotic 
molecule Fas (CD95), and not the anti-apoptotic protein BCL-2, is consistent with them 
being highly sensitive to negative selection (Carsetti et al., 1995). T l B cells that 
successfully enter the splenic B cell follicles become T2 B cells.
BCR signalling pathways are different in Tl and T2 B cells. After BCR cross-linking, 
T l B cells express little cyclin D2 or A l, and a reduced amount of active AKT, whereas 
T2 B cells express high levels of cyclin D2 and Al and active AKT (Su and Rawlings, 
2002).
T-cell help signals, such as CD40-CD40 ligand (CD40L) interactions and IL-4 rescue T2 
B cells from BCR-induced apoptosis and promote vigorous proliferation (Chung et al.,
34
2002). This is consistent with the idea that T2 cells are located in the splenic follicles, 
where they can receive T cell signals.
1.4.2 Mature peripheral B cell populations
Subsets of mature B lymphocytes have been described based on phenotypic, topographic 
and functional characteristics, which have different generation and maintenance 
requirements. After maturation, B cells either recirculate through secondary lymphoid 
organs as part of a long-lived pool (mature recirculating follicular (MRF) or B2 B cells), 
or join more static compartments enriched in specific locations, in the marginal zone of 
the spleen (MZ B cells) or in the pleural and peritoneal cavities (B1 cells). These 
compartments are present in germ-free mice and rats, suggesting that they are indeed 
part of the pre-immune repertoire (Martin and Kearney, 2000a).
In studies of B cell homeostasis, Rag-2 was conditionally deleted at specific times in 
adult mice (Hao and Rajewsky, 2001). In these mice, splenic naive follicular B cells 
were gradually lost over a year of observation. By contrast, the pool of MZ B cells in the 
spleen and B1 cells in the peritoneal cavity were kept at normal levels. This study might 
suggests that MZ and B1 cells represent self-renewing populations.
1.4.3 Mature recirculating follicular (MRF) B cells
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MRF B cells have low levels of surface IgM and high levels of surface IgD. MRF B 
cells are naive B cells and are by far the largest B cell subset. They are present primarily 
in the follicles of secondary lymphoid organs and in the circulation, and in the bone 
marrow as recirculating cells. They are also known as B2 cells and respond to T- 
dependent antigens, undergo germinal center reactions and give rise to memory B cells. 
The differentiation and maintenance of MRF B cells clearly require signals derived from 
the BCR, as incompetent BCR signalling causes the arrest of B cell differentiation at the 
transitional stage and the loss of a BCR by mature B cells results in cell death (Lam et 
al., 1997).
Tonic signalling is ligand-independent signalling generated by the expression of the 
BCR. It has been demonstrated that the cytoplasmic domains of Iga and Igp in the 
absence of antigen binding are sufficient to drive B cell differentiation into a splenic B 
cell, arguing that a basal BCR tonic signal is sufficient for B cell maturation (Bannish et 
al., 2001). However, it is not clear if the resting splenic B cells from this experiment are 
MRF B cells. By contrast, over the years evidence has been accumulated supporting the 
role for ligand-mediated positive selection in MRF B cell maturation: CD45-deficient B 
cells are arrested at the immature B cell stage. CD45'1' HEL-specific B cells are also 
arrested, but become mature if soluble HEL is available (Cyster et al., 1996).
Furthermore, transitional B cells can be induced to differentiate into MRF-like B cells 
upon BCR ligation in vitro (Su and Rawlings, 2002). It has also been demonstrated that 
B cells expressing a single VH segment, VH12, are developmental^ arrested at a 
transitional stage, but can be induced to become MRF B cells in vivo upon treatment 
with a low dose of anti-IgP antibody (Wang and Clarke, 2003).
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Taken together, these data suggest that the BCR tonic signal alone is not enough to fully 
convert transitional B cells into MRF B cells, and that weak ligand stimulation is 
required for MRF B cell maturation.
1.4.4 Marginal zone (MZ) B cells
MZ B cells are IgMhlCD23,0CD21hl and are non-recirculating cells enriched primarily in 
the marginal zone of the spleen. MZ B cells are considered to be self-renewing (Hao and 
Rajewsky, 2001; Pillai et al., 2004). MZ B cells are thought to be critical for T- 
independent responses to blood-borne pathogens (Martin et al., 2001). MZ B cells 
express higher levels of B7-1 (CD80) and B7-2 (CD86) than MRF B cells and they 
might also present blood-borne antigens to naive T cells and possibly contribute to T- 
dependent responses (Martin and Kearney, 2000a; Pillai et al., 2005).
1.4.5 B1 cells
The B1 cells make up the major B cell subset of the peritoneal cavity (PEC) and a minor 
population in the spleen. B1 cells can be distinguished from B2 cells by their surface 
phenotype, which is similar to MZ B cells. They have an IgMhlIgDloCD23'B220l0 
phenotype, with Mac-1 (CDlib, C3) expression on peritoneal but not on splenic B1 
cells. B1 cells are absent from peripheral lymph nodes and variably make up about 5% 
of splenic B cells (Berland and Wortis, 2002).
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Originally, B1 cells were identified by their expression of CD5. Subsequently, a 
population of peritoneal CD5' B cells was identified whose surface phenotype was in 
other respects identical to that of B1 cells. By consensus, CD5+ B1 cells are referred to 
as B la cells and CD5" B1 cells as B lb cells.
Splenic B la cells have not been studied extensively, because of their low frequency. 
They differ, however, from peritoneal B la cells in two important aspects. Peritoneal B la 
cells contain constitutively active STAT-3, an inducible transcription factor, while 
splenic B la cells do not (Rothstein et al., 2000). Splenic B la cells, unlike those isolated 
from the peritoneal cavity, flux calcium normally upon BCR ligation (Chumley et al., 
2000).
B1 cells are responsible for the majority of non-immune serum IgM and contribute 
substantial amounts of resting IgA (Kroese et al., 1993; Rothstein, 2002). B1 cell- 
derived immunoglobulin generally adheres more closely to the germline state than B2 
immunoglobulin, as a result of diminished somatic mutations and reduced length of 
nontemplated N-insertions (Rothstein, 2002). Transfer experiment studies have revealed 
that B1 cells have self-renewal capacities, which also distinguishes them from 
conventional B2 cells (Herzenberg, 2000). B1 cells are thought to be key players in early 
humoral response against pathogens and are thought to be the primary antibody 
producers in response to T-cell-independent type 2 (TI-2) antigens along with MZ B 
cells.
Two main hypotheses (lineage versus differentiation) have been proposed for the 
generation of B1 cells. Early work suggested that B1 cells exist as a separate lineage, 
distinct from conventional B cells. Studies comparing adoptive repopulation by fetal
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omentum, fetal liver and adult bone marrow precursors demonstrated distinct tissue and 
developmental specificity in the location of progenitors for B1 (fetal omentum and fetal 
liver) and B2 cells (adult bone marrow) (Hardy and Hayakawa, 1991).
Bone marrow reconstitution studies also suggest that B la and B ib cells derive from 
different progenitors (Herzenberg, 2000). In essence, while B la cells are very poorly 
reconstituted from progenitors in the adult bone marrow, Bib cells are reconstituted to 
their normal frequency.
The lineage hypothesis discussed above proposes that certain B cell precursors are 
destined to become B1 cells. In contrast, the differentiation hypothesis proposes that 
every B cell has the same potential to become B1 cells. The B1 phenotype was proposed 
to be a consequence of TI-2 like activation. BCR crosslinking, in the absence of an 
innate antigen, T cell help, or CD40 ligation, resulted in the induction of CD5 expression 
of B2 cells. The combination of BCR crosslinking and IL-6 treatment induced two 
additional features of B1 cells, the downregulation of CD23 and IgD (Haughton et al., 
1993; Wortis et al., 1995). It was subsequently shown that BCR crosslinking also 
induced in B2 cells the ability to proliferate in response to phorbol ester, another feature 
of B1 cells (Rothstein et al., 1991).
According to the differentiation model, encounters with natural occurring TI-2 antigens 
account for the appearance of B1 cells in vivo. Differences in the ability of precursors 
from adult and fetal sources to generate B1 cells are due to differences in the repertoires 
and hence specificities of B cells derived from these sources (Berland and Wortis, 2002). 
The fetal repertoire is skewed towards the expression of immunoglobulins that bind
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frequently to TI-2 antigens. The adult repertoire rarely generates these specificities and 
therefore generates few B1 cells.
The importance of BCR specificity in the generation of B1 cells suggests that the 
requisite BCR signalling is ligand-dependent. Transgenic mice were made in one study 
expressing the SM6C10 heavy chain, which was derived from a Bl-hybridoma, 
expressing an anti-T cell antibody (ATA) specific for the T cell glycoprotein Thy-1. 
These mice showed high titres of ATA, all of which was produced by transgene- 
expressing B la cells (Hayakawa et al., 1999). The majority of these cells expressed an 
endogenous light chain identical to that in the original SM6C10 hybridoma. When 
SM6C10 pi transgenic mice were crossed onto a Thyl'" background, ATA-producing B 
cells and transgene-expressing B la cells were absent. Thus, engagement of the BCR by 
antigen, in this case Thyl, is necessary for B la development.
B1 cell development and maintenance appear to depend critically on BCR signalling, 
because B1 cell numbers are reduced if there is insufficient BCR signalling. It is 
generally found that mutations in positive regulators of BCR signalling, including 
deficiency in CD 19 costimulatory transmembrane protein (Inaoki et al., 1997), the 
BLNK/SLP-65 adaptor protein (Xu et al., 2000), the Cr2 gene-encoded CD21 molecule 
that complexes with CD19 (Carroll, 1998), Vavl (Gulbranson-Judge et al., 1999; 
Tarakhovsky et al., 1995) the PI3-kinase p85a (Suzuki et al., 1999) and Btk tyrosine 
kinase (Khan et al., 1995), all result in a greater reduction of B1 cells compared to 
peripheral B cells,.
BCR mediated signalling is also controlled by negative regulators, which also show 
altered B1 cell development. While SHP-1 mutant motheaten (Me) show an increase in
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Bla cells, mice lacking CD22, lyn or PD-1 all show an increase in Bib cells (Chan et 
al., 1997; Nishimura et al., 2000; Sidman et al., 1986).
1.4.6 Generation o fB l , MRF and MZ B cells -  signal strength hypothesis
The analysis of mutant mice in which antigen receptor signalling in B cells is either 
attenuated or enhanced has revealed the existence of a follicular versus marginal zone B 
cell fate decision. These analyses indicate that weak antigen receptor-derived signals 
favour MZ B cell generation, and relatively strong signals favour the development of 
MRF B cells. Even stronger signals derived from the antigen receptor favour the 
generation of B1 cells (Pillai et al., 2004; Pillai et al., 2005).
The first studies proposing such a model came from the Aiolos'1'IXid double mutant mice 
(Cariappa et al., 2001). Aiolos is a zinc-finger protein of the Ikaros family, expressed 
primarily in B cells. These data suggest that Aiolos is a negative regulator of the Btk 
pathway. In the absence of Aiolos BCR signal strength is enhanced, MRF B cell 
numbers are greater than in wild-type mice, but MZ B cells are lost. In mice deficient for 
both Aiolos and Btk, MZ B cells reappear (Cariappa et al., 2001).
Additional evidence supporting this signal-strength hypothesis, is that in the absence of 
CD21/CR2, a known positive regulator of BCR signalling, MZ B cell number is 
increased (Cariappa et al., 2001). Mice lacking CD22, a negative regulator of BCR 
signalling, are deficient in MZ B cells, whereas the number of B1 cells is increased 
(Samardzic et al., 2002).
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In addition, mice in which the Epstein-Barr virus LMP2A gene has been integrated into 
the IgH locus produce either B1 cells or MZ and MRF B cells, depending on the strength 
of the promoter used to drive LMP2A expression. When LMP2A expression was driven 
by a strong pormotor, B1 cells were mainly produces and when LMP2A was driven by a 
weak promotor, MZ and MRF B cell generation was increased. LMP2A is thought to act 
as a surrogate BCR in this model and therefore it was interpreted that signal strength 
might influence B cell development (Casola et al., 2004).
However, the hypothesis of the weakest BCR signals promoting MZ B cell development 
is inconsistent with a recent publication of Hayakawas group, where they found that, 
using a monoclonal BCR mouse line, specific for the self-Thyl/CD90 glycoprotein, an 
increase in BCR signal strength, induced by a low-dose self-antigen, directed naive 
immature B cells to mature into MZ B cells, and not MRF B cells (Wen et al., 2005).
B1 and MZ B cells share many similarities:
It is of interest that MZ B cells are the only other B cells subset that seems to show 
similar properties to B1 cells. They share phenotypic similarities, since they are 
IgMhlIgDloCD23l0/\  They are the source of natural antibodies and are presumed to be 
critical for T-independent responses to blood-borne pathogens (Martin et al., 2001)
In contrast to MRF B cells, the generation of MZ and B1 cells appears to require ligand- 
induced positive selection through the BCR (Berland and Wortis, 2002; Martin and 
Kearney, 2002). A restricted repertoire that is weakly self-reactive is selected 
preferentially in these populations, which indicates that BCR signalling induced by self­
ligands is required for the generation and maintenance of MZ and B1 cells.
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Given the different anatomical locations of MZ B and B1 cells compared to MRF B 
cells, unique signals might affect the development of these B cell subsets. Microbial 
products that are recognised specifically through toll-like receptors (TLR), are sufficient 
to drive T2 cells into MZ B cells in vitro. In mice lacking the normal commensal 
intestinal microflora, the generation of MZ B and B1 cells is impaired (Niiro and Clark, 
2002).
Although MZ and B IB  cells have many similarities, a direct developmental link has not 
been demonstrated. Several mouse models that have defects in B1 cells have altered 
development of MZ B cells. For example, the aly mutation, known to impair the MZ 
development, has been shown to inhibit B1 cell migration from the PEC to effector sites 
(Fagarasan et al., 2000). Mice deficient for CD19 are deficient in both B1 and MZ B 
cells (Martin and Kearney, 2000b; Rickert et al., 1995; Sato et al., 1996). This finding is 
inconsistent with the signal-strength hypothesis, as is the fact that mice lacking Aiolos, 
despite their hyperresponsive BCR signalling have reduced numbers of B1 cells (Wang 
et al., 1998).
Furthermore, Notch2+/' mice show a reduction in frequency and absolute number of both 
B1 and MZ B cells, suggesting firstly that Notch2 plays a role in determining the 
generation of MZ and B1 cells. Secondly this supports the notion that these two subsets 
share some common elements in their developmental pathways (Witt et al., 2003).
1.4.7 Plasma cells
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After antigen encounter, plasma cells can develop from naive mature B cells, from 
activated germinal centre B cells and from memory B cells. Which B cell subset 
becomes terminally differentiated depends on the nature of the antigen, its dose and 
form, and the location of the encounter.
Plasma cells are the sole producers of secreted antibody and are therefore crucial for an 
effective immune response. Numerous cell surface proteins change upon plasma cell 
differentiation. The expression of B220, CD 19, CD21 and CD22 on the cell surface 
decreases, whereas Syndecan-1 (CD 138) increases.
The first B cells to respond to foreign antigen by differentiating into plasma cells are MZ 
B cells and B1 cells (Pillai et al., 2005; Shapiro-Shelef and Calame, 2005). When B1 
cells (mainly Bla) become activated in the pleural or peritoneal cavities, they migrate to 
the spleen or gut, lose expression of CD5 and become antibody-secreting plasma cells 
(Bikah et al., 1996). The unique location of the two B cell subsets facilitates early 
encounter with blood-borne antigens. Within a few hours of immunisation with a TI-2 
antigen, MZ B cells move from the marginal zone to the bridging channel and the red 
pulp of the spleen, where they undergo a burst of proliferation. This occurs together with 
differentiation to form foci of plasmablasts, which secrete immunoglobulin but continue 
to proliferate (Lopes-Carvalho and Kearney, 2004). MZ B cells have a lower threshold 
for antigen activation than MRF B cells, and, when stimulated with LPS, proliferate to a 
greater extent (Oliver et al., 1997).
MRF B cells that both encounter antigen and receive help from T cells can also respond 
rapidly, albeit more slowly than MZ B cells. They undergo proliferation and plasmacytic 
differentiation to form extrafollicular foci of plasmablasts and plasma cells. Two days
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after immunisation with a T cell-dependent antigen, foci are observed along the 
periphery of the PALS. These foci expand until day 8 after immunisation and then 
diminish (Jacob et al., 1991).
Plasma cells formed from either MZ or MRF B cells in this early extrafollicular 
response do not have somatically mutated immunoglobulin genes and are short-lived, 
undergoing apoptosis in situ (Calame et al., 2003; Smith et al., 1996).
1.4.8 Germinal centre B cells
When MRF B cells both encounter antigen and receive T cell help, a second 
developmental possibility is the establishment of a germinal centre (Calame et al., 2003; 
Shapiro-Shelef and Calame, 2005). Germinal centres are specialised areas in the splenic 
follicle where B cells undergo rounds of proliferation, which is accompanied by affinity 
maturation and class-switch recombination of immunoglobulin.
Affinity maturation is the process that leads to increased affinity of antibodies for a 
particular antigen and is the result of somatic hypermutation of immunoglobulin genes, 
in and around the V-region of IgH and IgL genes. Somatic hypermutation is followed by 
selective survival of B cells producing antibody with the highest affinity (Jacobs and 
Bross, 2001). B cells in germinal centres can also modify their constant region by a 
genetic process called class-switch recombination. These B cells begin to express IgH 
chain classes other than pi and 6, for example y, a  or e.
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Antigen-specific T helper cells and follicular dendritic cells are important for the 
germinal centre response. Interactions between CD40-ligand and CD40, and inducible T 
cell co-stimulator (ICOS) and ICOS-ligand, which are expressed on T cells and B cells 
respectively, are important for the germinal centre response (Shapiro-Shelef and 
Calame, 2005). The germinal centre response peaks between day 10 and 14 after 
immunisation and then diminishes. Plasma cells and memory B cells, which mainly have 
somatically mutated, high affinity BCRs and express switched immunoglobulin isotypes, 
exit the germinal centre.
1.4.9 Memory B cells
Post-germinal-centre memory B cells retain high-affinity BCR at their surface, but do 
not secrete antibody. Memory B cells have the intrinsic ability to respond more rapidly 
than naive B cells, and they show a proliferative burst on secondary encounter with 
antigen (Tangye et al., 2003).
1.5 B cell signalling
The B cell receptor has two main roles. The first role is to transmit signals that regulate 
B cell fate decisions. The second is to mediate antigen processing, leading to the 
presentation of antigen to T cells, which allows full activation of B cells in the effector 
phase (Niiro and Clark, 2002).
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Signalling through the BCR is mediated by Iga and Igp. The signalling capacity of both 
Iga and Igp are dependent upon a specific motif, found within each cytosolic tail, 
known as the immunoreceptor tyrosine-based activation motif (ITAM) (Reth, 1989). 
The core of this motif (D/E(X)7D/EXXYXXI/L(X)7YXXI/L) comprises two tyrosine 
residues separated by 11 residues, each followed by leucine or isoleucine at the +3 
position. Other receptors involved in antigen responses, including the TCR and many Fc 
receptors, also contain IT AMs (Samelson and Klausner, 1992). Mutational analysis has 
illustrated that the tyrosines, the 11 amino acid spacer between them and the +3 
leucine/isoleucine residues, are all required for proper initiation of BCR-mediated 
signalling pathways (Sanchez et al., 1993).
Aspects of Iga and IgP function in B cell development were studied in transgenic and 
gene-targeted mice. In Igp knock-out mice, B cell development is completely blocked at 
the pro-B cell stage (Gong and Nussenzweig, 1996). Critical role of the cytoplasmic tails 
of Iga and Igp were revealed in IgaAC/ACand IgpAC/AC (Reichlin et al., 2001; Torres and 
Hafen, 1999). In both mutants, B cell development is severely impaired resulting in a 
drastic reduction of peripheral B lymphocyte numbers. Unexpectedly, IgaAC/AC yields an 
antigen receptor complex on immature B cells that signals constitutively, indicating a 
role for Iga in negatively regulating antigen receptor signaling during B cell 
development (Torres and Hafen, 1999).
Three families of protein tyrosine kinases (PTK) have been implicated in the earliest 
steps of BCR signalling. Members of the Src-family (in B cells mostly Lyn, Fyn and 
Blk), Syk from the Syk/Zap70-family and Btk from the Tec-family (Fig. 1.3). The resting 
BCR is assembled with Src-family tyrosine kinases, which become activated following
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receptor ligation (Burkhardt et al., 1991; Wang and Clark, 2003). Syk can also be 
detected in the resting receptor complex. Upon BCR ligation the first kinases to be 
activated are the Src-family kinases. These in turn phosphorylate the tyrosine residues in 
the ITAMs of Igct and Igp. The phosphorylated ITAMs serve as docking sites for the 
tandem Src-homology (SH2)-domain-containing PTK Syk, which is then activated by 
means of tyrosine phosphorylation by Src-family PTKs. The activation of Syk leads to 
the phosphorylation of several molecules, which in turn, activate signalling networks 
that lead to proliferation, actin cytoskeleton reorganization, gene transcription and cell 
motility.
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Figure 1.3. Overview of the components of the BCR signalosome and their 
interactions.
Figure was adapted Niiro, et al. (Niiro and Clark, 2002)
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1.5.1 Src-family kinases
The primary Src-family PTK in B cells is Lyn, although B cells also express other Src 
family kinases, including Fyn, Blk, Hck and Fgr. Mice deficient for individual Src- 
family PTKs have little effect on B cell function (Hibbs et al., 1995; Lowell and 
Soriano, 1996; Nishizumi et al., 1995; Stein et al., 1992; Texido et al., 2000). However, 
mice deficient for Blk, Fyn and Lyn, showed reduced numbers of pre-B cells followed 
by substantial reduction in peripheral B cell numbers (Saijo et al., 2003). Furthermore, 
Blk'1'Fyn''Lyn1' mice have completely abrogated pre-BCR-mediated NF-kB activation. 
Src-family PTKs seem to be connected to NF-kB activation through the atypical protein 
kinase C (PKC)-T,, which is hypophosphorylated in the absence of the three Src family 
PTKs and if activated can bypass the requirement for Src-family PTKs in pre-BCR- 
mediated NF-kB activation.
Lyn is not absolutely required for phosphorylating Iga/p ITAMs. B cell development in 
the bone marrow of Lyn-deficient mice is normal suggesting that in the absence of Lyn 
this function can occur through other Src-family kinase members as mentioned before 
(Chan et al., 1997). While the positive role of Lyn is redundant, Lyn also plays a role as 
a negative regulator of BCR signalling. Its negative function was first suggested by the 
analysis of Lyn-deficient mice in which peripheral B cells exhibit enhanced activation of 
downstream effectors, intracellular Ca2+ flux, proliferative responses in vitro, and B cell 
hyperactivity in vivo that leads to increased levels of autoantibodies (Dal Porto et al., 
2004). Lyn’s inhibitory function depends on its ability to phosphorylate FeyRIIB and 
CD22, two immunoreceptor tyrosine-based inhibitory motif (ITIM) containing
inhibitory receptors, which recruit tyrosine phosphatases and suppress the BCR 
response, as discussed later.
1.5.2 Tec-family kinases
The Tec-family kinases consist of 5 members: Btk, Tec, Itk/Emt/Tsk, Etk/Bmx and 
Rlk/TXK. A crucial role for the non-receptor tyrosine kinase, Bruton’s tyrosine kinase 
(Btk) in B cell development and function was illustrated by the B cell 
immunodeficiencies X-linked agammaglobulinemia (XLA) in humans and X-linked 
immunodeficiency (Xid) in mice (Lewis et al., 2001; Satterthwaite et al., 1998). XLA is 
caused by loss of Btk expression or more subtle functional changes in any Btk 
subdomain including the pleckstrin homology (PH), Tec homology (TH), SH3, SH2 or 
kinase motifs. It is characterized by a block in B cell development at the pro- to pre-B 
cell stage. Xid mice, which have a point mutation in the PH domain of Btk, and Btk- 
deficient mice have a milder phenotype than XLA patients. Xid and Btk-deficient mice 
have decreased numbers of mature B cells and lack B la cells. IgM and IgG3 levels are 
low and response to TI-2 antigens is impaired.
Activation of Btk downstream from antigen receptors requires two steps: membrane 
localization followed by phosphorylation by a Src-family kinase. Membrane localization 
occurs by virtue of the interaction of an intact PH domain of Btk with 
phosphatidylinositol-(3,4,5)-triphosphate (PIP3), a product of phosphoinositide-3-kinase 
(PI3K). Once at the membrane, Btk can be phosphorylated at the activation loop of the 
kinase domain by Src-family kinases, which fulfills the second requirement for
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activation. Subsequently the SH3 domain is autophosphorylated, rendering Btk fully 
activated (Lewis et al., 2001; Satterthwaite et al., 1998). Analysis of mutant cells 
suggests that Btk is required for full activation of Phospholipase Cy (PLCy) 
(Scharenberg and Kinet, 1998).
1.5.3 Vav-family
The Vav-family of guanine-nucleotide exchange factors (GEF) consists of three 
structurally related Vav proteins. Vavl is expressed primarily in cells of the 
heamatopoietic system, whereas Vav2 and Vav3 have broader pattern of expression 
(Turner and Billadeau, 2002). The DBL homology domain containing GEFs promote the 
activation of RHO-GTPases by catalysing the exchange of GDP for GTP. Vavl is 
primarily a GEF for Racl, Rac2 and RhoG, whereas Vav2 and Vav3 act primarily on 
RhoA, RhoB and RhoG GTPases (Crespo et al., 1997; Movilla and Bustelo, 1999; 
Schuebel et al., 1998). The recruitment of Vav proteins to activated receptors on 
lymphocytes and their subsequent tyrosine phosphorylation requires an intact SH2 
domain. Several tyrosine kinases, including Fyn and Syk, have been shown to 
phosphorylate Vav (Deckert et al., 1996; Schuebel et al., 1998). Furthermore, Vavl and 
Vav2 have been shown to interact, by means of their SH2 domain, with the tyrosine 
phosphorylated Tyr391-Glu-Glu-Pro motif in the cytoplasmic tail of CD19 (O'Rourke et 
al., 1998). It is thought that CD19 activates Vav-family members through the 
recruitment of Lyn. The significance of Vav binding to CD 19 is highlighted by the 
observation that CD19 signal transduction is less efficient in B cells that lack Vavl, and
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that the Tyr391Phe mutation of CD19 abolishes both Vavl binding and CD19-regulated 
responses (Fujimoto et al., 2000; O'Rourke et al., 1998).
Studies of Vavl'l'Vav2'l'm\ct showed clearly that Vav proteins have a crucial role in B 
cell signalling. In Vavl'1', Vav2''' and Vavl'1'Vavl1' mice, normal numbers of immature B 
cells are found in the bone marrow, which indicates that the early developmental 
transitions occur independent of these proteins. However, Vavl'^Vavl1' immature B cells 
fail to complete their maturation into recirculating B cells. They remain immature 
expressing high levels of IgM and low levels of IgD (Doody et al., 2001; Tedford et al., 
2001). Furthermore, in V a v l1', Vav2'!' and V a v l'V a v l1' mice, peripheral B cells are 
impaired in their in vitro proliferative and Ca2+ responses after BCR engagement, which 
provides evidence for the role of Vav proteins in the regulation of Ca2+ mobilization. A 
target of Vavl, Racl has been indicated to play a role in the activation of 
phosphatidylinositol-4-phosphate 5-kinase (PIP5K) and therefore regulating the level of 
PIP2, the substrate for PLCy proteins (O'Rourke et al., 1998; Tolias et al., 1995). 
Interestingly, mice deficient for Racl and Rac2 GTPases, the substrates of Vavl, have 
defective BCR signalling and B cell development is arrested at the immature-Tl 
transition (Walmsley et al., 2003).
1.5.4 Phosphoinositide-3-kinase (PI3K)
PI3Ks are a family of proteins that regulate diverse biological functions in every cell 
type by generating lipid second messengers. The PI3K family can be subdivided into 
three classes, class I, class II and class III. Whereas little is known about the role of class
II and class III PI3Ks in lymphocytes, class I PI3K are well characterised (Okkenhaug 
and Vanhaesebroeck, 2003). Class I PI3Ks are further subdivided into class IA and class 
IB. Class IA PI3Ks are activated by tyrosine kinase-associated receptors, such as antigen 
receptors and co-stimulatory receptors (e.g CD19). Upon BCR stimulation, the co­
receptor CD 19 is phosphorylated on tyrosine residues and provides binding sites for 
PI3Ks, which are important for activation of the enzyme. Class IA PI3Ks are 
heterodimeric enzymes consisting of a regulatory subunit (p85a, p85p or p55y) and a 
catalytic domain (pi 10a, pllOp or pi 106). Class IB PI3Ks are activated by G-protein- 
coupled receptors. The function of class I PI3Ks is to convert phosphatidylinositol-(4,5)- 
bisphosphate (PIP2) to phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) at the inner 
leaflet of the plasma membrane. PIP3 acts as a binding site for numerous intracellular 
proteins that contain PH domains with selectivity for this lipid, such as Btk and the 
serine/threonine kinase Akt.
Knock-out studies have shown that B cell development is partially blocked at the pro-B 
to pre-B cell transition in mice that lack the catalytic domain pi 106 or the regulatory 
subunit p85a (Clayton et al., 2002; Koyasu, 2003). Furthermore, p i 10b'1' mice have 
reduced numbers of MZ B cells and B1 cells and an impaired antibody production in 
response to TD and TI antigens. In addition, the splenic B cells of mice deficient in 
pi 106 or p85a undergo poor proliferative responses following stimulation at the BCR 
indicating that the activation of PI3K is required for BCR-driven proliferation (Clayton 
et al., 2002).
The key downstream signal of PI3K is Akt, which is recruited by PIP3 to the plasma 
membrane via its PH domain. Akt is a serine/threonine protein kinase that promotes cell
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survival by a variety of mechanisms including phosphorylating and inhibiting pro- 
apoptotic proteins such as Bad (Brazil et al., 2002).
1.5.5 Phospholipase Cy (PLCy)
Two PLCy isoforms are expressed in B cells, PLCyl and PLCy2, with the latter 
generally being most abundant. Both isoforms appear to participate in BCR signal 
transduction, however it is not clear whether they play distinct functional roles (Marshall 
et al., 2000). Upon BCR ligation, Syk associates and phosphorylates B-linker protein 
(BLNK), leading to binding of PLCy through its SH2 domain. This brings PLCy into 
proximity with Syk, leading to its phosphorylation and partial activation (Fu et al., 1998; 
Kurosaki and Tsukada, 2000). Btk is recruited to the membrane by binding to PIP3 
generated by PI3K, and becomes tyrosine phosphorylated, probably by Lyn. Activated 
Btk then may also phosphorylate PLCy leading to its full activation (Rodriguez et al., 
2001). Alternatively the adapter protein BLNK, phosphorylated by Syk, provides 
docking sites for Btk as well as PLCy2, thus bringing Btk into close proximity with 
PLCy2. The activated Btk then phosphorylates PLCy2, which leads to its full activation 
(Hashimoto et al., 1999). PLCy hydrolyzes, PIP2, to produce soluble inositol-1,4,5- 
trisphosphate (IP3) and membrane-anchored diacylglycerol (DAG). IP3 can then bind to 
IP3 receptors on the endoplamatic reticulum and induces the release of calcium from 
intracellular stores. The elevation of cytosolic calcium levels activates downstream 
signalling molecules, including calcineurin and conventional protein kinase C (PKC) 
isoforms (a , p , y). By contrast, DAG activates all phorbol ester-sensitve isoforms of
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PKC (a, p, y, 6, tj, e, 0), as well as other proteins such as the Ras guanine nucleotide 
releasing protein (RasGRP) family of Ras GEFs. Calcium flux and PKC activation 
induce activation transcription factors, including nuclear factor-KB (NF-kB) and nuclear 
factor of activated T cells (NF-AT).
1.5.6 Erk MAPK pathway
Erk MAPK activation in B cells has been associated with a variety of cellular responses 
as diverse as proliferation and apoptosis. The Erk MAPK pathway is activated primarily 
via the adaptor protein Grb2, which can associate with the BCR complex via She or 
BLNK (Harnett et al., 2005). The SH3 domains of Grb2 bind to guanine-nucleotide 
exchange factor SOS (son of sevenless), which activates the small GTPase Ras by 
exchanging GDP for GTP. Ras can also be activated by RasGRPs (Oh-hora et al., 2003). 
Ras-GTP can bind and activate serine/threonine protein kinase Rafl, leading to the 
stimulation of the dual-specificity protein kinases MEK1 and MEK2, which activate Erk 
by phosphorylating the threonine-glutamate-tyrosine (TEY) motif of its activation loop.
1.5.7 NF-kB pathway
NF-kB, a family of dimeric transcription factors, has been shown to protect many cells 
from pro-apoptotic signals (Barkett and Gilmore, 1999). In mice that are deficient for 
inhibitor of NF-kB (IkB) kinase-a (IKKa), IKK [3 and the regulatory subunit NF-kB
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essential modulator (NEMO), which are upstream molecules of NF-kB activation, B cell 
apoptosis is increased markedly (Kaisho et al., 2001; Pasparakis et al., 2002). PLC-y2- 
induced Ca2+ flux and PKC activation are both required for NF-kB activation, which 
indicates that the activation of calcium-dependent PKC isoforms might regulate the 
activation of NF-kB. And indeed, it has been shown that PKCp is required for activation 
of IKKa/p (Saijo et al., 2002). NF-kB induces expression of anti-apoptotic Bcl-2 family 
members, such as Bcl-2, Bcl-xL and A l. These molecules counteract the effect of pro- 
apoptotic Bcl2 family members, thereby protecting cells from BCR-induced cell death. 
Bcl-xL was reported to block expression of IP3-receptor in a B cell line, which indicates 
that Bcl-xL might also regulate BCR-induced cell death by inhibiting the release of 
calcium through the IP3-receptor (Li et al., 2002).
1.5.8 Positive modulator: CD19
Although Iga/p are the primary signal transducers for BCR complexes, the signal 
quality and quantity can be significantly influenced by co-receptors.
BCR-associated CD 19 molecules positively contribute to Iga/p signalling by enhancing 
the recruitment and activation of Lyn, PI3K, Btk and Vav (Fujimoto et al., 2000). 
Genetic ablation of CD19 has revealed a role for this molecule in B cell development as 
well as the importance of CD19 to the B cell response to TD antigens (Rickert et al., 
1995). Studies in mice expressing CD 19 molecules incapable of binding to PI3K exhibit 
a phenotype identical to that of mice deficient in CD 19, indicating that an essential 
contribution of CD19 to B cell responses is the activation of PI3K (Wang et al., 2002).
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However, the CD 19 tyrosines mutated in these mice are also required for amplification 
of Lyn activity following BCR ligation (Fujimoto et al., 2000).
CD19 is recruited to the BCR via two mechanisms. First, CD19 form a complex with the 
tetraspanin molecule CD81 and the receptor for the C3d component of complement, 
CD21 (Cr2). This complex can then associate with the BCR through the co-recognition 
of antigen, which have affixed complement (Fearon and Carter, 1995). The second 
mechanism is a direct association of CD19 with the BCR, and is supported by the 
finding that CD 19 molecules become phosphorylated and transduce signals upon 
ligation of surface BCR alone (Carter et al., 1997).
1.5.9 Negative modulator: CD22
CD22 is a sialic acid-binding immunoglobulin-like lectin superfamily member that binds 
a2,6-linked sialic acid residues and is tyrosine-phosphorylated upon BCR ligation (Dal 
Porto et al., 2004). CD22 contains three ITIMs (Immunoreceptor Tyrosine-based 
Inhibitory motifs) in its cytoplasmic domain, which are phosphorylated by Lyn upon 
BCR ligation. CD22-deficient mice display increased sensitivity to BCR aggregation, as 
measured by calcium mobilization and proliferation and have a reduction of MZ B cells 
(Nitschke et al., 1997; Samardzic et al., 2002). CD22 exerts its negative effect in part by 
recruiting SH2-containg tyrosine phosphatase-1 (SHP-1). Possible SHP-1 substrates 
include Iga, Igj3, Syk, Vav and BLNK (Mizuno et al., 2000).
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1.5.10 Negative modulator: FcyRIIB
The low affinity receptor for IgG, FcyRIIB, is a potent transducer of signals that block 
antigen-induced B cell activation. Coligation of FcyRIIB with BCR causes premature 
termination of phosphoinositide hydrolysis and calcium mobilization and inhibits 
proliferation. Similar to CD22, the inhibitory signal transduction by FcyRIIB is mediated 
primarily by its ITIM region, phosphorylated in a Lyn-dependent fashion. Tyrosine 
phosphorylation of FcyRIIB recruits the SH2-containing inositol 5’-phosphatase (SHIP), 
which prevents PIP3  accumulation, by hydrolysing PIP3  to PIP2.
1.6 The role o f Syk-familv kinases in B cell signalling
1.6.1 Structure o f Syk-family tyrosine kinases
The Syk-family of tyrosine kinases consists of two members: Syk and Zap70. These 
kinases contain a C-terminal kinase domain and tandem N-terminal SH2 domains that 
bind phosphorylated ITAMs (Fig. 1.4) (Turner et al., 2000). A linker region, designated 
interdomain B that contains multiple tyrosines separates SH2 domains from the kinase 
domain. These tyrosines, once phosphorylated act as docking sites for proteins such as 
PLCyl and 2 (Law et al., 1996; Takata and Kurosaki, 1996) and the Vav family of GEFs 
(Deckert et al., 1996), which might be substrates for Syk and Zap70.
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Though similar in overall structure, there are important differences between Syk and 
Zap70. In particular, the most abundant form of Syk contains a 23 amino acid insert in 
the linker region, which is not found in Zap70. A less abundant, alternatively spliced 
form of Syk, SykB, does not contain this insert and is thus more similar to Zap70. 
Experiments have shown functional consequences of this difference. Syk couples the 
FcsRI receptor of mast cells to downstream intracellular signalling pathways much more 
efficiently than SykB (Latour et al., 1998). This difference correlates with a higher 
binding affinity of Syk to phosphorylated ITAMs compared to SykB. According to these 
findings, Zap70, which also lacks the linker region, behaved much more like SykB. It 
was inefficient at coupling FceRI signalling and bound less avidly to phosphorylated 
ITAMs than Syk.
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Figure 1.4. Structure of Syk and Zap70
The tandem SH2 domains are shown as orange cylinders and the kinase domain in 
green. Interdomain A connecting SH2-SH2 is shown in a blue tube, and Interdomain B 
connecting SH2-kinase domain is shown in purple. The tyrosines, which have been 
shown to undergo phosphorylation are indicated. Numbers indicate beginning and ends 
of domains and positions of tyrosine residues. Syk contains a 23 amino acid insert in its 
linker domain, which is missing in Zap70. Figure was adapted from a review (Turner et 
al., 2000).
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Many tyrosines have been shown to undergo phosphorylation and may be important in 
regulation of enzymatic activity or recruitment of other signalling proteins. 
Phosphorylation of Y317, Y342 and Y346 in Syk is dependent on Lyn, whereas 
phosphorylation of Y130, Y519 and Y520 is dependent on Syk itself and thus these may 
be sites of auto-phosphorylation. Tyrosines 518 and 519 were found to be major 
autophosphorylation sites on Syk and in vivo they are important for signal propagation 
(Kurosaki et al., 1995). Since Syk with mutated tyrosines 518 and 519 is still almost 
fully kinase-active, these sites seemed to be more important for protein-protein 
interaction, e.g. Src-family kinase or PLCy2 binding (Couture et al., 1997). Tyrosines 
342 and 346 within the linker region of Syk are important for interaction with Vavl 
(Deckert et al., 1996). The phosphorylation of Y342 and Y346 enhances the 
phosphorylation and activation of PLCy and calcium release. However, phosphorylation 
of Y317 seems to play an inhibitory role, because in cells lacking Lyn, the 
phosphorylation of Y317 is suppressed leading to elevated production of IP3  and 
amplified calcium signal (Hong et al., 2002). Furthermore, Y317 is a putative Cbl 
binding site (Deckert et al., 1998). In addition, phosphorylated Y130 causes 
conformational changes in the inter-SH2 domain, altering both SH2-SH2 interface 
interactions and the interactions between the inter-SH2 region and the kinase active site. 
Phosphorylation of Y130 negatively influences the binding of Syk to the antigen 
receptor and at the same time allows increased access of the catalylic site to protein 
substrates (Keshvara et al., 1997)
Zap70 has homologous tyrosines, although Y290 and Y358 are missing. Among the 
best-studied phosphorylation sites in Zap70 are Y492 and Y493, analogous to Y519 and 
Y520 in Syk. A model has been proposed, whereby Y493 becomes phosphoryated by
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the Src-family PTK Lck. This phosphorylation is then followed by auto-phosphorylation 
at Y492. Y292 in the interdomain B, analogous to Y317 in Syk, is proposed to play a 
negative regulatory function by recruiting the E3 ubiquitin ligase c-Cbl. Y315 and Y319 
have been proposed to be positive regulatory sites and have been demonstrated to be 
phosphorylated upon TCR-crosslinking, either by Zap70 itself or by Lck (Brdicka et al., 
2005).
Several studies suggest that Syk is less dependent upon Src-family kinases for its 
function than Zap70. T cell hybrids expressing a CD16-Zap70 chimeric receptor 
required co-crosslinking of the receptor with Src-family kinases Fyn and Lck to activate 
their cytotoxic potential. By contrast, crosslinking of CD16-Syk alone activated 
cytotoxicity (Kolanus et al., 1993). Furthermore, Jurkat T cells that lack Lck or the 
tyrosine phosphatase CD45, which is implicated in the activation of Lck, show defective 
TCR-induced Zap70 activation and no TCR-induced gene expression (Chu et al., 1996). 
Interestingly, introduction of Syk into either mutant line restores TCR-mediated 
signalling. In a related experiment, Zap70 expressed in COS cells required co-expression 
of Lck or Fyn for optimal activity (Chan et al., 1992). By contrast, Syk was 
phosphorylated when expressed by itself in COS cells, although this phosphorylation 
was strongly enhanced by co-expression of Src-family kinases (Kurosaki et al., 1994). 
Furthermore, expression of Lyn, BCR and Syk in Drosophila S2 Schneider cells 
revealed that Syk can interact with the BCR independently of Lyn (Rolli et al., 2002). 
Taken together, these results suggest that the activation of Zap70 by immune receptors 
requires Src-family PTKs, whereas Syk can function in a Src-family kinase-independent
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manner. This difference might be due to the ability of Syk, but not Zap70, to induce 
phosphorylation of ITAMs independently of Src-family kinases (Zoller et al., 1997).
1.6.2 Syk and Zap70 in afi T  cells
Syk was initially characterized as an abundant PTK in thymus and spleen. During T cell 
development, Syk is expressed by DN and DP thymocytes, but expression levels are 
significantly reduced in CD4+ and CD8 + SP thymocytes and peripheral T cells (Chan et 
al., 1994). By contrast, Zap70 is expressed throughout thymocyte development and at 
high levels in pheripheral T cells (Chan et al., 1994). The different expression profile of 
Syk and Zap70 suggests that these two tyrosine kinases play distinct roles in T cell 
development. In radiation chimeras reconstituted with Syk-deficient fetal liver cells, 
mature CD4+ and CD8 + T cells bearing ap-TCRs develop in normal numbers and 
proliferate normally in vitro to TCR-signals. By contrast, Zap70-deficient mice display 
a profound block in T cell development at the DP to SP thymocyte transition, Zap70 
appears to be necessary for positive and negative selection of T cells (Chan et al., 1994; 
Negishi et al., 1995).
Forced overexpression of Syk in the thymi of Zap7(T'~ mice rescues the block in positive 
selection and restores peripheral T cell numbers to normal levels, showing that 
overexpression of Syk can compensate for the lack of Zap70 in T cell development 
(Gong et al., 1997). However in wild-type mice it appears that only Zap70 transduces 
these positive selection signals because Syk is not expressed at sufficiently high levels 
(Chu et al., 1999).
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Mice deficient for either Syk or Zap70 develop DP thymocytes, however, in mice bred 
to be deficient for both Syk and Zap70, development was arrested at the DN stage 
(Cheng et al., 1997). This suggests that although Syk is not essential for TCR-mediated 
positive selection, it does play a role in pre-TCR signalling during the maturation of DN 
to DP thymocytes.
1.6.3 Syk and Zap70 in yd T cells
Syk-deficient mice do not have a defect in ap  T cell development, but show a deficit in 
specific populations of yb T cells, namely the dendritic epidermal yb T cells of the skin 
and the intraepithelial yb lymphocytes of the intestine (Mallick-Wood et al., 1996; 
Turner et al., 1995). A similar defect in intraepithelial yb lymphocytes development is 
also seen in Zap70-deficient mice (Gong et al., 1997; Kadlecek et al., 1998). Although 
normal numbers of yb T cells are found in the spleen and lymph nodes of Zap70''' mice, 
dendritic epidermal yb T cells are decrease in numbers and show an abnormal 
morphology in these animals. Thus, in certain yb T cell subpopulations, Syk and Zap70 
cannot fully compensate for each other in case of a deficiency of either kinase. Notably, 
expression of a Syk transgene in Zap70-deficient mice did not restore development of 
the intestinal intraepithelial yb T cells (Gong et al., 1997).
1.6.4 Syk and Zap70 in natural killer (NK) cells
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NK cells are BM-derived lymphocytes that do not express rearranged TCRs or BCRs. 
NK cells mediate cytotoxic killing without prior sensitization. Evidence that Syk is not 
required for the differentiation of NK cells comes from studies of R a g l'ly / ' radiation 
chimeras reconstituted with Syk'1' fetal liver. RagT' ly^1' host are completely depleted of 
all mature lymphoid cells, including NK cells, and their progenitors (Colucci et al., 
1999a). Phenotypically mature Syk'1' NK cells develop naturally and demonstrate normal 
natural killing (Colucci et al., 1999b). However, NK cells lacking Syk are partially 
defective in antibody-dependent cell mediated cytotoxicity. In contrast, NK cells from 
Zap7&~ mice kill NK-susceptible targets and demonstrate normal antibody-dependent 
cell mediated cytotoxicity (Negishi et al., 1995). It is likely that Syk and Zap70 are 
functionally redundant in NK cell development and peripheral NK cell function. 
However, in mice deficient in both kinases, NK cells still develop normally and Syk and 
Zap70 seem to be dispensable for natural cytotoxicity, although they seem to be 
essential for triggering NK cells via IT AM-bearing receptors (CD 16 and Ly49D), 
because crosslinking of these receptors in the absence of both kinases leads to decreased 
cytotoxicity (Colucci et al., 2002).
1,6.5 Syk and Zap70 in myeloid cells
Activation of mast cells by antigen-IgE complexes stimulates the release of 
inflammatory mediators in form of secretory granule contents, cytokines and arachidonic 
acid metabolites. The receptor for antigen-IgE complexes, FceRI, contains an IgE 
binding a  subunit complexed with a p chain and a dimer of y chains that each contains
64
an ITAM. The y chain of FceRI (FcRy) binds Syk, whereas the ITAM of the (3 chain 
binds Lyn (Lin et al., 1996). Stimulation of leukotriene production and granule release 
was inhibited in permeabilized rat basophilic leukaemia (RBL-2H3) cells by a mutant 
form of Syk, consisting only of the SH2 domains (Taylor et al., 1995). The development 
of a variant of RBL-2H3 cells lacking Syk further demonstrates that Syk is essential for 
degranulation. In the absence of Syk, the antigen-receptor could not activate PLCy and 
hence intracellular calcium release (Zhang et al., 1996). Studies using murine mast cell 
cultures established from Syk'' fetal livers further demonstrated that degranulation, 
leukotriene production and cytokine release were all dependent on Syk, as was NF-AT 
activation and stimulation of ERK and JNK protein kinase pathways (Costello et al.,
1996).
Syk also associates with the tyrosine phosphorylated FcRy chain of FcyRI and FcyRIII. 
Reconstitution experiments using COS cells indicate that the FcRy chain and Syk are 
essential for FcyR-mediated phagocytosis, because co-transfection of Syk and FcyRI into 
COS cells results in enhanced phagocytosis (Indik et al., 1995). Furthermore, clustering 
of a Syk-FcyRIII fusion protein in COS cells leads to phagocytosis that is abrogated by a 
point mutation in the kinase domain of Syk (Greenberg et al., 1996). In addition to these 
findings, macrophages cultured from Syk1' fetal liver are defective in their ability to 
phagocytose antibody-coated sheep red blood cells, but retain the ability to phagocytose 
latex beads, bacteria and complement-coated zymosan (Kiefer et al., 1998).
Syk is also an essential component of integrin signalling in neutrophils. It has been 
reported that Syk1' neutrophils fail to undergo respiratory burst, degranulation, or 
spreading in response to pro-inflammatory stimuli while adherent to immobilised
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ligands or when stimulated by direct crosslinking of integrins (Mocsai et al., 2002). 
Furthermore, signalling from the p i, p2 and p3 integrins, which leads to activation of 
neutrophil effector functions, is also defective in Syk'1' neutrophils.
Syk is also involved in differentiation and function of osteoclasts. When cultured in the 
presence of receptor activator of NF-KB-ligand (RANK-L), a tumor necrosis factor- 
related cytokine, wild-type bone marrow cells form large multi-nucleated osteoclasts, 
which are able to resorb bone in vitro (Teitelbaum, 2000). However, Syk'1' osteoclasts do 
not go through such a morphological differentiation and they also fail to resorb bone 
(Mocsai et al., 2004).
Furthermore, Syk is required for monocyte/macrophage chemotaxis to CX3CL1, which 
is the only member of the 6/CX3C subclass of chemokines. It has been reported that 
treatment of monocyte/macrophage RAW cell line with CX3CL1 elicits a rapid and 
transient increase in F-actin and the formation of F-actin-enriched cell protrusions 
(Gevrey et al., 2005). CX3CL1 also triggers tyrosine phosphorylation of proteins 
localised in this protrusion. Syk is activated upon CX3CL1 treatment, and reduction of 
Syk expression using RNA-mediated interference results in an impairment of RAW cell 
migration to CX3CL1 (Gevrey et al., 2005). In contrast, Zap70 was not found to be 
expressed in myeloid cells.
1.6.6 Syk and Zap70 in platelets
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Analysis of Syk'1' platelets has allowed a direct assessment of the role of Syk in 
signalling from a variety of receptors. Signalling through GPVI collagen receptor was 
shown to require Syk, because Syk'1' platelets fail to respond to collagen (Poole et al.,
1997). In contrast, signalling by the thrombin receptor, a G-protein coupled receptor, 
appears to be intact in Syk'1' platelets. The absence of Syk had no effect on fibrinogen- 
induced signalling from the integrin a IIbp3  (Law et al., 1999).
The most striking feature of Syk deficiency in mice was the lethal phenotype associated 
with petechiae, diffuse haemorrhage and chylous ascites (Cheng et al., 1995; Turner et 
al., 1995). Interestingly, the bleeding phenotype is transferable when Syk-deficient bone 
marrow is transplanted into wild-type mice suggesting that it is due to a defect in 
haematopoietic cells (Poole et al., 1997). The haemorrhagic diathesis could be a 
consequence of platelet dysfunction, but classical tests of platelet function such as 
bleeding time are normal in radiation chimeras reconstituted with Syk'1' platelets and 
mice deficient for platelets do not show this fetal haemorrhaging (Poole et al., 1997). 
More recently the reason for the haemorrhaging phenotype in Syk'1' embryos was found 
to be a failure to separate emerging lymphatic vessels from blood vessels (Abtahian et 
al., 2003).
1.6.7 Syk and Zap70 in B cell development
Radiation chimeras reconstituted with Syk'1' fetal liver show a partial block in B cell 
development at the pro-B to pre-B cell transition. A few immature B cells develop, but 
there is a second complete block at the immature to mature B cell transition. In contrast,
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Zap7&' mice develop mature B cells (Negishi et al., 1995). Although a very small 
number of bone marrow-derived immature Syk'1' B cells migrate to the red pulp and the 
outer T zone of the spleen, they fail to enter B cell follicles (Turner et al., 1997). 
Furthermore, they are completely blocked in their ability to mature into MRF B cells. 
Reconstituting radiation chimeras with Syk'1' fetal liver containing a 3-83p 6  BCR 
transgene, revealed that B cell development was also completely blocked at the 
immature B cell stage suggesting that this defect is due to the role of Syk in the B cells 
themselves. However, radiation chimeras reconstituted with Syk'1' fetal liver containing a 
3-83p6 BCR transgene on a deleting background showed that Syk-deficient and Syk- 
sufficient chimeras had very few 3-83+ B cells in the bone marrow and no 3-83+ B cells 
in the spleen or lymph nodes, indicating that negative selection proceeds even in the 
absence of Syk (Meade et al., 2004).
Radiation chimeras reconstituted with Syk'l'Zap70rl' fetal liver show a complete block of 
B cell development at the pro-B to pre-B cell transition, indicating that Zap70 plays a 
role in B cell development at this first checkpoint (Schweighoffer et al., 2003). In 
addition, radiation chimeras reconstituted with Syk'l'Zap70'1' fetal liver containing a 3- 
83p6 BCR transgene, demonstrated that in the absence of both kinases, B lineage cells 
do not shut off heavy chain rearrangement despite the presence of a rearranged BCR, 
resulting in the generation of cells expressing two different functional heavy chains, thus 
revealing a failure of heavy chain exclusion (Schweighoffer et al., 2003). Furthermore, 
chimeras reconstituted with Syk'1' fetal liver containing a 3-83p6 BCR transgene showed 
low levels of endogenous heavy chain rearrangement and therefore a partial failure of 
allelic exclusion. This finding revealed that Syk and Zap70 play a role in heavy chain
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allelic exclusion. In addition, Syk is also necessary for light chain allelic exclusion, as in 
radiation chimeras reconstituted with Syk'1' fetal liver containing a 3-83^6 BCR 
transgene on a deleting and non-deleting background the frequency of X-expressing cells 
was dramatically increased when Bcl-2 was overexpressed (Meade et al., 2004). 
Furthermore, Zap70 expression was shown in pro-B cells, pre-B cells and splenic B cells 
in the mouse. Zap70 was also reported to be expressed in splenic and tosillar human B 
cells, and it was found to be phosphorylated upon BCR stimulation (Nolz et al., 2005).
1.6.8 Zap70 in B cell chronic lymphocytic leukaemia (B-CLL)
Zap70 is also expressed in some B-CLL. B-CLL cells can be segregated into two major 
subsets based upon the mutational status of the expressed IgH chain variable region 
(IgVH) (Chen et al., 2005; Chen et al., 2002; Fais et al., 1998; Hamblin et al., 1999). 
Patients with B-CLL cells that have unmutated IgVH tend to have a relatively aggressive 
clinical course. Patients rapidly need intensive treatment and their median survival after 
diagnosis ranges between 79 and 119 months (Wiestner et al., 2003). On the other hand, 
patients, who have B-CLL cells that have rearranged IgVH genes with somatic mutations 
have a less aggressive disease. Patients might not need therapeutic interventions at all 
and their median survival after diagnosis reaches 293 months (Oscier et al., 2002; 
Wiestner et al., 2003). Microarray-based gene expression analysis has shown that Zap70 
is the gene whose expression best distinguishes the B-CLL subtypes. Zap70 expression 
was 5.54-fold higher in unmutated IgVH B-CLL cells than in mutated IgVH B-CLL cells 
and distinguishes the subtypes with a statistical significance of P e l O' 2 1  (Wiestner et al.,
2003). The existence of these B-CLL subsets, differing in whether or not their IgVH 
genes are mutated and in the expression of Zap70, suggests that the may have different 
origins. B-CLL cells expressing unmutated IgVH genes may originiate from antigen- 
inexperienced B cells, whereas B-CLL cells expressing mutated IgVH genes may come 
from antigen-experienced B cells. Furthermore, it is interesting that unmutated IgVH B- 
CLL cells show a higher degree of tyrosine phosphorylation than IgVH B-CLL cells, and 
Zap70 can associate with the BCR in unmutated IgVH B-CLL cells (Chen et al., 2005; 
Chen et al., 2002). Further work will be needed to define the functional role of Zap70 in 
B-CLL in vivo.
70
1,7 Aims o f the work in this thesis
I wanted to further understand the role of Syk-family of PTKs in B cell development and 
function. It has been shown that Zap70 is expressed in B cells, and not only in T cells 
and NK cells. I wanted to investigate whether Zap70 is expressed differentially in 
distinct developing and mature B cell subsets and to study the role of Zap70 in B cell 
development, by analysing B cell populations in the lymphoid organs in Zap7&' mice. 
In addition, I analysed B cell function, by investigating whether Zap70r'' B cells were 
able to mount TD- and Tl-immune responses and whether BCR-induced calcium release 
was normal in Zap70r'~ B cell subsets. Furthermore, I wanted to explore whether Zap70 
and Syk perform similarly during B cell development or whether these two kinases have 
distinct functions, by overexpressing Zap70 in Syk'1' fetal liver cells to see whether they 
were able to develop into mature B cells. Finally, I was interested in the role of Syk in 
mature B cell development and tried to establish a model, with an inducible form of Syk 
that would allow this question to be addressed.
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2. Materials and Methods
2.1 Solutions and media 
TE
ACK lysis buffer
FACS buffer 
For Western blotting:
4 x Lower Tris Buffer 
4 x Upper Tris Buffer 
10 x Running Buffer 
2 xRSB
1 0  % polyacrylamide gel
Stacking gel
CAPS buffer 
Stripping buffer
10 mM Tris-HCl, pH 7.4,1 mM EDTA, pH 8.0 
0.15 M NH4 C1,1 mM KHCO3 , 0.1 mM Na^DTA, 
pH 7.2-7.4
PBS, 0.1 % Sodium Azide, 0.5 % BSA
1.5 M Tris-HCl, 0.4 % SDS, pH 8 . 8  
0.5 M Tris-HCl, 0.4 % SDS, pH 6 . 8
3.03 M Tris-HCl, 1 % SDS, 14.42 % Glycine, pH 8.3 
20 % glycerol, 6  % SDS, lx Upper Tris Buffer, 
0.005% bromophenol blue 
10 % Acrylamide/Bis-acrylamide, lx Lower Tris 
Buffer, 0.033 % ammonium-persulphate, 0.066 % 
TEMED
3.75 % Acrylamide/Bis-acrylamide, lx Upper Tris 
Buffer, 0.05 % ammonium-persulphate, 0.1 % 
TEMED
2.21 % CAPS (3-[cyclohexylamino]-l- 
propanesulphonic acid) in H2 0 , pH 11.0
62.5 mM Tris.Cl, pH 6.7, lOOmM 2-mercaptoethanol,
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Blot wash, ELISA wash 
For Southern blotting:
50 x TAE 
20 x SSC
Denaturing Solution 
Pre/Hybridization solution
DT40 medium
PlatE / HSC medium
Lockes Buffer
NP40-solution 
ELISA 
coating buffer 
blocking buffer
2 % SDS
0.05% Tween-20 in PBS
40 mM Tris-acetate, 2 mM Na2 EDTA.2H20
3 M NaCl, 0.3 M Na3 citrate.2H2 0 , pH 7.0
0.5 M NaOH, 1.5 M NaCl
0.2 M NaP04, 1 mM EDTA, 1 % BSA, 7 % SDS,
15 % formamide
RPMI-1640 (Sigma), 10% heat inactivated FCS,
2% heat inactivated chicken serum, 100 U/ml 
Penicillin, 0.1 mg/ml Streptomycin, 2mM glutamine, 
50p,M 2-Mercaptoethanol 
DMEM (Life Technology), 10% FCS, lOOU/ml 
Penicillin, 0.1 mg/ml Streptomycin, lx non-essential 
amino acids, 5//g/ml Glutamine, 2mM glutamine, 50pM 
2-Mercaptoethanol
1.54M NaCl, 56mM KC1, 22mM CaCl2, lOmM MgCl2, 
60mM NaHC03, lOOmM Glucose, 20mM HEPES; 
pH7.4
1% NP-40,150mM NaCl, 50mM Tris
50mM NaHC03  
PBS, 3 % BSA
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ABTS substrate 0.3mg/ml ABTS in 0.1M citric acid, pH 4.35
2.2 Antibodies
Company
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Becton-Dickinson
Antibody Clone/Cat.Number
B220-CyChr RA3-6B2
CD4-PerCP L3T4, RM4-5
CD8 -PerCP Ly-2, 53-67
TCR-PE H57-597
IgM-APC 11/41
IgD-FITC 11-26
CD2-PE RM2-5
Ly5.1/CD45.1-bio A20
Ly5.2/CD45.2-bio 104
Ly9.1 /CD229.1 -bio 30C7
Streptavidin-PerCP 554064
Streptavidin-PE 554061
huCD2-PE 555325
CD23-FITC B3B4
CD21-PE 7G6
Terl 19-bio Ly-76
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Becton-Dickinson CD5-HTC 53-7.3
Caltag B220-APC RA3-6B2
Caltag CD 19-Tricolour RM7706
Caltag CD4-PETR MCD0417
Caltag B220-PETR RM2617
eBiosciences Macl/CDl lb-bio MI/70
eBiosciences AA4.1-APC AA4.1
eBiosciences Zap70-PE 1E7.2
Stratech IgM-F(ab’)2-FITC
Stratech F(ab’ ) 2  fragment Goat a-mouse IgM 115-006-075
Stratech Goat anti-mouse IgG+IgM (H+L) 115-005-044
Transduction Lab. Zap70 Z24820
DAKO rabbit-a-mouse-Ig-HRP PO260
Amersham Biosciences Protein-A-HRP NA9120V
For ELISA:
SouthemBiotech Mouse Standard Panel kit 5300-01
SouthemBiotech Clonotyping System-HRP-kit 5300-05
24G2, anti-FcR hybridoma was a gift from G.Stockinger.
M4, mouse anti-chicken IgM was a gift from T.Kurosaki.
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2.3 Mice
Transgenic and gene targeted mutant mice were bred and maintained in the animal 
facilities of the National Institute for Medical Research according to Home Office 
regulations. Syk-mutant mice (SyktmlTyb/tmlTyb) were generated in our laboratory (Turner et 
al., 1995), Rag-1 knock-out mice were provided by D. Baltimore (Spanopoulou et al., 
1994), Zap7&~ mice by Art Weiss (Kadlecek et al., 1998), TCRa';‘ mice (Mombaerts et 
al., 1992) by Gitta Stockinger and p M l  mice (Kitamura et al., 1991) by Jean Langhome. 
129/Sv, B10.D2/O, BALB/c, C57BL/10, C57BL/6J, C57BL/6SJL-Ly5.1 and CBA/Ca 
were provided by the SPF (specific pathogen free) facility of the Institute.
2.4 Cloning pApuro-N-ERT2
First a BamHI site was introduced into Syk between amino acids 8  and 9 using 
polymerase chain reaction (PCR). The primers used for this purpose were:
1. CCCAAGCTTGAATTCAGGAAGGTACTTCTCCAT
2. CGCGGATCCGCTGTCCACAGCACTTC
3. CGCGGATCCGCCAACCACCTGACCTAC
4. TCCCCGCGGCTCAAAGGGTCCGGTCTT
Fragment 1 (using primers 1+2) and fragment 2 (using primers 3+4) were cloned into 
pBluescriptll SK+/- (Stratagene) as an intermediate vector. Syk with introduced BamHI 
site (Syk-BamHI) was cloned back into pcDNA.
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The ERT 2  was PCR-amplified from pCre-ERT 2  (gift from P. Chambon) with flanking 
BamHI -sites using the following primer combinations:
1. CGCGGATCCTCTGCTGGAGACATGAG
2. CGCGGATCCAGCTGTGGCAGGGAAAC
The new ERT2-BamHI was introduced into the N-terminus of Syk using BamHI-digest. 
Syk-N-ERT 2  was then cloned into the pApuro-vector.
2.5 Statistical analysis
All statistical analyses were carried out using the non-parametric two-tailed Mann- 
Whitney test, with levels of statistical significance as indicated.
2.6 Calcium Fluorimetry
DT40 cells (107  cells/ml) were loaded with Indo-1 acetoxymethylester (4pM: Molecular 
Probes) in RPMI-1640 containing 0.5% bovine serum albumin (BSA) at 37°C for 30 
min in the dark. Cells were then washed twice in Lockes Buffer supplemented with 
0.05% BSA. The fluorescence ratio of Indo-1 emission at 405 nm and 485 nm was 
measured in live cells on a BD-LSR flow-cytometer. M4 antibody was added to 
crosslink the BCR. The ratio of fluorescence at 405nm to 485nm was used as a measure 
of intracellular calcium concentration.
Splenocytes and peritoneal cells were cell surface stained as described and then 106  
cells/ml loaded with 4piM Indo-1 AM as above. Cells were washed with RPMI-1640
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containing 0.5% BSA and fluorescence detected as above. B cells were stimulated with 
F(ab’ ) 2  fragment Goat a-mouse IgM using 0.5//g, I pig or 2.5 pig of antibody per 106  cells.
2.7 DNA precipitation
DNA to be electroporated was precipitated by adding 2.5 volumes of 100% Ethanol and 
1/10 volume NaAc (3M, pH 4.6), kept at -70°C for 1 hr and centrifuged for 30 min at 
13000 rpm. The pellet was then washed with 70% Ethanol and re-centrifuged. The 
supernatant was removed in a laminar flow hood and the pellet was left to air dry, before 
resuspending the DNA in sterile-filtered TE at a final concentration of lpg/pl.
2.8 Electroporation ofDT40 cells
Wild-type and Syk'1'  DT40 cells were cultured in DT40 medium. Prior to 
electroporation, cells were harvested and washed twice in serum-free RPMI-1640. Cells 
were resuspended in serum-free RPMI-1640 at 8xl0 7  cells/ml and 450p,l of the cell 
suspension was used for each electroporation in an elelectroporation cuvette (0.4cm, 
BioRad). Plasmid DNA was precipitated (as described above). 10pg DNA/450pl cells 
were used for each electroporation.
Electroporation was carried out in a BioRad Gene Pulser at 350V, 500pF. Cells were 
then let stand at room temperature for 5-10 min, before reculturing them in flasks 
containing 20ml DT40 media. Puromycin (0.5pg/ml) was added to each flask 24 hr later.
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Two days later no live cells were found in the mock-transfected (no DNA) cultures (data 
not shown). To obtain stably transfected clones, cells were plated out on 96-well plates 
in limiting dilutions (20000 -  10000 -  5000 -  1000 cells/well).
2.9 Purification ofM 4 monoclonal antibody
Supernatant of M4 hybridoma (from T. Kurosaki) was harvested and precipitated 
overnight by dialysing against water. The precipitate was resuspended in PBS and 
protein concentration was determined by measuring optical density at 280nm on a 
spectrophotometer.
2.10 Western Blotting
Cytoplasmic lysates were prepared using Triton Lysis Buffer (NEB), mixed with equal 
amounts of 2xRSB (reducing sample buffer) and denatured at 100°C for 5 min. Samples 
were loaded onto a 10% polyacrylamide gel, then transferred onto a PVDF membrane 
by electroblotting in CAPS solution. Blots were blocked in 10% dry milk in PBS/Tween 
overnight or for at least 1 hr, incubated in the primary antibody (in PBS/Azide/Milk) for 
1  hr, washed extensively, incubated with the secondary antibody for 1  hr and washed 
again. Signal was revealed by ECL (Amersham) using Kodak XB200 film.
Before reprobing blots, they were stripped for 20 min at 55°C in Western Stripping 
Buffer, washed extensively and blocked again.
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2.11 Southern Blotting
Genomic DNA was prepared from 129/Sv or C57BL/6J tails. Tails were incubated 
overnight in 500/d tail-lysis buffer containing O.lmg/ml Proteinase K (Boehringer 
Mannheim) in a water-bath at 55°C. Next day tubes were spun down for 20 min at 
13000 rpm and supernatant transferred to fresh tubes. Genomic DNA was precipitated, 
by adding 0.7 volume isopropanol, then centrifuged 30 min at 13000rpm. The pellet was 
washed in 70% Ethanol, air-dried and resuspended in appropriate amounts of TE. 
Genomic DNA was digested overnight with the appropriate restriction enzymes. Digests 
were separated on a 0.8% agarose gel overnight. Gel was then denatured, using lx 
Denaturing solution and DNA transferred onto Hybond N+ nylon membrane 
(Amersham) via capillary action in 20xSSC. DNA was fixed onto the membrane with 
0.4M NaOH. Probes were labelled with 3 2 P-CTP using the Ready-To-Go DNA Labelling 
Beads (Amersham) according to the manufacturer’s instructions.
Hybridization was carried out at 65 °C for 16 hr. Blots were washed in 2xSSC/0.5%SDS 
twice for 20min, then in 0.1xSSC/0.5%SDS twice for 20 min. Blots were placed into 
phosphoimager cassettes and scanned 1 to 3 days later. Alternatively, blots were placed 
into autoradiograph cassettes with Kodak Xomat AR films. Films were developed 2 to 3 
days later.
2.12 Flow cytometric analysis and sorting
a.) Bone marrow, spleenJvmph nodes, peritoneal cavity and thymus
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Bone marrow (BM) cells were obtained by flushing out cells from femur and tibia of 
both legs. Spleens, lymph nodes and thymi were pressed through a 75/mi nylon mesh to 
obtain cell suspensions. Peritoneal cells were obtained by washing the peritoneum with 
5ml of PBS, 5 mM EDTA using a 27G needle to introduce and a 19G needle to recover 
injected medium. Cell suspensions from BM and spleen were spun down and 
resuspended in 1ml ACK lysis buffer to lyse red blood cells. 1 to 2 min later, when 
hemolysis was visible, cells were washed in FACS-buffer. 106  cells were stained in 50/d 
FACS-buffer, containing the appropriate, pre-titered antibodies. To avoid non-specific 
binding through Fc receptors, cells were pre-treated with 24G2 antibody, before adding 
specific antibodies. Flow cytometric analysis was done on FacsCalibur (BD) or on BD- 
LSR flow-cytometer and sorting on MoFlo (Cytomation), and data was analysed using 
Flowjo (Treestar) software.
b.) Blood
Peripheral blood was collected using heparinized capillaries. Blood was treated with 
24G2 for 5 min before FACS-buffer containing the appropriate antibodies was added 
and incubated for 20 min on ice. Then 1ml ACK lysis buffer was added to lyse red blood 
cells. After 2 min (hemolysis visible) cells were washed with FACS buffer and analysed 
on FacsCalibur (Becton Dickinson).
2.13 Intracellular Zap70 staining
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Surface staining of samples was carried out as described above. After two washes in 
PBS, cells were fixed in 3% paraformaldehyde on ice for 20 min. Samples were washed 
twice with PBS, then autofluorescence from paraformaldehyde was quenched by 
incubation with 50mM NH4 C1. After another wash with PBS, cells were permeabilised 
using 0.1% NP-40 solution for 3 min, followed by a wash with PBS. Cells were then 
stained with Zap70 in FACS-buffer over night, then washed and analysed on the 
FacsCalibur (BD).
2.14 Harvesting and freezing fetal livers
Timed matings were set up, and vaginal plugs checked every morning. The day the plug 
is found is considered day 0.5. Embryos were sacrificed at day 12.5 or 16.5 of gestation, 
fetal liver was removed, made into cell suspension in RPMI medium, using 70/mi cell 
strainer (Falcon), and spun down for 5 min at 1400 rpm. Cells were frozen at -70°C in 
900 ]A FCS and 100 ji\ DMSO per liver.
2.15 Infection o f fetal liver cells
Frozen fetal liver (from embryos at E15.5) was thawed, washed once and cultured 
overnight in PlatE/HSC medium containing 6  pi g/m\ IL-3, 10 pig/ml IL-6 , 100 pig/m\ 
Stem cell factor (SCF), 100 piglml trombopoietin (TPO) and 20 pig/ml Flt3L. Cells were 
infected (see below) twice in the next two days, as described below.
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2.16 Generation o f infectious retrovirus
The day before transfection, PlatE cells (packaging cell line) were split and plated out on 
6 -well plates (2xl0 5 /well). The following day, the cells were transfected using 6 /d 
Genejuice (Novagen) and 2pig DNA/well according to the Manufacturer’s protocol. The 
vector used for the transfections was pMSCV-IREShuCD2 or pMSCV-IRES-GFP (a gift 
from Owen Williams). 48 -  72 hr later, retroviral supernatant was harvested and filtered 
through a 0.45/<m filter unit to remove all cells. Retrovirus was concentrated by 
centrifugation for 1 hr at 13000 rpm at 4°C in a microcentrifuge and resuspension of the 
pellet in a smaller volume of PlatE / HSC-medium.
2.17 Retroviral infection o f fetal liver cells
48 or 96-well plates were coated with Retronectin (recombinant human fibronectin 
fragment, Takara Bio Ing.; 25//g/ml) and incubated for 2 hr at room temperature. 
Retronectin was then removed, plates were blocked in PBS containing 2% BSA and 
washed with PBS before aliquoting the concentrated viral supernatant into each 
Retronectin-coated well. Cultured fetal liver cells were harvested and added to wells and 
incubated overnight at 37°C. Infection procedure was repeated the next day and cells 
were injected the day after that.
2.18 Infection o f 3T3 cells fo r  viral titre determination
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3T3 cells were split the day before infection (2xl05  cells/well) and plated out on 6 -well 
plates. Next day, medium was removed and 1 ml medium containing polybrene (8 /^g/ml) 
and different dilutions of the concentrated viral supernatant ( 1 : 1 0 0  or 1 :2 0 0 ) was added. 
Cells were incubated at 37°C for 3 hr, before adding an additional 1 ml of PlatE / HSC- 
medium. Cells were then incubated overnight. 3T3 cells were analysed the next day for 
surface expression of either GFP or huCD2 using flow cytometry and viral titres were 
calculated as follows: %huCD27100 x number of cells plated x dilution factor.
2.19 Generation o f Radiation Chimeras
On the day of the transfer, recipient mice received two doses of 475 rad (4.75 Gy) total 
body irradiation from a 137Caesium Source, administered 3 hr apart to minimise 
gastrointestinal tract damage. Donor fetal liver (infected or uninfected) or BM cells were 
washed twice in serum-free medium and filtered through a 75/«n nylon mesh before 
injecting cells in 0.2 ml volume intravenously (tail-vein) into irradiated recipients. Mice 
were treated with 0.16% Neomycin-sulphate (Sigma) in their drinking water for at least 4 
weeks post-transfer. Mice were analyzed 8-12 weeks after the transfer.
2.20 Immunisations
6 - 8  weeks old wt/^iMT or Zap70 ' /\iMT chimeras were injected intraperitoneally with 
TNP-KLH (100^g/mouse) in endotoxin-free PBS, TNP-Ficoll (25/fg/mouse) or TNP- 
LPS (50/^g/mouse). Mice were bled one day before immunisation (day -1), at day 7 and
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day 14 after immunisations. Mice immunised with TNP-KLH were re-immunised at day 
2 1  and bled at day 28.
2.21 Serum
Peripheral blood was collected without the use of heparin and left for 10-20 min before 
spinning it down for 10 min at 13000 rpm. Serum was collected and respun. Serum was 
collected and immediately frozen at -70°C.
2.22 ELISA
Flat-bottom 96-well plates were coated with 50/d of either AffiniPure goat anti-mouse 
IgG+IgM (H+L) in coating buffer (10/ig/ml) for the standard curves or with TNP-BSA 
(Biosearch Technmologies Inc.) (33.3/ig/ml) in coating buffer. Plates were incubated 
overnight in a humid chamber at 4°C. 96-well plates were washed 2 x with ELISA-wash 
and then blocked in 200/d/well Blocking Buffer. Plates were incubated at room 
temperature for at least 2 hours, then washed twice with ELISA-wash. 40/d of Standards 
(Mouse Standard Panel) was added to the standard wells (in a 2-fold dilution series from 
a concentration of lOOOng/well to 15.6ng/well) or 40/d of Serum-dilutions (1:100,1:200, 
1:500) was added to wells coated with TNP-BSA. Triplicates were prepared for each 
serum-dilution and Standards. Plates were incubated for 2 hours at room temperature and 
then washed twice with ELISA-wash. 40/d of HRP-conjugated secondary antibody 
(Clonotyping System-HRP) in a 1:500 dilution was added to the wells. Plates were
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incubated for 1 hour at room temperature and washed twice with ELISA-wash. Then 
40/d of ABTS, 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid), substrate was added 
to the wells. Plates were incubated for 10-20 min at room temperature in the dark, until 
the green colour developed. Finally, plates were read at X = 405 on a 96-well-plale multi- 
scanEX.
2.23 Screening mouse genomic RPCI21-PAC Library
The mouse PAC library (RPCI21, UK HGMP Resource Centre) was provided by S. Ley. 
The source is female 129/SvevTACfBr mouse spleen genomic DNA. The library 
consists of 128 000 PAC clones in 336 microtiter plates. The average insert size is 147 
kb. The library has been gridded in a 4x4 array on 22.2x22.2 cm Hybond N Nylon 
membrane. Each clone has been spotted twice. 7 filters cover the whole library.
7 filters were put into 2 hybridization tubes with meshes in between each filter. 100ml 
pre-hybridization buffer was added to each tube and they were incubated at 65°C for 4 
hr, before the probe was added and incubated overnight at 65°C.
The probe is a 457 bp fragment of murine Syk gene, containing 275 bp of exon 2 
obtained by cutting pcDNA3SyMUTR with EcoRI and Xcml and gel purified using 
Qiagen gel purifying kit. Probe was labelled with 3 2 P-CTP using the Ready-To-Go DNA 
Labelling Beads (Amersham) according to the manufacturer’s instructions.
Filters were washed in 2xSSC, 0.5%SDS twice for 20 min, then in O.lxSSC, 0.5%SDS 
twice for 20 min. Then they were placed into autoradiograph cassettes with Kodak 
Xomat AR films. Films were developed the next day.
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6  clones were identified (clone number: 539-K16, 560-L2, 401-L23, 501-N5, 452-H12 
and 473-H3) and ordered from UK HGMP Resource Centre.
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3. Role of Zap70 in B cells
In the absence of Syk, B cell development is partially blocked at the pro-B to pre-B cell 
transition. A few immature B cells develop, however there is a complete block at the 
immature to mature B cell transition (Turner et al., 1995). The partial block in B cell 
development at the pre-BCR checkpoint suggested the possibility of functional 
redundancy with another kinase substituting for Syk. The only other known Syk-family 
kinase is Zap70, which was reported to be expressed exclusively in T cells and NK cells, 
but not in B cells. However, in the absence of both kinases, Syk and Zap70, B cell 
development was found to be completely blocked at the pro-B to pre-B cell transition, 
confirming that in the absence of Syk, Zap70 indeed plays a compensatory role at the 
pre-BCR checkpoint (Schweighoffer et al., 2003). Zap70 has been reported to be 
expressed in pro-B cells, pre-B cells and splenic B cells in the mouse (Schweighoffer et 
al., 2003). Zap70 expression was also seen in human splenic and tonsillar B 
lymphocytes (Nolz et al., 2005). Furthermore, in tonsillar B cells, Zap70 was shown to 
be phosphorylated upon BCR stimulation.
Interestingly, Zap70 is also expressed in some B-CLL, where it could be used as a 
marker for the aggressive disease. However, the role of Zap70 in B-CLL is not clear.
All these findings clearly indicate that Zap70 is not only expressed in T cells and NK 
cells, but also in B lineage cells. Furthermore, Zap70 appears to compensate for the lack 
of Syk at the pro-B to pre-B cell transition and hence may transduce signals from the 
pre-BCR (Schweighoffer et al., 2003). However it remains unknown whether Zap70
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may have a function at other points during B cell development or activation, other than 
the pre-BCR checkpoint.
3.1 Zap70 expression in different B cell populations
Zap70 expression has previously been shown in pro-B, pre-B and splenic B cells in the 
mouse (Schweighoffer et al., 2003) and recently also shown in human tonsillar and 
splenic B cells (Nolz et al., 2005). I wanted to find out whether all mature B cell 
populations expressed Zap70 and whether there were any subsets of B cells, which 
expressed higher levels of Zap70 than others.
My first choice of method was detecting Zap70 expression in different mature B cell 
subsets by intracellular staining and flow cytometry. I optimised the conditions for 
intracellular Zap70 staining using thymocytes, which express high levels of Zap70 
(Fig.3.1). The histogram in Fig.3.1c shows intracellular Zap70 expression of CD4+CD8+- 
thymocytes of radiation chimeras reconstituted with wt or Syk'1' fetal liver or of a 
Zap70f'' mouse as a control. Zap70 expression levels in wt and Syk'1' DP thymocytes 
were easily distinguishable compared to Zap7d'' DP thymocytes. A radiation chimera 
reconstituted with Syk'1' fetal liver was included in the analysis as a control for the 
Zap70-specificity of the intracellular antibody used. I conclude that this staining method 
can clearly detect Zap70 and that the antibody does not detect the related Syk kinase.
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Figure 3.1. Zap70 expression in DP thymocytes
A) Flow cytometry analysis of CD4 and CD8 levels on thymocytes from radiation 
chimeras reconstituted with wild-type (wt) or Syk'1' fetal liver or from a Zap70'' 
mouse. Percentage of cells falling into a CD4+CD8+ gate are indicated.
B) Histogram of Zap70 expression in CD4+CD8+ thymocytes, gated as in (A), from 
wild-type (blue), Syk'1' (red) or Zap70'' mice (green).
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Next I attempted to measure Zap70 expression levels in B cell subsets in the bone 
marrow using intracellular flow cytometry (Fig. 3.2). Bone marrow cells were stained to 
identify pro-B cells (CD19+CD2IgM), pre-B cells (CD19+CD2+IgM) and 
immature/mature B cells (CD19+CD2+IgM+) and stained for intracellular Zap70 using 
the same method that had been optimised for thymocytes. Whereas Zap70 expression 
was readily detected in thymocytes, no Zap70 expression was detectable in pro-B, pre-B 
or immature/mature B cells.
In conclusion, Zap70 expression could not be detected in B lineage cells in the bone 
marrow using intracellular staining methods and flow cytometry. The same result was 
achieved in B lineage cells from the spleen and peritoneal cavity (data not shown). 
Because Zap70 expression levels appear to be much lower in B cells compared to T 
cells, it is likely that this method was not sensitive enough to detect Zap70 in B lineage 
cells.
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Figure 3.2. Zap70 expression in bone marrow B cells.
A) Flow cytometric analysis of CD2 and IgM levels on CD19+ cells from the bone 
marrow of radiation chimeras reconstituted with wild-type (wt) or Syk'1' fetal liver or 
from the bone marrow of Zap70'~ mice. Numbers show percentages of cells falling 
into the indicated gates.
B) Histogram s of Zap70 expression in pro-B (CD19+CD 2IgM ), pre-B 
(CD19+CD2+IgM) and immature/mature B cells (CD19+CD2+IgM+) from the bone 
marrow of radiation chimeras reconstituted with wild-type fetal liver (blue), Syk'1' 
fetal liver (red) or from a Zap7&' mouse (green). Each set of histograms was gated 
on gates shown in (A).
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Next I examined Zap70 expression in B lineage cells using immunoblotting. I could 
indeed detect Zap70 in cytoplasmic lysates from sorted Zap7(tl+ splenic B cells (CD19+) 
(Fig.3.3a). In contrast, no Zap70 was found in sorted Zap7&' splenic B cells, confirming 
that the antibody used was specific for Zap70.
I then examined Zap70 expression in cytoplasmic lysates of different B cell subsets in 
the spleen. Zap70 could be detected in sorted MRF B cells (CD19+CD21+CD23+), MZ B 
cells (CD 19+CD21 hiCD23 ) and also in NF B cells (CD19+CD21CD23 ) (Fig. 3.3b). 
Zap70 expression could also be detected in cytoplasmic lysates from sorted B la and Bib 
cells, which are the major B cell populations of the peritoneal cavity (Fig. 3.3c). All 
populations were sorted to 98-99% purity (data not shown).
To quantify Zap70 expression during B cell development from the bone marrow to the 
spleen and compare it to levels in thymocytes, I sorted pro-B (CD19+CD2'IgM ) cells 
from C57BL/10-/tog7'A bone marrow, pre-B cells (CD19+CD2+IgM ) from bone marrow 
of C57BL/10-Rag/7' mice containing a heavy chain transgene, and immature 
(CD19+IgMTgD') and mature B cells (CD19+IgMTgD+) from bone marrow of 
C57BL/6J mice. MRF (CD19+CD21'CD23+) B cells were sorted from the spleen of 
C57BL/6J mice. The same B cell populations were also sorted from Zap7&' mice as a 
control for staining specificity. All B cell populations were sorted to a purity of 98-99% 
(data not shown). Unfortunately, I was unable to sort sufficient numbers of MZ and NF 
B cells in this particular experiment to include these populations in the analysis.
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Figure 3.3. Zap70 expression in mature B cell subsets
A) Immunoblot of total cytoplasmic lysates wt splenocytes and of sorted CD19+ 
splenocytes from wt or Zap70~!~ mice, probed with antibodies to Zap70. Arrow 
points to Zap70. The upper band is non-specific since it is seen in Zap70~'~ cells.
B) Immunoblot of total cell lysates of total wt splenocytes and sorted wt mature B cell 
populations in the spleen: MZ, marginal zone B cells (CD19+CD23 CD21hl), MF, 
mature recirculating follicular B cells (CD19+CD23+CD21+), NF, newly formed B 
cells (CD19+CD23 CD21) probed with antibodies to Zap70.
C) Immunoblot of total cell lysates of wt thymocytes or sorted wt B1 B cells from the 
peritoneal cavity: B la cells (CD19+M acl+CD5+) and B ib  cells (CD19+M acl+CD 5) 
probed with antibodies to Zap70.
Cell numbers loaded are indicated in parenthesis. All cell populations were sorted to 
98-99% purity (data not shown).
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Immunoblot of cytoplasmic lysates of these B cell subsets in shown in Fig. 3.4 along 
with lysates of thymocytes from TCRa1' or Zap7&' mice, both of which consist mainly 
(>80%) of CD4+CD8+ double positive cells. Zap70 expression could be detected in all 
sorted wt B cells populations, whereas no Zap70 expression was seen in sorted Zap70~'~ 
B cell subsets. Quantification of Zap70 expression levels in sorted B cell subsets 
revealed that normalised to expression of ERK2 (Fig. 3.4a), pro-B cells express 30-fold 
less Zap70 than thymocytes, whereas pre-B, immature and mature B cells express 
around 60 to 100-fold less compared to TCRa1' thymocytes. However, ERK2 expression 
levels seemed to be lower in thymocytes compared to B lineage cells. If Zap70 
expression in sorted B cell populations is normalised to the number of cells loaded, one 
can observe 8 -fold less Zap70 expression in pro-B cells, and 30-fold less Zap70 
expression in all other sorted B cell subsets compared to double positive thymocytes.
In conclusion, Zap70 could be detected in all developing and mature B cell populations. 
Furthermore, pro-B cells expressed 2 to 3 times more Zap70 that all other B cell subsets 
examined.
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Figure 3.4. Zap70 expression in B cell subsets
Immunoblot of total cytoplasmic lysates of TCRa1' or Zap70'~ thymocytes and wt or 
Zap70'' sorted proB cells (CD19+CD2IgM), preB cells (CD19+CD2+IgM ), immature B 
cells (CD19+IgM+IgD ) and mature B cells (CD19+IgM+IgD+) from bone marrow and 
MRF B cells (CD19+CD21+CD23+) from the spleen probed with antibodies to Zap70. 
The same blot was also probed with antibody to ERK2 as indicated. Number of cells 
loaded into each lane (xlO6) is shown. All cell pupolations were sorted to 98-99% purity 
(data not shown).
(A) Densitometric analysis of Zap70 expression in B cell populations normalised to 
levels of ERK2, setting expression of TCRa1' thymocytes to be 100.
(B) Densitometric analysis of Zap70 expression in B cell populations normalised to the 
number of cells loaded, setting Zap70 expression in TCRa1' thymocytes to be 100.
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3.2 Role ofZap70 in B cell development
I set out to explore whether Zap70 plays a role at distinct stages of B cell development 
other than the pre-BCR checkpoint. To address this question, I examined B cell 
populations from the bone marrow, spleen, lymph nodes and peritoneal cavity of 
Zap70r>' mice and compared them to wild type mice. Zap7&' mice have no CD4+ or 
CD8 + mature T cells (Negishi et al., 1995; Wiest et al., 1997). Although ap  T cells and 
epithelial y6  T cells are severely affected by the lack of Zap70, some y6  T cells in the 
peripheral tissues are still present in Zap7&' mice (Gong et al., 1997; Kadlecek et al., 
1998). To control for whether any differences found in Zap7&' B cell populations were 
due to the absence of Zap70 in these cells or due to the lack of ap  T cells in these mice, 
I decided to also compare B cell subsets from Zap70~'~ mice to TCRa1' mice, which lack 
all ap  T cells but still have y6  T cells. In order to match genetic backgrounds, Zap70~'\ 
which were two times backcrossed to C57BL/6J, and TCRa'1' mice, which were fully 
backcrossed to CBA/Ca, were compared to C57BL/6J and CBA/Ca mice respectively.
The following data is a summary of 3 subsequent experiments using 4-5 Zap7&' and 4-5 
C57BL/6J mice per experiment or 2 individual experiments with 4-5 TCRa'1' mice and 
4-5 CBA/Ca mice as their control.
3.2.1 Bone Marrow
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First, I examined B cell populations in the bone marrow. I distinguished B cell subsets at 
different stages of B cell development based on their cell surface marker expression: 
pro-B cells were defined as CD19+CD2'IgM'IgD‘; pre-B cells were CD19+CD2+IgM‘ 
IgD'; immature B cells were CD19+CD2+IgM+IgD' and mature B cells were defined by 
their expression of CD19, CD2, IgM and IgD (Fig.3.5). Counts of cell numbers showed 
that compared to wt controls, Zap70''' bone marrow had a slight reduction in 
lymphocytes (as defined by forward and side scatter) and in total numbers of CD19+ B 
lineage cells (Fig.3.5b). Furthermore, examining different populations within the B cell 
lineage in the bone marrow, a significant reduction in pre-B cells and immature B cells 
was observed. However, the number of mature B cells from Zap7&' mice compared to 
control mice was similar. Examining the percentage of each B cell population in the 
bone marrow, only a reduction in percentages of lymphocytes could be observed 
(Fig.3.6a). The percentage of CD19+ cells and of pro-B, pre-B and immature B cells, 
was similar between Zap70'' and wild-type mice. However a slight increase in 
percentage of mature B cells could be seen in Zap7&' mice.
The number of lymphocytes in the bone marrow of TCRa1' mice was similar to their 
wild-type control animals. However, they had more CD19+ cells, and therefore more 
pro-B cells, pre-B cells and immature B cells. Surprisingly the number of mature B cells 
was reduced (Fig. 3.5b). These findings correlated with the percentages of B cell subsets 
in the bone marrow (Fig.3.6b). A higher percentage of CD19+ cells was observed in 
TCRa'1' bone marrow compared to wild-type. The percentage of pro-B, pre-B and 
immature B cells was similar in TCRa'1' compared to wt. The percentage of mature B 
cells however was decreased.
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Figure 3.5. Zap70 in B cell development: bone marrow (I)
Graphs show numbers of total lymphocytes (lymph, defined by forward and side 
scatter), CD19+ cells, pro-B cells (CD19+CD 2IgM IgD ), pre-B cells (CD19+CD2+IgM‘ 
IgD), im m ature B cells (CD19+CD2+IgM+IgD) and m ature B cells 
(CD19+CD2+IgM+IgD+).
(A) An example of the gated subsets is shown on wild-type bone marrow cells.
(B) Zap70~'' mice (n= ll) (pink) compared to C57BL/6J mice (n= ll) (green). Data are 
summaries of three independent experiments with 3-5 Z a p 7 0 and wt mice per 
experiment.
(C) TCRa " mice (n=6) (red) compared to CBA/Ca mice (n=6) (blue). Data is summaries 
of 1 experiment.
Each circle represents one mouse. Black lines show the mean value for each subset. All 
mice were between 8 and 10 weeks of age. Asterisk indicates statistically significant 
differences between samples (★, p < 0.05).
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Figure 3.6. Zap70 in B cell development: bone marrow (II)
Graphs show percentages of B cell populations in the bone marrow defined as in Fig.3.1.
(A) Zap70r'~ mice (n= ll) (pink) compared to C57BL/6J mice (n=l 1) (green). Data are 
summaries of three independent experiments with 3-5 Zap70'~ and wt mice per 
experiment.
(B) TCRcl1' mice (n=6) (red) compared to CBA/Ca mice (n=6) (blue). Data is summary 
of 1 experiment.
Each circle represents one mouse. Black lines show the mean value for each subset. 
Asterisk indicates statistically significant differences between samples (★ p<0.05, ★★ 
p<0.005). Data are summaries of three independent experiments.
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3.2.2 Spleen
Next I examined B cells in the spleen. I divided the B cell populations in the spleen 
according to the cell surface expression of CD 19, CD23, CD21 and IgM. I could 
distinguish between mature recirculating follicular (MRF) B cells 
(CD19+CD23h,CD21+), also known as B2 cells, marginal zone (MZ) B cells 
(CD 19+CD23'/l0CD21hi) and Transitional 1 (Tl) B cells (CD19+CD21IgM+) and 
Transitional 2  (T2 ) B cells (CD19+CD21+IgM+).
Zap7(T'' and wt mice had comparable numbers of lymphocytes, but increased numbers of 
CD19+ cells (Fig.3.6a). Examining the B cell populations in more detail, revealed a 
slight increase in MRF B cell number and, surprisingly, a very significant increase in 
MZ B cells. The number of Zap7&' T l and T2 B cells was increased to that in control 
mice. Similar results were found by examining the percentages of different B cell 
subsets in the spleen and also by using Allman staining method to distinguish between 
MRF and MZ B cells as well as T l, T2 and T3 cells (data not shown) (Allman et al., 
2001).
TCRa'1' mice also had more CD19+ cells and MRF cells in the spleen compared to wt 
mice (Fig.3.6b). However no increase in MZ B cells could be seen in TCRa1' mice. The 
number of Tl and T2 B cells was also increased, which was similar to the results of 
Zap70'' mice.
The increase in B cells, in particular the MRF B cell subset, which is the biggest B cell 
population in the spleen, was similar in Zap7&' and TCRa1' mice. The significant
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increase in MZ B cells however, was specific to Zap7&~mice, because no increase could 
be seen in number of MZ B cells in TCRa1' mice.
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Figure 3.7. Zap70 in B cell development: spleen
Graphs numbers of lymphocytes (lymph, defined by forward and side scatter), all CD19+ 
cells, mature recirculating follicular B cells (MRF, CD19+CD23+CD21+), marginal zone 
B cells (MZ, CD 19+CD23,0CD21hi) and Tl B cells (CD19+CD21IgMhi) and T2 B cells 
(CD19+CD21+IgMhi) in the spleen.
(A) An example of gated subsets is shown on wild-type splenocytes.
(B) Zap7&' mice (n= ll) (pink) compared to C57BL/6J mice (n = ll) (green). Data are 
summaries of three independent experiments with 3-5 Zap70''' and wt mice per 
experiment.
(C) TCRa' mice (n=10; T1,T2 n=5) (red) compared to CBA/Ca mice (n=l 1; T1,T2 
n=5) (blue). Data are summaries of two independent experiments with 5 TCRa'1 and wt 
mice per experiment.
Each circle represents one mouse. Black lines show the mean value for each subset. 
Statistically significant differences are indicated (★, 0.01<p<0.05; p<0.0005).
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1.2.3 Peritoneal cavity
Next I examined B cell populations in the peritoneal cavity, which has two B cell 
subsets: B2 cells and B1 cells, defined by their expression of CD19 and Macl. B1 cells 
can further be subdivided into B la and B ib cells, which are CD5+ and CD5‘ 
respectively.
Similar numbers of B2 cells were observed in the peritoneal cavity of Zap7&' and wt 
mice (Fig.3.8). Furthermore, no difference in numbers of B la cells was found. However, 
the number of B ib cells was significantly increased in Zap7&' mice (Fig.3.8a). TCRa1' 
mice also showed unchanged numbers of B2 and B la cells, however the number of B ib 
cells was decreased compared to wt mice (Fig.3.8b). Similar results were seen in an 
analysis of percentages of B1 and B2 cells in the peritoneal cavity (Fig.3.9).
Therefore, the increase in Bib cells in Zap70'1' mice seems not to be a consequence of a 
lack of T cells, since this subset is decreased in TCRa'1' mice.
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Figure 3.8. Zap70 in B cell development: peritoneal cavity (I)
Graphs show numbers of lymphocytes (lymph, defined by forward and side scatter), all 
CD19+ cells, B la cells (CD19+M acl+CD5+), B ib cells (CD19+M acl+CD5 ), and B2 cells 
(CD19+Macl'CD5') in the peritoneal cavity.
(A) An example of gated subsets is shown on wild-type cells in the peritoneal cavity.
(B) Zap7(J'' mice (n=13) (pink) compared to C57BL/6J mice (n= ll) (green). Data are 
summaries of three independent experiments with 3-5 Zap70'' and wt mice per 
experiment.
(C) TCRa'1' mice (n = ll) (red) compared to CBA/Ca mice (n=10) (blue). Data are 
summaries of two independent experiments with 5-6 TCRa'1' and 5 wt mice per 
experiment.
Each circle represents one mouse. Black lines show the mean value for each subset. 
Significant differences are indicated (★, p<0.05).
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Figure 3.9. Zap70 in B cell development: peritoneal cavity (II)
Graphs show percentages of lymphocytes (lymph), all CD19+ cells and B cell 
populations in the peritoneal cavity as described in Fig.3.8.
(A) Zap7(T' mice (n=13) (pink) compared to C57BL/6J mice (n= ll) (green). Data are 
summaries of three independent experiments with 3-5 Zap70'' and wt mice per 
experiment.
(B) TCRa ' mice (n = ll) (red) compared to CBA/Ca mice (n=10) (blue). Data are 
summaries of two independent experiments with 5-6 TCRa1' and 5 wt mice per 
experiment.
Each circle represents one mouse. Black lines show the mean value for each subset. 
Significant differences are indicated (★, p<0.05).
1.2.4 Lymph nodes
Finally, I examined B cells in the lymph nodes. Major B cell population in the lymph 
nodes are B2 cells (MRF). Lymph nodes of Zap70'' mice had significantly reduced 
numbers of lymphocytes. However, the number of B cells was unchanged. No TCR+
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cells could be found in the Zap70'' lymph nodes, consistent with previous publications 
(Fig. 3.10a). TCRa1' mice gave a very similar picture: reduced numbers of lymphocytes, 
similar numbers of B cells and no T cells in TCRa1' mice (Fig. 3.10b).
This result contrast with the spleen, where in the absence of T cells, the number of B 
cells was increased.
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Figure 3.10. Zap70 in B cell development: lymph nodes
Graphs show numbers lymphocytes (lymph, defined by forward and side scatter), all 
CD19+ and TCR+ cells in the lymph nodes.
(A) An example of gated subsets is shown on wild-type cells in lymph nodes.
(B) Zap70'' mice (n=8) (pink) compared to C57BL/6J mice (n=8) (green). Data are 
summaries of two independent experiments with 4 Zap7(T1' and 4 wt mice per 
experiment.
(C) TCRa ' mice (n=5) (red) compared to CBA/Ca mice (n=5) (blue). Data are summary 
of one experiment with 5 TCRa'1' and 5 wt mice.
Each circle represents one mouse. Black lines show the mean value for B cells and T 
cells. Data are summaries of three independent experiments.
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3.2.5 Mixed bone marrow radiation chimeras
To further explore whether differences observed in B cell populations in the spleen and 
peritoneal cavity in Zap70'l‘ mice, were due to the lack of Zap70 in these B cell subsets 
themselves or due to the lack of a|3 T cells in these mice, I examined mixed bone 
marrow chimeras with ZapKT1' bone marrow mixed in a 1:1 ratio with pM T  BM 
(Zap70'l'lpMT) or wt BM mixed in a 1:1 ratio with pMT BM (wt//<MT) as donors that 
reconstituted sublethally irradiated C57BL/10-RagI'1' mice. Because Zap7&~ mice lack 
mature T cells and NK cells, differences in B cell subsets seen in Zap70~'~ mice might not 
be due to the lack of Zap70 in B cells, but the lack of Zap70 in other populations 
affecting B cells.
To investigate whether changes in B cell populations in Zap70f'' mice are Zap70 
intrinsic, I examined B cell subsets in mixed BM chimeras, where all B cells were 
Zap70-deficient and all T cells came from pMT mice, and were therefore not deficient 
for Zap70. As a control I examined mixed BM chimeras that received wt BM mixed 
with pMT BM as donors.
As shown in Fig. 3.11a, percentages in the spleen of CD19+ cells were increased in 
Zap7&'!pMl radiation chimeras compared to wt//*MT chimeras. Examining B cells 
subsets in the spleen of these radiation chimeras, one can observe that the percentages of 
NF, MRF B cells and MZ B cells were similar in Zap70'l'/pMT chimeras compared to
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wt//*MT chimeras. A significant increase in numbers of lymphocytes, all CD19+ cells, 
MRF and MZ B cells could be observed (Fig.3.1 lb).
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Figure 3.11. Role of Zap70 in B cell development: mixed BM-chimeras, spleen
Mixed BM chimeras were made with Zap70~'~ BM mixed with pMT BM in a ratio of 1:1 
(Zap70''7pMT, red, n=9) and C57BL/6J BM and pMT BM in a ratio of 1:1 (wt/^MT, 
green, n=9) as donors and sublethally irradiated C57BL/10-Rag-I1' mice as recipients. 
Mice were analysed 11 weeks after reconstitution. Lymphocytes (lymph), all CD19+ 
cells, MRF B cells, MZ B cells were defined as described in Fig.3.7, NF B cells were 
defined as CD19+CD23 CD21. Percentages (A) and cell numbers (B) of these 
populations are shown in graphs. Each circle represents one mouse. Black lines show the 
mean values. Significant differences are indicated (★, 0.005<p<0.0001).
B cell subsets in the peritoneal cavity in these mixed BM chimeras confirmed the results 
obtained in Zap70~'~ mice. Percentage of B la cells in the peritoneal cavity was similar in
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Zap70'l'/pMT chimeras compared to wt/^MT chimeras (Fig.3.12). However, the 
percentage of B ib  cells was significantly increased in Zap70~'7piMT chimeras. A 
tendency of the increase in B ib  cells could also be observed examining cell numbers 
(Fig.3.12b), although this difference did not reach statistical significance.
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Figure 3.12. Role of Zap70 in B cell development: mixed BM-chimeras, PEC
Mixed BM chimeras were made with Zap70~'~ BM mixed with pMT BM in a ratio of 1:1 
(Zap70~'~/pMT, red, n=9) and C57BL/6J BM and pMT BM in a ratio of 1:1 (wt//*MT, 
green, n=9) as donors and sublethally irradiated C57BL/10-Rag-1'1' mice as recipients. 
Mice were analysed 11 weeks after reconstitution. Lymphocytes (lymph), all CD19+ 
cells, B la  cells, B ib cells and B2 cells were defined as described in Fig.3.8. Percentages 
(A) and cell numbers (B) of these populations are shown in graphs. Each circle 
represents one mouse. Black lines show the mean values. Significant differences are 
indicated (★, 0.01<p<0.001).
In summary, an increase in MZ B cells and in B ib  cells, both reaching statistical 
significance, could be observed in Zap70 ' mice compared to wt mice. No difference in
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these two B cell populations was seen in percentages or cell numbers in TCRa1' mice, 
indicating that these differences are due to the lack of Zap70 in these B cell populations 
themselves. Radiation chimeras reconstituted with Zap70’l7pMT bone marrow showed a 
significant increase in the number of MZ B cells in the spleen and in the percentage of 
B ib cells in the peritoneal cavity.
3.3 The role ofZap70 in B  cell function
3.3.1 Thymus-dependent and Thymus-independent immune responses
It is of interest to find out whether or not Zap70 plays a role in the function of B cells. 
Are B cells deficient in Zap70 able to mount normal Thymus-dependent (TD) and 
Thymus-independent (Tl) antibody responses?
Since in Zap7&' mice, T cell development is blocked at the DP stage and no mature T 
cells develop, it is not possible to monitor TD immune responses in these mice. 
Therefore I decided to make mixed bone marrow chimeras with equal contribution of 
Zap7d'' bone marrow and pMT  bone marrow used to reconstitute sublethally irradiated 
CSTBLlO-RagT1' mice. pMT mice have a mutation in the p  heavy chain and are unable 
to express a functional p  chain on the cell surface. B cell development is therefore 
blocked at the pro-B cell stage (Kitamura et al., 1991). In these chimeras all mature B 
cells come from the Z a p 7 0 bone marrow and all mature T cells were derived from the 
pMT bone marrow. As a control I made similar mixed bone marrow chimeras using wt
and pMT bone marrow. These radiation chimeras were then immunised eight weeks 
after reconstitution with TD or Tl antigens and the sera of these mice were analysed for 
the presence of anti gen-specific immunoglobulins.
3.3.2 Tl-type 2 response
To examine Tl-type 2 immune responses in vivo, I immunised the radiation chimeras 
with 2,4,6-trinitrophenol-Ficoll (TNP-Ficoll), a commonly used Tl-type 2 antigen. Tl- 
type 2 antigens activate B cells by strongly crosslinking the BCR (Fultz et al., 1989; 
Inman, 1975). The predominant isotype produced in this case is IgM, although some 
class switching can occur to IgG3.1 measured TNP-specific antibody responses 7 and 14 
days after immunisation.
Although analysis was performed for all Ig Isotypes (IgA, IgGl, IgG2a, IgG2b, IgG3 
and IgM), only IgM contained TNP-specific antibodies (Fig.3.13). Radiation chimeras 
reconstituted with wt/pMT or Zap7&'lpMY bone marrow showed no significant TNP- 
specific response.
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Figure 3.13. Immune response in mice immunised with TNP-Ficoll
Mixed radiation chimeras reconstituted with wt/^MT (green) or Zap70~'7pMT (red) bone 
marrow were immunised 8 weeks after reconstitution with 2,4,6-Trinitrophenyl (TNP)- 
Ficoll to elicit Tl-type II responses. Concentration of TNP-specific IgM on the day 
before immunisation (day -1) and 7 and 14 days after immunisation with TNP-Ficoll 
(day +7, day +14) are shown for 7 radiation chimeras of each phenotype. Values for 
individual mice are shown as circles, and the line indicates the mean of each group. 
TNP-specific antibody levels for IgG l, IgG2a, IgG2b, IgG3 and IgA were also 
determined, but were undetectable. No significant difference could be detected (data not 
shown).
3.3.3 Tl-type 1 response
To examine Tl-type 1 responses, the radiation chimeras were immunised with 2,4,6- 
trinitrophenol-lipopolysaccharide (TNP-LPS) (Jacobs and Morrison, 1975). LPS, a 
major component of the cell walls of gram-negative bacteria, is a typical Tl-type 1 
antigen, activating B cells via Toll-like receptor (TLR) 4.
All mice showed significant TNP-specific IgM, IgG2b and IgG3 responses, which were 
similar between wt//*MT and Zap70''7pMT radiation chimeras. Four out of seven
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chimeras of each genotype also showed an anti-IgGl response at day 14, but again there 
was no difference between the genotypes.
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Figure 3.14. Antibody production in mice immunised with TNP-LPS
Mixed radiation chimeras reconstituted with wt//*MT (green) or Zap70~'7piMT (red) bone 
marrow were immunised 8 weeks after reconstitution with 2,4,6-Trinitrophenyl (TNP)- 
LPS to monitor Tl-type I responses. Concentration of TNP-specific antibodies on the 
day before immunisation (day -1) and 7 and 14 days after immunisation with TNP-LPS 
(day +7, day +14) are shown for 7 radiation chimeras of each genotype. Values for 
individual mice are shown as circles, and the line indicates the mean of each group. (A) 
TNP-specific IgM response, which reached statistical significance (0.001 <p<0.01); (B) 
TNP-specific IgGl response; (C) TNP-specific IgG2b response, which reached 
statistical significance (p<0.01) and (D) TNP-specific IgG3 response, which reached 
statistical significance (p<0.05). TNP-specific antibody levels for IgG2a and IgA were 
also determined, but were undetectable (data not shown).
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3.3.4 TD-immune response
Finally, I wanted to examine the role of Zap70 in TD-immune responses in vivo. The 
response of B cells to TD antigens requires direct contact with T cells. Mixed bone 
marrow chimeras of both genotypes were immunised with a haptenated protein, 2,4,6- 
trinitrophenol-keyhole limpet haemocyanin (TNP-KLH) (Ludviksson et al., 1997) and 
anti-TNP immunoglobulin isotypes were measured. Immunisations were carried out 
without adjuvant, in order to maximise the chances of detecting subtle differences in 
response. Therefore radiation chimeras were immunised with TNP-KLH in PBS and 
primary TNP-specific immune responses were measured 7 days and 14 days after 
immunisation, re-immunised at day 21 and TNP-specific immune responses measured at 
day 28.
IgM and IgG2b contained TNP-specific antibodies. However, no significant response 
was obtained after immunisation (Fig. 3.15 a,c). Significant TNP-specific IgGl and 
IgG3-responses were obtained only after re-immunisation (Fig. 3.15 b,d). However, no 
difference was observed between immune responses responses from wild-type or 
Zap7&' mice.
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Figure 3.15. Antibody production in mice immunused with TNP-KLH
Mixed radiation chimeras reconstituted with wt/piMT (green) or Zap70~ ~lpiMT (red) bone 
marrow were immunised 8 weeks after reconstitution with 2,4,6-Trinitrophenyl (TNP)- 
KLH to monitor TD responses. Concentration of TNP-specific IgM on the day before 
immunisation (day -1) and 7 and 14 days after immunisation with TNP-KLH (day +7, 
day +14) are shown for 7 radiation chimeras of each genotype. Responses against the 
second immunisation day 21 (black arrow) were measured at day 28 (day +28). Values 
for individual mice are shown as circles, and the line indicates the mean of each group.
(A) TNP-specific IgM response; (B) TNP-specific IgGl response, which reached 
statistical significance (p<0.02); (C) TNP-specific IgG2b response and (D) TNP-specific 
IgG3 response (for three mice of each phenotype). TNP-specific antibody levels for 
IgG2a and IgA were also determined, but were undetectable (data not shown).
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In summary, I examined the role of Zap70 in the function of B cells by analysing TD 
and Tl immune responses. To do this, I made mixed bone marrow radiation chimeras 
with Zap7&~ or wt bone marrow mixed with pM T  bone marrow and reconstituted 
sublethally irradiated C57BL/10-Rag I'1' mice. In these mice B cells come from wt or 
Zap70r'~ bone marrow and T cells from pMT bone marrow. Immunisation of these mice 
with Tl antigens TNP-LPS and TNP-Ficoll and with TD antigen TNP-KLH showed no 
significant differences in the responses of wt and Zap7&' B cells. However the TNP- 
Ficoll and TNP-KLH responses were very weak, so these studies will need to be 
repeated and extended.
I conclude that at least for the responses measured, Zap70 does not play an important 
role. In contrast Syk, the other member of this kinase family may play a dominant role.
3.3.1 Calcium flu x  in B cells
One of the earliest proximal signalling events after engagement of the BCR is the 
mobilization of intracellular calcium. It is known that intracellular calcium mobilization 
in B cells is completely dependent on Syk. In Syk'1' DT40 cells, which are chicken B 
lymphoma cells, calcium flux is impaired (Kurosaki et al., 1995).
I wanted to determine whether or not the absence of Zap70 affects BCR-induced 
calcium flux. Splenic cells were stained with antibodies to CD 19, CD21 and CD23 and 
then labelled with Indo-l-AM. MZ B cells, MRF B cells and NF B cells were defined by 
CD19 expression and by their different expression of CD21 and CD23 (Fig. 3.16 a).
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Cells were stimulated with anti-IgM-F(ab’ ) 2  and calcium mobilization was measured in 
splenic B cell subsets of wt or Zap7&~ mice. Calcium flux was observed in all B cell 
populations, whereas no calcium flux was seen in CD 19' cells in the spleen (Fig. 3.16 b 
and data not shown). An overlay of calcium fluxes in the different B cell subsets of wt 
and Zap7&' mice showed little or no difference between the genotypes (Fig. 3.16 c). In 
the experiment shown it appears that Zap70-/- MRF B cells have a lower BCR-induced 
calcium flux than wt MRF B cells, however this difference was not observed in a 
subsequent experiment.
Next I examined calcium fluxes in B cell populations of the peritoneal cavity (Fig. 3.17). 
Staining with antibodies to CD19, CD5 and CD23 was used to distinguish B2 cells 
(CD 19+CD5'CD23+) from B la cells (CD19+CD5+CD23) and B ib  cells (CD19+CD5' 
CD23 ). Cells were stimulated through the BCR by using anti-IgM-F(ab’ ) 2  and calcium 
flux was measured. Calcium flux was observed in all B cell subsets and once again no 
differences were observed between wt and Zap7&' mice (Fig. 3.17b,c)
In summary, similar calcium fluxes were obtained in different B cell subsets of the 
spleen and peritoneal cavity in wt and Zap70~'' mice. Similar results were also obtained 
using more (2.5/^g/lO6  cells) and also less (0.5/*g/106  cells) anti-IgM to stimulate the 
cells (data not shown). These results suggest that Zap70 does not play an important role 
in mobilising calcium flux in response to BCR stimulation.
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Figure 3.16. Calcium flux in B cell subsets in the spleen
Splenocytes were loaded with Indo-IAM and stained for different B cell subsets.
(A) Flow cytometry plots of wt or Zap7& ' splenocytes gated on CD19+ cells, 
distinguishing MZ B cells (CD23CD21hi), MRF cells (CD23+CD21+) and NF B 
cells (CD23 CD21). Numbers are percentages of cells falling into this gate.
(B) Graphs show the mean ratio of Indo-1 fluorescence at 405nm/485nm as a measure 
of intracellular calcium in splenic B cell populations: MZ B cells (blue), MRF B 
cells (red), NF B cells (green) and CD19- cells (orange). Cells were stimulated with 
anti-F(ab’)2 IgM (l^g /1 0 6 cells) at the time indicated (arrow).
(C) Graphs show the mean ratio of Indo-1 fluorescence at 405nm/485nm as a measure 
of intracellular calcium in splenic B cell populations from wt (blue) or ZapK)'1' (red) 
mice.
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Figure 3.17. Calcium flux in mature B cell subsets in the peritoneal cavity
Peritoneal cavity cells were loaded with Indo-1 AM and stained for different B cell
subsets.
(A) Flow cytometry plots of wt or Zap7&' cells gated on CD19+ cells, distinguishing 
B la  cells (CD23CD5+), B ib  cells (CD23CD5) and B2 cells (CD23+CD5). 
Numbers are percentages of cells falling into this gate.
(B) Graphs show the mean ratio of Indo-1 fluorescence at 405nm/485nm as a measure 
of intracellular calcium B cell populations: B la cells (red), B ib  cells (blue), B2 
cells (green) and CD 19- cells (orange). Cells were stimulated with anti-(Fab)2 IgM 
(1 pg/ 106 cells) at the time indicated (arrow).
(C) Graphs show the mean ratio of Indo-1 fluorescence at 405nm/485nm as a measure 
of intracellular calcium B cell populations of the peritoneal cavity of wt (blue) or 
Zap70''' (red) mice.
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4. Overexpression of Zap70 can rescue the S yk '1' phenotype
In the absence of Syk, B cell development is partially blocked at the pro-B to pre-B cell 
transition (Cheng et al., 1995; Turner et al., 1995). A few IgM+IgD' immature B cells 
develop, but then there is a second complete block at the immature B to mature B cell 
transition.
In mice deficient in Zap70 or carrying a mutation that inactivates Zap70 kinase function, 
there is an arrest at the DP to SP stage in the thymus, due to a block of T cell 
development at the second checkpoint, i.e. positive selection (Kadlecek et al., 1998; 
Negishi et al., 1995; Wiest et al., 1997). Zap70'~ mice show no block in B cell 
development. Conversely, no defect in TCR a|3 thymocyte development is found in 
Syk'1' mice (Cheng et al., 1995; Turner et al., 1995).
Mice deficient in both members of the Syk family kinases, Syk and Zap70, show a 
complete block in B cell development at the pro-B to pre-B cell transition 
(Schweighoffer et al., 2003), confirming that Zap70 plays a role in early B cell 
development, most likely because both Syk and Zap70 can transduce signals from the 
pre-BCR. Furthermore, these mice also show a complete arrest in progression from the 
DN to DP stage in T cell development, indicating that Syk plays a role at the DN to DP 
developmental checkpoint, probably because both Syk and Zap70 transduce pre-TCR 
signals.
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Thus while the pre-antigen receptors (pre-BCR and pre-TCR) can apparently signal 
through either Syk or Zap70, the mature antigen receptors (BCR and TCR) apparently 
only signal through either Syk or Zap70 alone, since the single knock-outs cause a 
complete arrest in development at these second checkpoints. This difference in the 
requirement for these kinases between the pre-antigen receptors and the mature antigen 
receptors may reflect differences in the expression levels of the kinases at the second 
checkpoint, or differences in the way these receptors signal. Thus mutation in Zap70 
alone arrests T cell development at the DP thymocyte stage due to a failure in positive 
selection. To address whether this was because not enough Syk was expressed in DP 
cells to compensate for the lack of Zap70, or whether the TCR is unable to transduce 
positive selection signals through Syk, Chan and collegues overexpressed Syk in the T 
cell lineage of Zap70'l~ mice. They found that this rescued the development of both CD4+ 
and CD8 + thymocyte and splenocyte populations (Gong et al., 1997). These thymocytes 
overexpressing Syk are fully functional as measured by their ability to increase [Ca2+], to 
up-regulate early T cell activation markers, and to proliferate in response to TCR 
activation. Thus the TCR appears able to signal through both Syk and Zap70, and the 
developmental block in Zap70''' mice results from insufficient expression of Syk in DP 
thymocytes.
A similar functional equivalence between Syk and Zap70 has also been suggested for 
BCR signal transduction. Expression of Zap70 in Syk'1' DT40 cells, which are chicken B 
lymphoma cells, reconstitutes B cell receptor signalling, as measured by induction of 
tyrosine phosphorylation of cellular proteins and mobilization of cytoplasmic [Ca2+]
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(Kong et al., 1995), suggesting that Zap70 is functionally equivalent to Syk in BCR 
signalling.
The same may be true for the transduction of pre-BCR and BCR signals during mouse 
development. While Zap70 can partially compensate for the lack of Syk in the pro-B to 
pre-B cell transition, the complete block at the immature to mature B cell stage in the 
absence of Syk may be due to the low expression level of Zap70, which is insufficient to 
drive cells through this second checkpoint.
Alternatively, Syk and Zap70 may have distinct functions at the immature to mature cell 
transition, and Zap70 may be unable to transduce the BCR positive selection signal. In 
favour of distinct roles for Zap70 and Syk are the observations that the specific kinase 
activity of Syk is 100-fold higher than that of Zap70 (Latour et al., 1996), which might 
lead to phosphorylation of a different set of downstream targets, and that the ability of 
Syk to be activated in an Lck-independent fashion is not shared by Zap70 (Chu et al., 
1996; Latour et al., 1997; Noraz et al., 2000)
To address this issue, I decided to overexpress Zap70 in Syk'1' B lineage cells using 
retroviral gene transfer technology. Syk'1' embryos die around birth, so as a source of 
hematopoietic stem cells (HSC) I used fetal liver cells, that were infected with retrovirus 
in vitro and then used to reconstitute irradiated recipients. This method generates 
chimeric mice in which the hematopoietic system is derived from the transduced donor 
cells and hence expresses any genes carried by the retroviral vector.
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4.1 Packaging cell lines, tranfection and infection conditions
The first step was to optimize retroviral gene transfer into HSC. A key requirement for 
such infections is high titres of the retrovirus. To achieve optimal titres I examined 
different packaging lines, transfection reagents and infection methods.
Packaging cell lines can efficiently produce large amounts of infectious, replication- 
incompetent retrovirus that can transfer genes into mammalian cells. Three different 
packaging cell lines were tested to determine which one gave the highest retroviral titres: 
PlatE, Phoenix and LinxE (Camero et al., 2000; Morita et al., 2000; Nolan).
The vector I used for optimising the transfection and infection conditions was the empty 
vector, pMSCV-IRES-GFP (Fig.4.1a). The advantage of using this vector for opimising 
experiments was that infected cells could be easily distinguished from uninfected cells 
by their expression of GFP without the need of staining the cells with antibodies.
I transfected the three different packaging cell lines using different amounts of the 
transfection reagents Fugene or Genejuice together with different DNA concentrations 
of retroviral vector.
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Figure 4.1. Schematic diagram of retroviral vectors
(A) pMSCV-IRES-GFP, (B) pMSCV-IRES-huCD2, Zap70 cDNA (blue) was inserted 
upstream of the IRES-huCD2, such that this vector expresses both ZAp70 and huCD2. 
Components of the vectors: IRES, internal ribosome entry site, creme; huCD2, tailless 
human CD2, red; 5 ’LTR and 3’LTR, long terminal repeats, pink; GFP, green 
fluorescence protein, green; xp, psi, extended viral packaging signal.
Supernatant containing virus was harvested either 24 hours or 48 hours after tranfection 
and dilutions of it used to infect the mouse fibroblast cell line, NIH-3T3. To measure 
viral titres, the percentage of GFP+ 3T3 cells was determined 24 hours after infection.
Compared to Phoenix and LinXE, the highest titres were consistently achieved using the 
packaging cell line PlatE (Fig.4.2). Furthermore higher titres were obtained when the 
retroviral supernatant was harvested at 48 hours rather than 24 hours after transfection. 
However, no significant difference was observed between the two transfection reagents
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Fugene and Genejuice. I decided to use Genejuice for further experiments since it is 
more cost-effective.
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Figure 4.2. Retrovirus production
Graph shows infectious retroviral particles in the supernatant of PlatE (green), Phoenix 
(orange) or LinXE (blue) cells transfected either 24 or 48 hours earlier with the pMSCV- 
IRES-GFP vector using either Fugene or Genejuice.
I achieved higher titres, when harvesting the supernatant containing virus at 48 hours 
rather than 24 hours after transfection. Next, I wanted to determine whether harvesting 
the virus 72 hours after transfection would give even higher viral titres. And indeed, the 
highest titres were achieved when harvesting the retroviral supernatant at 72 hours rather 
than 48 hours (Fig.4.3). Furthermore, in this experiment the highest titres were obtained 
using 6 \A transfection reagent and 0.5 pig DNA, although subsequent experiments did 
not confirm this (data not shown).
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In summary, the highest titres were achieved using the packaging cell line, PlatE and 
harvesting supernatant containing virus 72 hours after transfection. Both of the 
transfection reagents gave similar results, but Genejuice is more cost-effective.
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Figure 4.3. Determining optimal infection conditions
Graph shows the concentration of infectious retroviral particles in the supernatant of 
PlatE cells transfected 48 to 72 hours earlier with pMSCV-IRES-GFP using 6-12 p\ 
Genejuice and 0.5-1.5 pig DNA as indicated.
4.2 Overexpression ofZap70 in Sxk'1' mice via retroviral gene transfer
4.2.1 Radiation chimeras reconstituted with infected Syk'1' fetal liver
Is B cell development in Syk'1' mice completely blocked at the immature to mature B cell 
transition, because Zap70 cannot drive the cells through this selection checkpoint, or
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because Zap70 is not expressed at sufficiently high levels? To address this question I 
made radiation chimeras using Syk'1' fetal liver cells that had been infected in vitro with 
retrovirus expressing Zap70.
Syk'1' fetal livers (embryonic day 15.5 (E15.5), all Ly5.2+) were cultured to induce the 
HSCs to divide and then infected twice with retroviral supernatant from PlatE cells that 
were either transfected with pMSCV-IRES-huCD2-Zap70 or the empty pMSCV-IRES- 
huCD2 (Fig.4.1). pMSCV-IRES-huCD2 expresses a “tailess” human CD2 (huCD2) 
composed of the extracellular and transmembrane domains of huCD2, but missing the 
cytoplasmic domain (Fig.4.1b). The extracellular domain of human CD2 does not bind 
the murine ligands of murine CD2. These features make the tallies huCD2 a useful 
marker for infection by the retrovirus, because is unable to signal into the infected cell 
and so is unlikely to perturb cellular physiology.
These infected fetal liver cells were used to reconstitute lethally irradiated C57BL/6.SJL 
(Ly5.1+) hosts. A small number of infected Syk'1' fetal liver cells were kept in culture in 
order to determine the percentage of infected cells, by looking at the expression of 
huCD2 (Fig.4.4). Typically, 35-45% of cultured fetal liver cells were infected with the 
empty vector and 50-60% with retroviral vector expressing Zap70. This correlated with 
the retroviral titres obtained by infecting NIH-3T3 cells. Typically, retroviral titres in the 
supernatant from PlatE cells transfected with the empty vector were lower than titres 
achieved using pMSCV-IRES-huCD2-Zap70 (Fig.4.4 and data not shown).
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Figure 4.4. Efficiency of retroviral infection of fetal liver cells
Histograms showing expression of huCD2 on Syk'1' fetal liver cells that were uninfected 
(red line) or infected (blue line) with pMSCV-IRES-huCD2 (A) or pMSCV-IRES- 
huCD2-Zap70 (B). Marker indicates percentage of huCD2+ cells; titres of retrovirus in 
the supernatants used to infect the cells are shown.
Survival of mice 9 weeks after reconstitution confirmed that the ex vivo culture protocol 
did not compromise the ability of cultured HSC to mediate long-term radioprotection.
Mice were sacrificed 9 weeks after transfer and organs were analysed. Donor cells, 
which expressed the marker CD45.2 (Ly5.2) could be easily distinguished from host 
cells, which were CD45.1 (Ly5.1) positive.
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4.2.1.1 Bone marrow
First I examined the B lineage cells in the bone marrow of the radiation fetal liver 
chimeras (Fig.4.5). In radiation chimeras reconstituted with Syk'1' fetal liver cells that 
were infected with retrovirus expressing Zap70 (S,y&'/'*Zap70), over 60% of B lineage 
cells coming from the donor (CD19+Ly5.2+) were infected, as judged by expression of 
huCD2 (Fig.4.5a). Then, gating on infected B cells, I assessed whether these Syk'1' cells, 
presumably overexpressing Zap70, could overcome the developmental arrest and 
become mature IgM+IgD+ B cells. As shown in Fig.4.5a, only huCD2+ cells could 
develop into IgM+IgD+ cells (7% of cells). In contrast, uninfected (huCD2') cells, were 
still completely blocked at the immature B cell stage (IgM+IgD ).
Examining the bone marrow of chimeras, which were reconstituted with Syk'1' fetal liver 
cells infected with the empty vector (Syk^em pty  vector) showed that once again about 
60% of donor-derived B lineage cells were infected (huCD2+). But neither the infected 
nor the uninfected B lineage cells developed into mature IgM+IgD+ B cells (Fig.4.5b), 
remaining at the immature IgM+IgD' stage, typical of the developmental arrest 
previously seen in Syk'1' radiation chimeras.
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Figure 4.5. Bone marrow of radiation chimeras reconstituted with infected Syk'' 
fetal liver
Flow cytometric analysis of bone marrow cells from irradiated C57BL/6.SJL-Ly5.1 
mice reconstituted with Syk'1' fetal liver cells (Ly 5.2+) infected with pMSCV-IRES- 
huCD2-Zap70 (A) or pMSCV-IRES-huCD2 (B). Plots on the left show gated donor- 
derived B lineage cells (CD19+Ly5.2+), which are then separated into uninfected 
(huCD2) and infected (huCD2+) cells in the middle plots. Finally, in each of these 
populations, B cell development was assessed by examining expression of IgM and IgD, 
as shown in the plots on the right. Numbers show percentages of cells falling into the 
gates or quadrants.
4.2.1.2 Spleen
Next, I examined the spleen of radiation chimeras for the development of mature B cells. 
Up to 90% of all donor-derived B cells (CD19+Ly5.2+) from radiation chimeras 
reconstituted 9 weeks earlier with Syk'1'*Zap70 fetal liver cells, were infected, as 
identified by their huCD2 expression on the cell surface (Fig.4.6a). Furthermore,
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infected donor-derived B cells were able to develop into mature IgM+IgD+ B cells 
(Fig.4.6a).
In contrast, no donor-derived B cells could be found in the spleen of radiation chimeras 
reconstituted with Syk'1'*empty vector fetal liver cells (Fig.4.6b). This mimics the 
phenotype seen in Syk'1' radiation chimeras. Radiation chimeras reconstituted with Syk'1' 
fetal liver have no detectable IgMTgD+ conventional mature B cells (Turner et al., 
1995). To prove that donor-derived cells were infected, I looked at non-B cells coming 
from the donor (Ly5.2+CD19). Here I found over 20% of huCD2+ donor-derived cells 
(Fig.4.6b), confirming that the development of IgM+IgD+ B cells was dependent on the 
expression of Zap70.
>  huCD2
Figure 4.6. Spleen of radiation chimeras reconstituted with infected Syk'1' fetal 
liver
Flow cytometric analysis of spleen cells from irradiated C57BL/6.SJL-Ly5.1 mice 
reconstituted with Syk'1' fetal liver cells (Ly5.2+) infected with pMSCV-IRES-huCD2- 
Zap70 (A) or pMSCV-IRES-huCD2 (B), plots on the left show donor-derived B cells 
(CD19+Ly5.2+) or non-B cells (CD19'Ly5.2+). Plots in the middle show huCD2 
expression on the indicated populations. Plot in the top right shows IgM and IgD 
expression in the infected donor-derived B cells (CD19+Ly5.2+huCD2+). Numbers show 
percentages of cells falling into gates.
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4.2.1.3 Lymph nodes
The same was found in the lymph nodes of the radiation chimeras. Donor-derived B 
cells could only be detected in lymph nodes of chimeras reconstituted with Syk'1'*Zap70 
(Fig.4.7a), but not in radiation chimeras reconstituted with Syk'1'* empty vector 
(Fig.4.7b). HuCD2+ cells could be detected lymph nodes of both types of radiation 
chimeras. In chimeras reconstituted with Syk'1'*Zap70, 80% of donor-derived B cells 
were infected and were able to develop into mature B cells (Fig.4.7a). In contrast, no 
donor-derived B cells could be detected in chimeras reconstituted with Sy&'^empty 
vector (Fig.4.7b).
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Figure 4.7. Lymph Nodes of radiation chimeras reconstituted with infected Syk ' 
fetal liver
Flow cytometric analysis of lymph node cells from irradiated C57BL/6.SJL-Ly5.1 mice 
reconstituted with Syk'1' fetal liver cells (Ly5.2+) infected with pMSCV-IRES-huCD2- 
Zap70 (A) or pMSCV-IRES-huCD2 (B), plots on the left show donor-derived B cells 
(CD19+Ly5.2+) or non-B cells (CD19 Ly5.2+). Plots in the middle show huCD2 
expression on the indicated populations. Plot in the top right shows IgM and IgD 
expression in the infected donor-derived B cells (CD19+Ly5.2+huCD2+). Numbers show 
percentages of cells falling into gates.
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4.2.1.4 Zap70 expression levels
Next, I determined Zap70 expression levels in donor-derived B cells from chimeras 
reconstituted with Sy&/'*Zap70, compared to wild-type B cells from C57BL/6.SJL- 
Ly5.1 mouse as a control. Fig. 4.8 shows a typical example of Zap70 expression levels 
in lymph node cells of chimeras. Infected donor-derived B cells from chimeras 
reconstituted with Syk'^ZaplO had higher intracellular Zap70 expression levels than a 
normal wild-type B cell, but their Zap70 expression levels were still lower than that 
found in T cells (Fig.4.8c).
Figure 4.8. Zap70 expression levels in a radiation chimera reconstituted with 
infected Syk ' fetal liver
Flow cytometric analysis of CD 19 and Ly5.2 expression on lymph node cells from a 
radiation chimera reconstituted with Syk'1*Zap70 fetal liver cells (A) or lymph node 
cells from a C57BL/6.SJL-Ly5.1 mouse (B). Gates show donor-derived B cells (blue), 
donor-derived non-B cells (green) and uninfected B cells (red). (C) Histogram of Zap70 
expression levels in cells from gates in (A) and (B). Colours correspond to the colours of 
the gates. Numbers show percentages of cells falling within gates.
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In summary, these sets of experiment showed that by overexpressing Zap70 in Syk'1' B 
lineage cells, the developmental block at the immature B cells stage could be overcome 
and cells could develop into IgM+IgD+ mature B cells in the spleen, lymph nodes and the 
bone marrow. Furthermore, these experiments demonstrate, that higher than endogenous 
levels of Zap70 were necessary for Syk'1' B cells to develop into mature B cells, but that 
the expression levels of Zap70 did not need to be as high as found in T cells.
4.2.2 Radiation chimeras reconstituted with infected wt, Syk'1' or Syk','Zap70'1' fetal 
liver
Syk'1' B lineage cells still have endogenous Zap70, but Syk'l'Zap70'1' B cells have no 
member of the Syk-family of tyrosine kinases, and are therefore a cleaner model to 
observe whether overexpression of Zap70 via retroviral gene transfer, can drive cells 
through both selection checkpoints (pro-B to pre-B cell and immature B to mature B 
cell).
In the next set of experiments, I looked at B cell development in chimeras reconstituted 
with either Syk'1' fetal liver infected with retrovirus expressing Zap70 (Syk'1'*Zap70), 
Syk'l'Zap70'1' fetal liver infected with retrovirus expressing Zap70 (Syk'l'Zap7Cfl'*Zap70) 
or wild type fetal liver infected with retrovirus expressing Zap70 (wt*Zap70) as a 
control. In the case of chimeras reconstituted with infected Syk'1' fetal liver or wt fetal 
liver, donor fetal livers were Ly5.2+, H2b and the irradiated hosts were Ly5.1+, H2b. 
However, the only Syk'l'Zap70'1' fetal livers available were Ly9.2+, H2d. Therefore I had 
to use BALB/c mice as hosts, which were Ly9.1+, H2d. Chimeras were sacrificed 8-10
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weeks after transfer, a time point sufficient to ensure long-term reconstitution and donor- 
derived B lineage cells were analysed in organs of these mice.
4,2.2.1 Bone marrow
First I examined the bone marrow of the chimeras. In chimeras reconstituted with 
wt*Zap70 around 10% of all donor-derived bone marrow cells (Ly5.2+) were infected 
(Fig.4.9a). B cells were present in both infected and uninfected donor-derived cells and 
in both cases, developed into mature B cells (Fig.4.9a). Similarly, in chimeras 
reconstituted with S'y£'/‘*Zap70, around 5% of donor-derived cells (Ly5.2+) were 
huCD2+. As observed in section 4.2.1, infected Syk'1' B cells were able to develop into 
mature IgM+IgD+ cells, because they expressed Zap70, whereas uninfected B cells were 
completely arrested at the immature B cell stage (Fig.4.9b). In chimeras reconstituted 
with Syk'l'Zap70~l'*Z2qfJ0 more than half of all donor-derived cells (Ly9.1) were 
huCD2+. Once again, infected B cells were able to develop into mature B cells, whereas 
uninfected B cells were mostly IgM'IgD' B cells (Fig.4.9c). Surprisingly, a few 
IgM+IgD+ B cells were observed in the uninfected Syk'l'Zap7(71' B cells. One possible 
explanation was that these B cells were infected and thus expressed Zap70, but their 
huCD2 expression was below detection levels. To examine this, I looked at the Zap70 
expression levels in B cell populations of these mice. I found that both huCD2+ and 
huCD2' donor-derived B lineage cells expressed higher levels of Zap70 than found in 
host-derived B lineage cells (Fig.4.10). Thus at least some huCD2' donor-derived B
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lineage cells must have been infected, but the level of huCD2 expressed by them was 
below the level of detection.
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Figure 4.9. Bone marrow of radiation chimeras
Flow cytometric analysis of bone marrow cells from radiation chimeras. (A) 
C57BL/6.SJL-Ly5.1 mice reconstituted with wt*Zap70 fetal liver cells (Ly5.2+). (B) 
C57BL/6.SJL-Ly5.1 mice reconstituted with Syk^ZaplQ  fetal liver cells (Ly5.2+). (C) 
Balb/c mice (Ly9.1+) reconstituted with SyAf/'Z«p70'/'*Zap7O fetal liver cells (Ly9.2+). 
Donor-derived cells (Ly5.2+ in (A) and (B) and Ly9.2+ in (C)) were separated into 
infected and uninfected cells on the basis of huCD2 expression. B lineage cells (CD19+) 
in these populations were analyses for expression of IgM and IgD. Numbers represent
percentages falling into gates.
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Figure 4.10. Zap70 expression on bone marrow B cells of radiation chimeras 
reconstituted with infected Syk'l'Zap70'l'*Z2L\)7Q fetal liver cells.
Flow cytometric analysis of bone marrow cells from radiation chimeras made by 
reconstituting Balb/c (Ly9.1+) mice with Syk'ZapVO'^ZaplO fetal liver cells. (A) 
Expression of huCD2 and Ly9.1 distinguishes infected donor-derived cells 
(huCD2+Ly9.1), uninfected donor-derived cells (huCD2'Ly9.r) and host cells (huCD2‘ 
Ly9.1+). (B) Each of the three populations in (A) was analysed for B lineage cells 
(CD19+). (C) Zap70 expression in huCD2+ donor-derived B cells (red), huCD2' donor- 
derived B cells (blue) and host B cells (green), gates as in (A) and (B). Numbers 
represent percentages of cells falling into gates.
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4.2.2.2 Spleen
Next I examined the spleens of the chimeras. In chimeras reconstituted with wt*Zap70, 
B cells were present in both uninfected and infected donor-derived cells. As expected, 
both uninfected and infected B cells were able to develop into IgM+IgD+ mature B cells 
(Fig. 4.11a). huCD2+ and huCD2' B cells were able to develop into B2 (or MRF) cells 
(CD23+CD21l0W) as well as marginal zone (MZ) B cells (CD23 CD21high) and newly 
formed (NF) B cells (CD23'CD21) (Fig.4.12a).
As shown before, in chimeras reconstituted with Syk'''*Za.plO FL cells, only infected 
donor-derived cells gave rise to B cells, which developed into mature IgM+IgD+ B cells 
(Fig.4.11b). huCD2+ B cells were mostly B2 cells (Fig.4.12b). In contrast, MZ B cells 
and NF B cells could not be clearly distinguished.
The same was observed in chimeras reconstituted with Syk~,'Zap70rl'*Zapl0. IgMTgD+ 
mature B cells were found in infected donor-derived cells, whereas no B cells could be 
seen in uninfected donor-derived cells (Fig.4.12c). huCD2+ B cells developed into B2 
cells, but, as in chimeras reconstituted with Syk'^ZaplQ, MZ and NF B cells could not 
be clearly identified (Fig.4.12c). It may be that chimeras reconstituted with S'yAf/'*Zap70 
or Syk~l~Zap70'l'*Zapl0 do not express enough Zap70 to allow differentiation of MZ B 
cells, if the development of these cells is dependent on the strength of BCR signalling.
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Figure 4.11. Spleen of radiation chimeras (I)
Flow cytometric analysis of spleen cells from radiation chimeras made by reconstituting 
C57BL/6.SJL-Ly5.1 mice with (A) wt*Zap70 (Ly5.2+) or (B) Sy/c"'*Zap70 (Ly5.2+) fetal 
liver cells, or (C) Balb/c (Ly9.1+) mice with 7(7/'*Zap70 (Ly9.2+) fetal liver
cells. Plots on the left show gates on infected (huCD2+) or uninfected (huCD2 ) donor- 
derived cells ((A), (B) Ly5.2+; (C) Ly9.2+), which were then analysed for CD 19 
expression (middle plots) and CD19+ cells further analysed for expression of IgM and 
IgD. Numbers represent percentages falling into gates or quadrants.
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Figure 4.12. Spleen of radiation chimeras (II)
Flow cytometric analysis of spleen cells from radiation chimeras made by reconstituting 
C57BL/6.SJL-Ly5.1 mice with (A) wt*Zap70 (Ly5.2+) or (B) Sy£ / *Zap70 (Ly5.2+) fetal 
liver cells, or (C) Balb/c (Ly9.1+) mice with Syk~!~Zap70J'*Z2Lp70 (Ly9.2+) fetal liver 
cells. Plots on the left show gates on infected (huCD2+) or uninfected (huCD2 ) donor- 
derived cells ((A), (B) Ly5.2+; (C) Ly9.2+), which were then analysed for CD 19 
expression (middle plots) and CD19+ cells further analysed for expression of CD21 and 
CD23. Gates identify newly formed (CD21CD23 ), mature recirculating follicular 
(CD21+CD23+) and marginal zone (CD21h,CD23) B cells. Numbers represent 
percentages of cells falling into gates or quadrants.
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4.2.2.3 Lymph nodes
A similar picture was found in the lymph nodes of the chimeras (Fig.4.13). HuCD2+ and 
huCD2 B cells from chimeras reconstituted with wt*Zap70 could develop into 
IgM+IgD+ B cells (Fig.4.13a). Whereas chimeras reconstituted with l$y&'/"*Zap70 or Syk'1' 
Za/?70'/~*Zap7O, only huCD2+ donor-derived cells gave rise to IgM+IgD+ B cells 
(Fig.4.13b,c).
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Figure 4.13. Lymph nodes of radiation chimeras
Flow cytometric analysis of lymph node cells from radiation chimeras made by 
reconstituting C57BL/6.SJL-Ly5.1 mice with (A) wt*Zap70 (Ly5.2+) or (B) Syk'1' 
*Zap70 (Ly5.2+) fetal liver cells, or (C) Balb/c (Ly9.1+) mice with 70/~*Zap7O
(Ly9.2+) fetal liver cells. Plots on the left show gates on infected (huCD2+) or uninfected 
(huCD2 ) donor-derived cells ((A), (B) Ly5.2+; (C) Ly9.2+), which were then analysed 
for CD 19 expression (middle plots) and CD19+ cells further analysed for expression of 
IgM and IgD. Numbers represent percentages falling into gates or quadrants.
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4.2.2.4 Peritoneal cavity
Next, I analysed the peritoneal cavity of the chimeras. In chimeras reconstituted with 
wt*Zap70, huCD2+ and huCD2‘ donor-derived cells gave rise to B cells. These B cells 
were mostly B2 cells (CD19+M acl), although a small number of B1 cells 
(CD19+Macl+) could be seen (Fig.4.14a). However the number of B1 cells was much 
smaller than B2 cells. In radiation chimeras reconstituted with Syk' ^ZaplO or Syk'1' 
Zap7&'*Z?LplQ fetal liver cells, only huCD2+ donor-derived B cells were able to develop 
into B cells, which were mostly B2 cells (Fig.4.14b,c).
4.2.2.5 Thymus
Finally, the thymi of the chimeras were analysed. In chimeras reconstituted with either 
wt*Zap70 or Syk'1'*Zap70, both, huCD2+ and huCD2' donor-derived cells showed 
normal T cell development. This was not surprising, as both types of chimeras expressed 
Zap70 (Fig.4.15 a,b). However, in radiation chimeras reconstituted with Syk'l'Zap70'1' 
*Zap70 fetal liver cells, over 95% of donor-derived cells were huCD2+ and these cells 
showed normal T cell development, whereas huCD2' thymocytes were completely 
blocked at the DN stage (Fig.4.15c, and data not shown) as previously described in mice 
deficient for Syk and Zap70 (Cheng et al., 1997).
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Figure 4.14. Peritoneal Cavity of radiation chimeras
Flow cytometric analysis of lymph node cells from radiation chimeras made by 
reconstituting C57BL/6.SJL-Ly5.1 mice with (A) wt*Zap70 (Ly5.2+) or (B) Syk'1' 
*Zap70 (Ly5.2+) fetal liver cells, or (C) Balb/c (Ly9.1+) mice with Syk'1 Zap70'*Zapl0 
(Ly9.2+) fetal liver cells. Plots on the left show gates on infected (huCD2+) or uninfected 
(huCD2 ) donor-derived cells ((A), (B) Ly5.2+; (C) Ly9.2+), which were then analysed 
for CD 19 expression (middle plots), CD19+ cells were further analysed for expression of 
CD5 and M acl. Gates identify B la (CD5+M acl+), B ib (CD 5M acl+) and B2 (CD5‘ 
Macl ) B cells. Numbers represent percentages falling into gates or quadrants.
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Figure 4.15. Thymus of radiation chimeras
Flow cytometric analysis of lymph node cells from radiation chimeras made by 
reconstituting C57BL/6.SJL-Ly5.1 mice with (A) wt*Zap70 (Ly5.2+) or (B) Syk'1' 
*Zap70 (Ly5.2+) fetal liver cells, or (C) Balb/c (Ly9.1+) mice with Syk''~Zap7& *Zap70 
(Ly9.2+) fetal liver cells. Plots on the left show gates on infected (huCD2+) or uninfected 
(huCD2 ) donor-derived cells ((A), (B) Ly5.2+; (C) Ly9.2+), which were then analysed 
for the expression of CD4 and TCR. Numbers represent percentages falling into gates or 
quadrants.
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In summary, I have shown that overexpression of Zap70 in Syk'1' or Syk'''Zap7&' fetal 
liver cells, which were used to reconstitute radiation chimeras could compensate for the 
lack of Syk and allow B cell development to proceed all the way to an IgM+IgD+ mature 
B cell stage. In all chimeras reconstituted with 5,y^'/‘*Zap70 fetal liver cells, 
overexpression of Zap70 overcame the complete block of B cell development at the 
immature to mature B cell transition in B cells in the bone marrow, and mature B cells 
were found in the spleen and lymph nodes. The same was found in chimeras 
reconstituted with Syk''Zap7&'*ZaplO fetal liver cells. Overexpression of Zap70 could 
reconstitute B cell development from the pro-B to the mature B cell stage, alleviating the 
block at both the pre-BCR and the BCR checkpoints. Similarly, expression of Zap70 in 
thymi of these mice rescued T cell development.
4.2.3 Loss o f CD21 expression on wt splenic B cells overexpressing Zap70
The analysis of splenic B cell populations in radiation chimeras reconstituted with wt FL 
infected with Zap70 revealed an unexpected phenotype. In three out of four mice a loss 
of CD21 expression on cell surface of follicular B cells was observed (Fig.4.16 and Fig 
4.12a). Uninfected huCD2‘ B cells show a normal distribution of MZ (4.5-8%), MRF 
(70%) and NF (5.5-7.5%) B cells. Infected huCD2+ B cells however, showed a loss of 
CD21 expression on follicular B cells (CD23hi) and also a reduction in MZ B cells, 
which might be due to the loss of CD21 expression. HuCD2+ and huCD2' B cells have 
normal CD 19 expression (Fig.4.16) and showed normal IgM/IgD expression patterns 
(data not shown).
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Figure 16 . Loss of CD21 expression on splenic wt follicular B cells overexpressing 
Zap70.
Flow cytometric analysis of spleen cells from radiation chimeras made by reconstituting 
C57BL/6.SJL-Ly5.1 mice with wt*Zap70 (Ly5.2+) fetal liver cells. (A)-(D) show results 
from four different chimeras analysed 8 weeks (A), 9 weeks (B) and 10 weeks (C, D) 
after reconstitution. Plots on the left show infected (huCD2+) and uninfected (huCD2 ) 
donor-derived (Ly5.2+) cells. The plots in the central column show gates for CD19+ B 
cells, which were analysed in the plots on the right for expression of CD21 and CD23. 
Gates show newly formed (CD21CD23), mature recirculating follicular (CD21+CD23+) 
and marginal zone (CD21hlCD23 ) B cells. The unusual CD2FCD23+ population is 
marked with a bold gate. Numbers represent percentages of cells falling into gates.
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5. Hormone-inducible Syk-ER fusion protein
Radiation chimeras reconstituted with Syk'1' fetal liver show a partial block in B cell 
development at the pro-B to pre-B cell transition. A few Syk'1' pre-B cells can develop as 
far as the immature B cell stage. However these cells can never complete their 
maturation into recirculating follicular B cells (Turner et al., 1995). Therefore there is a 
second, complete block in B cell development at this later stage.
Because there are no Syk'1' mature B cells, we are unable to address the role of Syk in 
BCR signalling at this stage of B cell development. It would be important to know if Syk 
was involved in mature B cell proliferation, in the differentiation into plasma cells, 
germinal centre cells or memory cells. Syk could play a role in somatic hypermutation or 
class switching. Furthermore, the BCR is required for survival of mature B cells, as 
ablation of the BCR leads to death of the B cell, suggesting that Syk also might play a 
role in survival (Lam et al., 1997).
One way of studying the role of Syk in mature B cell development, is to make Syk 
inducible, to be able to switch Syk on and off at different stages of B cell development, 
but maintaining its responsiveness to BCR signalling. The system I decided to use was 
to fuse the hormone-binding domain (HBD) of the estrogen receptor (ER) to Syk, 
thereby rendering Syk hormone-inducible.
5.2 Estrogen Receptor hormone binding domain I Hsp90 system
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The activities of many intracellular proteins, including the protein kinase Src, Abl and 
Rafl (Jackson et al., 1993; Samuels et al., 1993), viral and cellular transcription factors 
HIV Rev (Hope et al., 1990), c-Myc (Eilers et al., 1989) v-Myb (Burk and Klempnauer, 
1991), p53 (Roemer and Friedmann, 1993) and STAT6 (Kamogawa et al., 1998) have 
been rendered hormonally-regulated upon fusion to the HBD of different steroid 
receptors (Mattioni et al., 1994; Picard, 1993). The proposed mechanism of action is 
hormone-reversible protein-inactivation. In the absence of hormone, the inactive state is 
maintained by an Hsp90-containing complex that causes steric hindrance by blocking 
access of other proteins or DNA/RNA targets to the HBD-fused heterologous protein. 
Addition of hormone causes the HBD-fusion protein to release Hsp90 and thus now 
become active (Fig.5.1) (Schwenk et al., 1998).
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Figure 5.1. Hormone-inducible Syk-ER fusion protein
Syk-HBD fusion protein (Syk, green cylinder; HBD, pink cylinder) is kept in an inactive 
state in the presence of Hsp90 (violet). If ligand (blue circles) is present in the cell, it 
binds to the fusion protein, which will then undergo conformational changes and is now 
no longer accessible to Hsp90. This is the active form of the fusion protein (Schwenk et 
al., 1998).
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The advantages of using this system are reversibility and rapid induction. Unlike 
systems employing inducible promoters it does not require transcription or translation 
for induction of activity, or apparently the decay of protein or mRNA for repression of 
activity. Furthermore, the system should work in all cells where the components of the 
Hsp90 complex are present; it has been demonstrated to function in mammalian, avian, 
amphibian and yeast cells.
Since estrogens are found in the serum added to tissue culture medium and are abundant 
in vivo in the mouse, they are likely to interfere with controlled induction. Therefore I 
chose to use mutant forms of ER-HBD (ER™ or ERT2), which are unable to bind 
estrogens, yet retain normal affinity for the synthetic ligand, 4-hydroxy-tamoxifen (4- 
OHT) (Danielian et al., 1993; Feil et al., 1996; Littlewood et al., 1995).
There are two different mutant versions of the ER-HBD, called ER™ or ERT2 (Fig.5.2). 
Both HBD are tamoxifen-dependent. However, due their different mutations, ERT2 was 
shown to be lOx more sensitive to tamoxifen in vivo than the earlier version ER™ (Indra 
et al., 1999).
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Figure 5.2. Tamoxifen-inducible estrogen hormone-binding domain (HBD)
The ER™ is mutant form of the mouse ER bearing a G525R mutation, which makes it 
tamoxifen-dependent, but not estrogen-dependent. In contrast, the ERT2 is a mutant form 
of the human ER bearing G400V/L539A/L540A mutation, which makes it unable to 
bind estrogens, but lOx more sensitive to tamoxifen than ER™.
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5.2 Syk-ER in DT40 cells
To test the function of Syk-ER fusion proteins, I decided to use an in vitro test system, 
the chicken B lymphoma cell line DT40. Using DT40 cells has several advantages. First, 
crosslinking of the BCR expressed on the surface of DT40 cells induces a calcium flux, 
which is absolutely dependent on Syk, providing a rapid assay (Fig.5.3). Second, DT40 
is a rapidly proliferating transformed cell line. Third, DT40 cells are very easy to 
transfect by electroporation. Finally, Syk'1' DT40 cells are available (Kurosaki et al., 
1995).
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Figure 5.3. BCR-induced Calcium flux in DT40 cells is Syk-dependent
Wild type (red line) and Syk1' (blue line) DT40 cells were loaded with Indo-l-AM. The 
graph shows the mean ratio of Indo-1 fluorescence at 405nm / 485nm as a measure of 
intracellular calcium. Cells were stimulated with anti-chicken IgM (M4) at the time 
indicated (black arrow).
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Three different Syk fusion proteins were constructed previously in the lab by Geoff 
Parsons, containing ER™-HBD at the N-terminus, hinge region or C-terminus of Syk 
(Syk-NER™, Syk-HER™, Syk-CER™) and were cloned into the pApuro vector 
(Fig.5.4). This vector has been shown to confer high levels of protein expression in 
DT40 cells, from a chicken actin promoter (Takata et al., 1994).
To test the fusion proteins for their ability to give tamoxifen-dependent activity, I 
decided to express them in Syk'1' DT40 cells and then analyse BCR-induced calcium 
fluxes in the presence and absence of 4-OHT.
SH2 SH2 kinase
C-ER
H-ER
N-ER
Figure 5.4. Syk-ER fusion proteins
The figure shows the three different fusion proteins containing the ER-HBD at the C- 
terminus, C-ER; hinge region, H-ER or N-terminus of Syk, N-ER. Structure of Syk is 
indicated on the top, with two N-terminal SH2 domains (orange and yellow) and a C- 
terminal kinase domain (purple); ER-HBD is marked in blue.
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I electroporated Syk'1' DT40 cells with vectors expressing the three different Syk-ER™ 
fusion constructs and selected clones stably expressing the protein. I obtained more than 
20 clones of Syk'1' DT40 cells transfected with vectors encoding Syk-NER™, Syk- 
HER™ or Syk-CER™ (Table 5.1). All clones were checked for protein expression, 
which showed that only a subset expressed the Syk protein. A typical example of 
expression is shown in Fig.5.5. Syk-CER™ was expressed in high levels in all clones, 
compared to the expression levels obtained for Syk-NER™ or Syk-HER™. The 
available antibodies against mouse Syk do not recognise chicken Syk (see also Fig.5.8), 
therefore the expression levels obtained with the clones could not be compared to 
endogenous Syk levels.
KO-S Ko-SNER™ Ko-SCER™ Ko-SHER™ Ko-SNERT2
Number of puromydr 
resistant clones 28 32 25 31 17
Number of clones 
expressing Syk-ER 10 11 5 4 12
Table 5.1. Clones containing Syk-ER fusion constructs
Table shows the number of puromycin-resistant clones obtained and the number of these 
that expressed Syk or Syk-ER. The table lists DT40 clones stably transfected with 
murine Syk (KO-S), with Syk-NER (KO-SNER™ or KO-SNERT2), with Syk-HER™ 
(KO-SHER™), or with Syk-CER™ (Ko-SCER™)
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Figure 5.5. Protein expression in stable clones transfected with Syk-ER™ fusion 
constructs.
Western blot of total cell lysates of Syk'1' DT40 cells stably transfected with vector 
expressing wildtype murine Syk (clone Ko-S-62, S), Syk-NER™ (clone Ko-S-NER™ 
64, N), Syk-HER™ (clone Ko-S-HER™ 63, H) or Syk-CER™ (clone Ko-S-CER™ 515, 
C). Total cell lysates of 3 million cells were loaded per lane. Blot was probed with rabbit 
anti-mouse Syk antiserum. Molecular weight marker (in kDa) is indicated in grey.
All expressing clones were used for calcium flux experiments, to test whether the 
introduced Syk-ER™ fusion proteins acted in a hormone-dependent manner. A typical 
example is shown in Fig.5.6. As shown in Fig. 5.6a calcium flux was induced in Syk'1' 
DT40 cells expressing murine Syk in response to IgM stimulation, but not in Syk'1' cells 
transfected with empty vector (Fig. 5.6a). This confirms that the defective BCR-induced
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calcium flux in Syk7' DT40 chicken cells can be rescued by expression of murine Syk. 
To test whether in Syk'1' DT40 cells stably transfected with vectors expressing one of the 
three Syk-ER™ fusion constructs, calcium flux was induced only in the presence, but 
not in the absence of 4-OHT, the stably transfected clones were pre-incubated for 20 min 
with 4-OHT before starting the analysis.
In Syk'1' DT40 cells expressing Syk-HER™ (Fig.5.6c) or Syk-NER™ (Fig.5.6d), calcium 
flux was induced in response to anti-IgM stimulation only when cells had been pre- 
incubated with 4-OHT. No calcium flux was seen in the absence of 4-OHT. However, 
Syk'1' DT40 cells expressing Syk-CER™ were hormone-independent. Calcium flux was 
induced in response to BCR stimulation in the presence, but also in the absence of 4- 
OHT (Fig. 5.6b). This might be due to the fact that cells expressing Syk-CER™ 
expressed much higher levels of the fusion protein than cells expressing Syk-H-ER™ or 
Syk-N-ER™ (Fig. 5.5) and there might not be enough Hsp90 in the cell to keep the 
fusion protein in an inactive state. Pre-incubation of these cells with 4-OHT (Fig. 5.6b), 
lead to an elevated intracellular calcium concentration, which could not be further 
increased by BCR crosslinking, suggesting 4-OHT-induced activation of Syk.
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Figure 5.6. [Ca2+] flux experiment on DT40 clones, stably transfected with Syk-
ER™
DT40 cells were loaded with Indo-l-AM. Graph shows the mean ratio of Indo-1 
fluorescence at 405 nm/ 485 nm as a measure of intracellular [Ca2+]. Cells were 
stimulated with anti-chicken IgM (M4) at the indicated time (black arrow).
(A) Syk'1' DT40 cells stably transfected with an empty pApuro vector (clone Ko-pA62, 
red) or with a pApuro vector expressing wild type Syk (clone Ko-S62, green).
(B) Syk'1' DT40 cells stably transfected with a pApuro vector containing Syk-CER™ 
(clone Ko-C515). Cells were pre-incubated with 4-OHT for 20 min (blue) or were 
given no 4-OHT (red).
(C) Syk'1' DT40 cells stably transfected with a pApuro vector containing Syk-HER1 M 
(clone Ko-H62). Cells were pre-incubated with 4-OHT for 20 min (blue) or were 
given no 4-OHT (red).
(D) Syk'1' DT40 cells stably transfected with a pApuro vector containing Syk-NER™ 
(clone Ko-N64). Cells were pre-incubated with 4-OHT for 20 min (blue) or were 
given no 4-OHT (red).
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A different approach to test the functionality of the Syk-ER™ fusion protein was to 
examine their tyrosine phosphorylation. As illustrated in Figure 5.7a, Syk'1' DT40 clones 
stably expressing murine Syk, showed tyrosine phosphorylation after BCR crosslinking. 
Clones expressing either Syk-NER™ or Syk-HER™ showed tyrosine phosphorylation 
after BCR stimulation only when pre-incubated with 4-OHT. No tyrosine 
phosphorylation was seen in the absence of the ligand (Fig.5.7b,c), confirming the N- 
terminal and H-regional HBDs were indeed able to repress Syk in the absence of 
hormone. Clones expressing Syk-CER™ however, showed higher basal levels of 
tyrosine phosphorylation. The Syk-CER™ protein was tyrosine phosphorylated after 
BCR crosslinking in the absence of 4-OHT. Once cells were pre-incubated with 4-OHT, 
high levels of tyrosine phosphorylation were observed even without BCR stimulation 
(Fig. 5.7d), similar to the calcium flux (Fig.5.6).
In summary, two of the three fusion constructs, the Syk-NER™ and Syk-HER™, were 
activated in a ligand-dependent manner, however the overall results from Syk-NER™ 
were more promising than from the Syk-HER™, since the return to basal calcium levels 
was closer to wild type in Syk-NER™ compared to Syk-HER™ (see Fig. 5.6 c,d).
The newer version of the ER, ERT2, was shown to need ten times less tamoxifen for its 
activation that the earlier version ER™ (Indra et al., 1999). As for later purposes in a 
mouse model, I want to use the lowest amount of tamoxifen as possible, I decided to 
make a Syk-NERT2.1 electroporated Syk'1' DT40 cells with the vector expressing Syk- 
NER12, selected clones and screened them for expression of the fusion protein. A typical 
example is shown in Fig. 5.8.
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Figure 5.7. Tyrosine-Phosphorylation of Syk-ER protein after anti-IgM 
stimulation
Immunoblot of total cell lystaes from DT40 clones stimulated crosslinking of the BCR 
for the indicated times. Cells were either not treated with 4-OHT, or were pre-incubated 
with 4-OHT for 10 min prior to stimulation. Blots were probed with rabbit anti-mouse 
phospho-Syk (P-Syk). Blots were then stripped and re-probed with rabbit anti-mouse 
Syk antiserum (Syk). Analysis of clones expressing Syk (A), Syk-NER™ (B), Syk- 
HER™ (C) and Syk-CER™ (D) are shown.
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Figure 5.8. Protein expression in clones stably expressing Syk-NERT 2
Immunoblot of total cell lysates of Syk'1' DT40 clones transfected with vector containing 
Syk-NERT2. 3 stably tranfected Syk-NERT2 clones are shown here (N l, N2, N3). N1 and 
N3, but not N2, express the Syk-ER fusion protein. Lysates from wt DT40 cells (wt) and 
Syk'1' DT40 cells (Syk1') are also shown. Blot was probed with rabbit anti-mouse Syk 
antiserum, which only recognises murine Syk and not endogenous chicken Syk (see wt- 
lane). Top arrow points to Syk-ER fusion protein band (109 kDa); bottom arrow 
indicates position of Syk (72kDa). The 83 kDa band visible in all lysates is an non­
specific band seen with this antibody.
All clones expressing Syk-NER12 were used for calcium flux analysis, to test whether it 
would function in a hormone-dependent manner, as did the Syk-NER™ fusion protein 
(Fig.5.9). Interestingly, in all clones stably expressing Syk-NERT2 calcium flux was 
induced in response to anti-IgM in the presence, but also in the absence of 4-OHT 
(Fig.5.9b). Although a greater calcium flux was observed when cells were pre-incubated 
with 4-OHT, calcium flux was not entirely hormone-dependent, in contrast to clones 
stably expressing Syk-NER™, where cells showed a BCR-induced calcium flux only 
when the hormone was present in the cell (Fig. 5.9a).
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Because the Syk-NERT2 did not appear to be fully hormone-dependent, I decided to use 
clones expressing the Syk-NER™ for further experiments.
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Figure 5.9. Calcium flux in DT40 clones expressing Syk-NER™ and Syk-NER1 2
DT40 cells were loaded with Indo-l-AM. Graphs show the mean ratio of Indo-1 
fluorescence at 405 nm/ 485 nm as a measure of intracellular Calcium. Cells were 
stimulated with anti-chicken IgM (M4) at times indicated (black arrow).
(A) Syk'1' DT40 cells stably transfected with pApuro vector containing Syk-NER™ 
(clone Ko-N5.1). Cells were either pre-incubated with 4-OHT for 20 min (blue), or 
were given no 4-OHT (red).
(B) Syk'*' DT40 cells stably transfected with pApuro vector containing Syk-NERT2 
(clone Ko-N5.8). Cells were either pre-incubated with 4-OHT for 20 min (blue), or 
were given no 4-OHT (red).
One of the potential advantages of the ER system over other inducible systems (e.g. 
tetracycline-inducible system) is its quick response time. Therefore, I wanted to 
determine the shortest pre-incubation time needed to observe a BCR-induced calcium
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flux in clones expressing Syk-NER™. To do this, cells were pre-incubated with 4-OHT 
for 5, 10, 15 or 20 min (Fig. 5.10a). Cells showed a BCR-induced calcium flux after 
only lOmin of pre-incubation with 4-OHT. However, cells pre-incubated for 15 min or 
20 min showed a greater BCR-induced calcium flux. In contrast, 5 min pre-incubation 
time seemed to be too short to achieve a visible BCR-induced calcium flux.
Next, I investigated the lowest concentration of 4-OHT needed to allow efficient BCR- 
induced calcium flux. Clones expressing Syk-NER™ were pre-incubated for 20 min 
with 400nM (standard concentration used in all previous experiments), 200nM, lOOnM, 
50nM and 25nM 4-OHT. As shown in Fig.5.10b, lOOnM of 4-OHT is the lowest 
concentration needed to permit a BCR-mediated calcium flux. A greater calcium flux 
was visible after pre-incubation with either 200nM or 400nM 4-OHT. However no 
calcium flux was obtained when pre-incubating cells with 50nM or 25nM 4-OHT.
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Figure 5.10. Time and concentration dependent activation of Syk-NER™
Syk'1' DT40 cells were stably transfected with a pApuro vector containing Syk-NER™. 
DT40 cells were loaded with Indo-l-AM. Graphs show the mean ratio of Indo-1 
fluorescence at 405 nm/ 485 nm as a measure of intracellular Calcium. Cells were 
stimulated with anti-chicken IgM (M4) at times indicated (black arrow).
(A) Cells were pre-incubated with 4-OHT for 20 min (light blue), 15 min (orange), 10 
min (green), 5 min (dark blue) before starting analysis or were analysed without the 
addition of 4-OHT (red).
(B) Cells were pre-incubated for 20 min with 400nM 4-OHT (pink), 200nM 4-OHT 
(green), lOOnM 4-OHT (light blue), 50nM 4-OHT (dark blue), 25nM 4-OHT 
(orange) before starting analysis or were analysed without addition of 4-OHT (red).
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In addition to being quick in responding, the ER fusion protein should also be reversible. 
Therefore, I wanted to assess the rapidity of inactivation of Syk-ER™ in transformed 
cells upon removal of 4-OHT. Syk'1' DT40 cells stably expressing Syk-NER™ were pre- 
incubated with 4-OHT before measuring BCR-induced calcium flux (Fig.5.11). 4-OHT 
was then removed by extensive washing before allowing the cells to rest in ligand-free 
medium for 1 hour, 2 hours, 7 hours or 24 hours before measuring calcium flux 
(Fig.5.11). Calcium flux was reduced already 1 hour after removal of 4-OHT. This was 
further reduced after 2 and 7 hours in the absence of 4-OHT and had completely 
vanished 24 hours after removal of the hormone.
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Figure 5.11. Time course of Syk-NER™ inactivation after removal of 4-OHT
Graph shows Syk'1' DT40 cells expressing Syk-NER™. DT40 cells were loaded with 
Indo-l-AM. Graphs show the mean ratio of Indo-1 fluorescence at 405 nm/ 485 nm as a 
measure of intracellular Calcium. Cells were stimulated with anti-chicken IgM (M4) at 
times indicated (black arrow).
Cells were analysed in the absence of 4-OHT (green) or pre-incubated with 400nM 4- 
OHT for 20 min (red), then washed extensively before starting analysis 1 hour (orange), 
2 hours (purple), 7 hours (light blue) or 24 hours (pink) after removal of 4-OHT.
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In summary, the calcium flux analysis in DT40 cells provided me with an appropriate 
read-out for assessing the functionality of the Syk-ER fusion constructs. Analysis of 
stably transfected clones expressing individual Syk-ER™ fusion constructs showed that 
clones expressing either Syk-NER™ or Syk-HER™ gave a BCR-induced calcium flux in 
the presence, but not in the absence of 4-OHT. Clones expressing Syk-CER™, however, 
were hormone-independent (Fig.5.6), which might be due to their high protein 
expression levels compared to the Syk-NER™ or Syk-HER™, allowing some of the 
fusion protein to “escape” inhibition perhaps because of limiting amounts of Hsp90.
The best results were achieved using the Syk-NER™ construct. Therefore I chose the N- 
terminus to test the ERT 2  HBD. This version of the ER HBD is reported to be lOx more 
sensitive to 4-OHT, which might have been useful for later in vivo studies in the mouse. 
Calcium flux analysis in clones stably expressing Syk-NERT 2  however revealed that this 
fusion construct was “leaky”. Although greater BCR-induced calcium fluxes were 
observed in the presence of 4-OHT, calcium flux was also induced in the absence of 4- 
OHT (Fig.5.9). Returning to analysis of Syk-NER™, I established the lowest 
concentration of 4-OHT (lOOnM) and the shortest pre-incubation time needed (10 min) 
to fully activate the Syk-ER (Fig.5.10). Furthermore, I found that 24 hours after removal 
of 4-OHT, Syk-ER was back to its inactive state, confirming that the system was indeed 
reversible (Fig.5.11).
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5.3 Future work: Syk-ER™ Knock-in mouse
The best tool to study the role of Syk in mature B cells using the hormone-inducible Syk 
in vivo, would be a knock-in mouse strain carrying Syk-ER in the endogenous Syk gene. 
I plan to introduce the ER™ domain at the appropriate position into the endogenous Syk 
gene via homologous recombination and thus to generate such a strain. The advantage of 
this approach is that the knock-in will result in correct temporal and tissue-specific 
expression of the fusion protein at the correct expression levels, since it will be under the 
control of endogenous regulatory elements. To circumvent the perinatal lethality of the 
Syk mutation, pregnant mice carrying the Syk-ER™ fusion gene could be treated with 
tamoxifen (which is metabolized into the active ligand 4-OHT in the liver) from mid­
gestation onwards in order to induce Syk activity. This procedure should also rescue B 
cell development. Such mice would be kept on tamoxifen continuously in order to keep 
Syk active, and thus prevent bleeding disorders.
As the N-terminal Syk-ER™ fusion construct gave the most promising results in DT40 
cells, I decided to knock-in the ER™ at this exact position in the Syk  gene. More 
precisely, the ER™ will be introduced into exon 2 between amino acids 8  and 9 
(Fig.5.12). That is the position where the ER™ was placed in the Syk-N-ER™ fusion 
construct.
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Figure 5.12. Knock-in strategy
Figure shows the knock-in strategy. The ER™ will be knocked in at the N-terminus of 
the Syk gene.
Syk is indicated in the cream rectangle; exons, small red rectangle; introns, red lines.
The position where the ER™ is going to be introduced is indicated in exon II between 
amino acids 8-9 (AA 8-9). As part of the targeting strategy, a neomycin resistance 
cassette (neo, blue rectangle) flanked by two loxP sites (black arrows) will be introduced 
into an Mfel site in intron 1, and will be subsequently removed by Cre-mediated 
excision either in the targeted ES cells or in the resultant mice.
165
I found two convenient BamHI sites in the genomic sequence of C57BL/6J mice, which 
flanked a region of 8 . 1 kb containing exon 2  and which will be used as homologous 
regions (HR) for the targeting construct.
Since the available genomic sequence is from the C57BL/6J strain, and the ES cell line I 
am intending to use is from 129/Sv, the next step was to check whether the BamHI sites 
also exist in 129/Sv mice. A Southern blot was performed using a 457bp probe 
containing exon 2 and was found to hybridise to a 8.1kb BamHI fragment in 129/Sv 
DNA (Fig. 5.13a.)
Next I screened a mouse 129/Sv PAC library with the 457bp probe. I obtained 6  PAC 
clones that hybridised to my probe. An example is shown in Fig. 5.14b. DNA from the 6  
clones was digested with BamHI and Southern blot analysis was performed using Syk 
cDNA as a probe to determine which one of the clones contained the 8.1kb fragment and 
which one of them, if any, contained the whole Syk gene, which might be useful for 
further targeting work. 3 of the 6  clones contained the whole Syk gene (one example is 
shown in Fig. 5.13 c, lane 1). One clone seemed to contain only the N-terminus of the 
Syk gene (Fig. 5.13 c, lane 2), spanning the regions from Exon 1 to 3, and one clone 
contained Exons 1 to 10 (Fig. 5.13 c, lane 3).
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Figure 5.13. Screening PAC library for homologous region
(A) Southern blot of 129/Sv genomic DNA digested with AccI, BamHI and BstEII and 
probed with 457bp probe. Arrow points to the 8.1 kb BamHI fragment.
(B) Part of one filter carrying the PAC mouse genomic library screened for Syk using 
the 457bp probe. One positive clone is indicated in the red box.
(C) Southern blot shows three different PAC clones (1,2,3) digested with BamHI and 
probed with Syk cDNA. Black arrow points to expected fragments (fragment sizes: 
11.4kb, 8.6kb, 8.1 kb, 2.9kb and 2.1kb). All three PAC clones contained the 8.1 kb 
fragment.
The next step will be to clone the ER™ into the N-terminus of Syk. Homologous 
recombination will be used in ES cells to knock-in the Syk-ER™ fusion construct into 
the endogenous Syk gene using standard techniques. Correctly targeted ES cells will be 
injected into mouse blastocysts to generate chimaeric mice and male chimaeras will be 
bred to wild type females to transmit the mutant allele carrying the N-ER™ to the next 
generation. Mice heterozygous for this mutant allele will be intercrossed and pregnant 
females will be treated with tamoxifen to prevent the perinatal lethality as described
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before. If tamoxifen is unable to rescue this lethality, perhaps because it is not 
compatible with maintenance of pregnancy, Syk-ER™ fetal liver will be transplanted 
into irradiated mice. These radiation chimeras in turn will be treated with tamoxifen in 
order to rescue B cell development.
The question of whether Syk was needed for maintenance / survival of mature peripheral 
B cells could then be addressed. Tamoxifen treatment of knock-in mice should allow the 
development of mature B cells. Upon removal of tamoxifen one could measure the 
persistence of these B cells. If removing the ligand fully from the host proves to be 
impossible, these cells could be adoptively transferred into a new ligand-free host.
Furthermore, to study the ability of B cells to transduce BCR signals in the absence of 
functional Syk, the mice will be taken off tamoxifen. First the disappearance of Syk 
activity following removal of tamoxifen could be monitored by stimulating B cells 
through the BCR and looking at phosphorylation of Syk. Once the Syk-ER™ is fully 
sequestered by Hsp90 it will no longer be recruited to the BCR and will not be 
phosphorylated.
To examine the role of Syk in B cell signalling, cells could be stimulated through the 
BCR in the presence and absence of 4-OHT and their ability to proliferate could be 
measured. The effect of a lack of Syk on intracellular signalling pathways could be 
studied. In particular the BCR-induced tyrosine phosphorylation of the BCR subunits, of 
Src-family kinases and of other intracellular proteins will be studied, as well as the 
ability of the cells to induce a rise of intracellular calcium.
The Syk-ER™ knock-in mice will also be used to study the role of Syk in BCR- 
mediated responses in vivo. B cell function in these mice will be assessed by taking the
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mice off tamoxifen, immunising them with T-dependent or T-independent antigens, and 
measuring antibody responses, germinal center formation, class switching and somatic 
hypermutaion, and the generation and persistence of B cell memory.
B cells coming from these knock-in mice will allow a direct study of the role of Syk in 
the function of mature B cells, which is not possible using Syk'1' mice, due to the 
complete lack of mature B cells.
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6. Discussion
The Syk-family of PTKs plays an important role in lymphocyte development and 
signalling. Gene targeted mutant mice revealed that Syk plays a significant role in B cell 
development, whereas Zap70 is important for T cell development. Syk'1' mice show a 
partial block in B cell development at the pro-B to pre-B cell transition and a complete 
block at the immature to mature B cell transition (Cheng et al., 1995; Turner et al., 
1995). Mice deficient for Zap70 have normal numbers of DP thymocytes, but no CD4+ 
and CD8 + SP T cells (Negishi et al., 1995).
Unexpectedly, mice deficient for both Syk and Zap70 show a complete block in B cell 
development at the pro-B to pre-B cell transition, indicating that Zap70 plays a role in B 
cells, as well (Schweighoffer et al., 2003). Furthermore, Zap70 is expressed in a B-CLL 
cells from a subset of patients (Orchard et al., 2004; Wiestner et al., 2003). Interestingly, 
Zap70 expression correlates very strongly with poor prognostic outcome.
I set out to further explore the role Zap70 plays in B cell development and function. 
Furthermore, I wanted to find out whether Syk and Zap70 play similar or differential 
roles and whether Zap70 was able to compensate for the lack of Syk in B cell 
development. I also wanted to investigate the role of Syk in mature B cells. In order to 
do this, I made a hormone-inducible Syk protein and tested it in a chicken B lymphoma 
(DT40) cell line.
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6.1 Zap70 expression in different B cell subsets
First, I wanted to determine which subset of mature B cells expressed Zap70 and 
whether there was a particular subset that expressed more or less Zap70 than other B cell 
populations. I attempted to use flow cytometry to measure intracellular Zap70 
expression levels in B lineage cells. I optimised the conditions for the detection of 
intracellular Zap70 using thymocytes, which express high levels of this kinase (Fig.3.1). 
With the optimised staining method I was able to clearly detect Zap70 in thymocytes. 
The antibody used only detected Zap70, and did not detect the related Syk kinase. 
However, using this method, I was unable to detect Zap70 expression in B lineage cells 
from the bone marrow, spleen or peritoneal cavity (Fig.3.2 and data not shown), 
suggesting that if B lineage cells do express Zap70 kinase, they do so at a level well 
below that seen in thymocytes or mature T cells.
Next, I examined Zap70 expression in B lineage cells using immunoblotting. Using this 
technique, I was indeed able to detect Zap70 expression in all developing and mature B 
cell populations, including B1 and marginal zone B cells. I also wanted to quantify 
Zap70 expression during B cell development from the bone marrow to the spleen and 
compare it to levels in thymocytes. Normalised to the expression of ERK2, pro-B cells 
expressed 30-fold less Zap70 than TCRa1' thymocytes, whereas pre-B, immature and 
mature B cells expressed between 60- to 100-fold less (Fig.3.4). When normalised to the 
number of cells lysed, pro-B cells expressed 8 -fold less while pre-B, immature and 
mature B cells expressed 30-fold less Zap70 than TCRa1' thymocytes. Thus pro-B cells 
appear to express 2 to 3 times more Zap70 than all other B cell subsets. This correlates
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with the fact that in Syk'1' mice B cell development is only partially blocked at the pro-B 
to pre-B cell transition, but completely arrested at the immature B cell stage (Cheng et 
al., 1995; Turner et al., 1995). Pro-B cells seem to have sufficient amounts of Zap70 to 
drive B cell development through the pre-BCR checkpoint in the absence of Syk. 
However, because Zap70 expression levels are lower in immature B cells, these cells 
may not express enough Zap70 to allow B cell development to progress further in the 
absence of Syk, thus leading to a complete block of B cell development at the immature 
B cell stage in Syk'1' mice.
As an extension of this study, it would be interesting to explore the expression pattern of 
Zap70 in plasma cells, memory B cells and germinal centre B cells. This would be 
difficult to achieve in naive mice, because the numbers of cells in the B cell populations 
mentioned above are too low to be able to detect Zap70 using immunoblotting. 
Therefore mice could be immunised to boost cell numbers, before purifying the above B 
cell populations for immunoblotting. Furthermore, I could look at expression of Zap70 
in activated B cells. This could be done by activating naive B cells in vitro with for 
example, anti-IgM or LPS, and comparing Zap70 expression levels in activated and 
naive B cells.
6.2 The role ofZap70 in B cell development
I wanted to explore whether Zap70 plays a role at distinct stages of B cell development, 
other than the pre-BCR checkpoint. Therefore, I examined B cell populations from bone 
marrow, spleen, lymph nodes and peritoneal cavity of Zap7&' mice compared to wild-
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type mice. I also compared Zap7&' B cell subsets to those obtained from TCRa1' mice 
that, similarly to Zap7&' mice, lack mature a p T  cells. This allowed me to assess 
whether differences seen in Zap7&~ B cell populations were due to the lack of Zap70 in 
these B cells or to the absence of ap  T cells, and cytokines produced by ap  T cells, that 
might differentially affect the development of specific B cell subsets.
A significant increase was found in MZ B cells in the spleen and B ib cells in the 
peritoneal cavity of Zap70~'' mice. In contrast, TCRa1' mice had no change in numbers of 
MZ B cells in the spleen and showed a decrease of Bib cells in the peritoneal cavity. 
These findings suggest that the increase in MZ B cells and Bib cells in Zap70/_ mice 
was due to the lack of Zap70 in the B cells themselves, and not due to the lack of ap  T 
cells. However, these results were only partly confirmed in radiation chimeras 
reconstituted with Zap70rl'/pMT bone marrow, where a significant increase in 
percentage of Bib cells and in MZ B cell numbers. However, because cell numbers vary 
a lot from mouse to mouse, more radiation chimeras need to be analysed.
Although MZ and B IB  cells are distinct subsets, they share many phenotypic and 
functional characteristics (Berland and Wortis, 2002; Martin and Kearney, 2000a; 
Martin et al., 2001). Cells of both subsets are long-lived and participate in antibody 
responses to TI antigens. Both B1 and MZ B cells maintain normal numbers throughout 
life after arrest of B lymphopoiesis, suggesting that they are self-renewing (Hao and 
Rajewsky, 2001). It is clear that BCR signalling is involved in the enrichment of certain 
B1 and MZ B cell clones, since this process is impaired in xid, CD 19'' and CD45'1' mice 
(Martin and Kearney, 2000b; Martin and Kearney, 2001). B1 cells, enriched in the
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peritoneal and pleural cavities, are generated and maintained through continuous IgM 
signalling (Arnold et al., 1994; Hardy et al., 1994). Selection into the B1 compartment 
might require higher strength BCR signalling than selection into MRF and MZ B cell 
population (Casola et al., 2004). It has been reported that B cells assume the MZ 
phenotype as a consequence of receiving lower levels of BCR signalling than are 
required for entry into the MRF B cell pool (Cariappa et al., 2001). This conclusion was 
based on the fact that mice lacking the transcription factor Aiolos have B cells that are 
hyperresponsive to BCR signalling and essentially lack MZ B cells. In contrast xid mice, 
which have defective BCR signalling, have normal numbers of MZ B cells. 
Interestingly, however, mice lacking Aiolos, despite their hyperresponsive BCR 
signalling have reduced numbers of B1 cells (Wang et al., 1998). Inconsistent with 
weaker BCR signalling being necessary for MZ B cell development is the fact that both 
MZ B and B1 cells are absent or significantly decreased in CD 19 knock-out mice, which 
should have a weakened BCR signal (Martin and Kearney, 2000b; Rickert et al., 1995; 
Sato et al., 1996). Furthermore, it has been reported recently using a monoclonal BCR 
mouse line, specific for the self-Thy-l/CD90 glycoprotein that an increase in BCR 
signal strength, induced by low-dose self-antigen, directed naive immature B cells to 
mature, not into the MRF B cell population, but instead into the MZ B cells subset (Wen 
et al., 2005).
Furthermore, Notch2+/‘ mice show a reduction in frequency and absolute number of both 
B1 and MZ B cells, suggesting that Notch2 plays a role in determining the generation of 
MZ and B IB  cells. This also supports the notion that these two subsets share some 
common elements in their developmental pathways (Witt et al., 2003).
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In addition, pi 106-mutant mice have reduced numbers of MZ B cells and B1 cells 
(Clayton et al., 2002; Okkenhaug and Vanhaesebroeck, 2003). The same phenotype is 
also observed in CD19!' mice, which is not surprising as CD 19 is one of the main 
regulators of PI3-K in B cells (Tuveson et al., 1993) and mice expressing a tyrosine-to- 
phenylalanine mutant of CD 19 that cannot bind PI3-K also lack B1 and MZ B cells 
(Wang et al., 2002). These results suggest that a PI3-K-transmitted signal from CD19 is 
required for the differentiation of B1 and MZ B cells.
These findings together suggest that B1 and MZ B cells might need similar factors and 
signal transduction pathways for their development and differentiation.
Zap70''' B cells may have altered BCR signal strength favouring the development of B1 
and MZ B cells rather than MRF B cells. To test this hypothesis, a future set of 
experiments could involve transducing wt, Syk'1', Zap7&’ or Syk~l~Zap70r'~ hematopoietic 
stem cells with Zap70 or Syk and reconstitute lethally irradiated hosts with these 
infected cells. In the resulting chimeric mice one could monitor the development of B 
cells expressing different amounts of Syk or Zap70 kinases and ask whether changes in 
signal-strength may cause skewing towards particular B cell subsets.
Alternatively, different BCR repertoires could favour the development of either MZ B 
and B1 cells or MRF B cells. A potential role of Zap70 and also Syk may be to facilitate 
positive selection into the MRF B cell pool, by enhanced proliferation and/or survival of 
immature B cells with BCR repertoires suited for MRF B cells. In the absence of Zap70 
immature B cells with BCR repertoires in favour of MZ and B1 B cells may be 
preferentially outgrown.
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As CD19, Btk and PI3-K have been shown to be involved in development of MZ and B1 
B cells, because mice deficient in these proteins lack or have reduced numbers of B1 and 
MZ B cells. It is possible that other molecules, for example Zap70, are involved in the 
preferential development and maintenance of MRF B cells rather than MZ B and B1 
cells.
Differences in B cell subsets in Zap70r'~ and wt mice could be more apparent in a 
competitive environment where Zap7&~ B cells have to compete with wild-type B cells 
for a specific ‘niche’. Therefore the generation of competitive chimeras, which are made 
with different ratios of Zap70~'~ and wild type fetal liver, is going to be my next 
approach. Fetal liver cells will be used rather than bone marrow cells for these specific 
chimeras, because the development of B1 cells is of particular interest, which appear to 
be generated to their full potential only from fetal liver stem cells.
Also, if in Zap7&' mice BCR repertoires and/or signalling is altered due to decreased 
expression levels of the Syk family of PTKs, a similar increase in MZ and B ib cells 
could be observed in mice heterozygous for Syk.
6.3 The role o f Zap70 in B cell function
I first examined the role of Zap70 in B cell function by analysing immune responses to 
TD (T cell dependent) and TI (T cell independent) antigens. I made radiation chimeras 
using sublethally irradiated Ragl'1' recipient mice reconstituted with a mixture of 
wt/pMT or Zap70'l'/pMT bone marrow. All B cells in these chimeras come from wt or 
Zap70''' bone marrow whereas T cells come from wt or pMT bone marrow and have no
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signalling mutations. I chose to immunize these mice using TD and TI antigens 
dissolved in PBS to generate weak responses that are more likely to reveal differences 
caused by Zap70 deficiency. Immunisation with TD antigen TNP-KLH and Tl-antigens 
TNP-Ficoll or TNP-LPS showed no significant difference in responses of Zap7&' and 
wt chimeras. However, the TNP-Ficoll and TNP-KLH responses were very weak and 
need to be repeated and extended, perhaps using more antigen, or antigen with adjuvant. 
Next, I examined the role of Zap70 in mobilisation of calcium flux upon BCR 
stimulation in B cell subsets in the spleen and peritoneal cavity. No difference in 
mobilising calcium fluxes could be observed in Z a p 7 0 and wt mice.
In conclusion, Zap70 does not appear to play a role in the B cell responses examined, 
which suggest that Syk, the other member of the Syk/Zap kinase family is the dominant 
kinase during these processes.
However, the study concerning the role of Zap70 in B cell function is still very 
preliminary and needs to be extended. Future experiments will include exploring the 
turnover rate of developing and mature B cells by Bromodeoxyuridine (BrdU) labelling. 
Furthermore, I am going to examine germinal centre formation in the spleen in response 
to TD immunisation using immunohistochemistry. These TD immunisations need to be 
done as above in radiation chimeras reconstituted with Zap70,'lpMX bone marrow 
compared to radiation chimeras reconstituted with wt//*MT bone marrow as controls. In 
addition, I could look at migration of Zap70t'+ and Zap7O'1' B cells. It would be 
interesting to find out whether Zap70 is involved in integrin signalling of B cells. 
Furthermore, I could explore whether Zap70 is involved in class switching, by culturing
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naive B cells and activating them with LPS or anti-CD40 or CD40L. Then cells could be 
monitored for proliferation and for class switch recombination.
6.4 Overexpression ofZap70 can rescue the Syk'1' phenotype
Radiation chimeras reconstituted with Syk'1' fetal liver cells show a partial block at the 
pro-B to pre-B cell transition and a complete block at the immature B cell stage (Cheng 
et al., 1995; Turner et al., 1995). The partial block is due to the fact that Zap70 can 
compensate for the lack of Syk at the pre-BCR checkpoint (Schweighoffer et al., 2003). 
Zap7&' mice have no block in B cell development, but are blocked at the DP to SP 
transition in the thymus during T cell development. Mice deficient for both Syk and 
Zap70 are arrested at the DN to DP stage in T cell development, indicating a role of Syk 
at the pre-TCR checkpoint.
It has been shown that expression of a Syk transgene in Zap70 '' mice can rescue T cell 
development and therefore overexpression of Syk can compensate for the lack of Zap70 
in these mice (Gong et al., 1997). Furthermore, expression of Zap70 in Syk'1' DT40 cells 
rescues BCR signalling, suggesting that Zap70 is functionally equivalent to Syk in BCR 
signalling at least in chicken B cells (Kong et al., 1995).
I wanted to investigate whether the same was true for pre-BCR and BCR signals during 
murine B cell development and whether the complete block at the BCR checkpoint is 
due to insufficient levels of Zap70 in immature B cells. Alternatively, Syk and Zap70 
could have distinct functions and Zap70 may not be able to transduce the signals through 
the BCR in quite the same way as Syk and may thus be unable to support the selection
178
of immature B cells into the peripheral B cell pool. In support of this suggestion, it has 
been shown that the specific in vitro kinase activity of Syk is 100-fold higher than that 
of Zap70 (Latour et al., 1996), which might lead to the phosphorylation of a different set 
of downstream targets, and that Syk, but not Zap70 can be activated in an Lck- 
independent fashion (Latour et al., 1997).
I used retroviral gene transfer technology to overexpress Zap70 in Syk'1’ B lineage cells. 
Syk'1' embryos die around birth, so as a source of HSC I used fetal liver cells that were 
infected with retroviruses in vitro and then used to reconstitute lethally irradiated 
recipient mice. This technology is faster than making a transgenic mouse and in a 
chimeric mouse there are donor-derived cells that are infected with the retrovirus 
expressing the gene of interest, but also donor-derived uninfected cells, which can be. 
used as internal controls.
I have also tried bone marrow cells as a source of HSC. These bone marrow cells were 
obtained from 5-FU (5-fluorouracil) treated Syk'1' chimeras to enrich for HSC and were 
then retrovirally infected as described for fetal liver cells (data not shown) and 
secondary chimeras were made. However, Syk'1' chimeras have Syk'1' as well as wild type 
HSC. Unfortunately Syk'1' cells were outcompeted by wt cells in the secondary chimeras 
and therefore could not be used to analyse the overexpression of Zap70 in Syk'1' B cells.
After optimising transfection of the appropriate packaging cell line (PlatE) and 
transfection reagent (Genejuice), I infected Syk'1' fetal liver cells with retrovirus 
expressing Zap70 (pMSCV-IRES-huCD2-Zap70) and reconstituted lethally irradiated 
recipients. This system had two main advantages: first, donor-derived cells could be
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easily distinguished from host cells, by their expression of the cell surface marker Ly5.2, 
whereas the host was Ly5.1+. Second, infected donor-derived cells were identified by the 
expression of huCD2.
In the first set of experiments, I infected Syk'1' fetal liver cells with a retrovirus 
expressing Zap70 or an “empty” retrovirus as a control. Radiation chimeras were 
sacrificed 8-10 weeks after reconstitution, a period that is sufficient to ensure long-term 
reconstitution. Survival of the mice 8-10 weeks after reconstitution also confirmed that 
the ex vivo culture protocol did not compromise the ability of cultured HSC to mediate 
long-term radioprotection. Infected, huCD2+ donor-derived B cells from radiation 
chimeras reconstituted with Syk'1'*Zap70 fetal liver cells were able to overcome the 
block at the BCR checkpoint, which is a feature of Syk'1' B cells, and develop into 
IgM+IgD+ mature B cells in the bone marrow, spleen and lymph nodes. In contrast, 
infected, huCD2+ donor-derived B cells from radiation chimeras reconstituted with Syk'1' 
*empty vector were still arrested at the immature B cell stage in the bone marrow, and 
no donor-derived B cells were found in the spleen and lymph nodes.
Next, I extended the experiment and infected wt, Syk'1' and Syk''Zap70r'' fetal livers cells 
with a retrovirus expressing Zap70 and reconstituted lethally irradiated hosts. Fetal 
livers deficient in both Syk and Zap70, have no member of the Syk-family of PTKs, and 
are therefore a ‘cleaner’ model to observe whether overexpression of Zap70 alone drives 
B cells through both pre-BCR and BCR checkpoints. Donor-derived infected B cells of 
radiation chimeras were observed 8-10 weeks after reconstitution and the presence of 
mature B cells in the bone marrow, B2 cells in the spleen, lymph nodes and peritoneal 
cavity confirmed that in radiation chimeras reconstituted with Syk1'*Zap70 and Syk'1'
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Za/?7(F/'*Zap70 fetal liver cells, overexpression of Zap70 can drive cells through both 
developmental checkpoints. However, B lineage cells in the spleen of radiation chimeras 
reconstituted with ,S'y&'/'*Zap70 and Syk~l'Zap70'l'*ZdL\)10 fetal liver, were mainly B2 
cells; MZ B cells could not be clearly distinguished. Furthermore, in the peritoneal 
cavity of these radiation chimeras, donor-derived B cells were again mainly B2 cells, 
whereas B1 cells could not be seen. Surprisingly, this was also true for radiation 
chimeras reconstituted with wt*Zap70 fetal liver cells. Although it is believed that fetal 
liver cells give rise to a normal compartment of B 1 cells in the peritoneal cavity and 
adoptive transfer studies have confirmed this (Herzenberg, 2000; Kantor and 
Herzenberg, 1993), it is unknown whether the in vitro culture of the fetal liver cells 
skews them towards the development of B2 cells rather than B1 and MZ B cells.
Zap70 expression determined by intracellular flow cytometry revealed that according to 
mean fluorescence intensities, infected B cells in the lymph nodes expressed at least 5 
times more Zap70 than uninfected B cells and around 4 times less than CD 19' lymph 
node cells, which are mainly T cells (Fig.4.8). This finding shows that Zap70 expression 
levels in these Syk'1' B cells do not need to be as high as in T cells to be able to overcome 
the Syk'1' B cell developmental block.
In conclusion my results from this part of the study showed that Zap70 is able to 
transduce signals from the pre-BCR and BCR that are required to allow B cell 
development to proceed to a mature B cell stage. My results also suggest that the reason 
why Zap70 is unable to compensate for the lack of Syk in developmentally arrested Syk'1' 
immature B cells is probably its very low expression level. Based on the above findings
181
I cannot exclude, however, that even if present in sufficient quantities, Zap70 may not be 
able to perform all the necessary tasks as efficiently as Syk.
6.5 Loss o f CD21 expression on wt splenic B cells expressing Zap70
An interesting observation was made while analysing radiation chimeras reconstituted 
with wt*Zap70 fetal liver cells. Splenic donor-derived infected B cells 
(huCD2+CD19+CD23+) have little or no CD21 expression, whereas donor-derived 
uninfected B cells had normal expression of CD21. This observation was made in 3 out 
of 4 radiation chimeras analysed. The expression pattern of other surface markers, e.g. 
CD 19, IgM and IgD were unchanged.
It is known that the surface expression of CD21 in follicular B cells decreases in 
autoimmune MRL/lpr mice, and it has been speculated that this decrease might reflect 
activation by antigen (Mandik-Nayak et al., 1999; Takahashi et al., 1997). A similar 
decrease in CD21 expression has been seen in patients with SLE (Wehr et al., 2004; 
Wilson et al., 1986). Anti-IgM crosslinking in vitro of normal human B cells has been 
shown to contribute to a decrease in CD21 expression (Boyd et al., 1985). Follicular B 
cells that lack Aiolos have markedly reduced expression levels of CD21, possibly 
because these cells receive constitutive BCR-derived signals (Cariappa et al., 2001). It is 
therefore possible that BCR signalling can cause a reduction in CD21 expression.
B cells that express normal amounts of endogenous Syk-family of protein tyrosine 
kinases and in addition express Zap70 from the retroviral vector, might receive enhanced
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or even constitutive BCR signals. This activation might result in a reduction or loss of 
CD21 expression on follicular B cells.
To address this further I will examine other cell surface markers on wild-type B cells 
overexpressing Zap70, e.g. activation markers like CD86 or MHC class II.
To take these experiments further, I plan to create a series of radiation chimeras 
expressing different levels of one or both of the Syk-family kinases. To achieve this I 
will use wt, Zap70~'\ Syk'1' or Syk'''Zap70''' fetal liver cells and transduce them with 
retrovirus carrying Syk, Zap70 or neither of these molecules.
If BCR strength does indeed influence cell fate decisions during B cell development, and 
if altering the levels of these kinases changes the strength of signalling, these chimeric 
mice could reveal the correlation between the presence or absence of different B cell 
populations and BCR signal strength.
6.6. Hormone-inducible Syk-ER fusion protein
As B cell development is completely blocked at the immature B cell stage in the absence 
of Syk, it is not possible to study the role of Syk in mature B cell development in 
conventional gene-targeted animals. However, by making Syk inducible, such that it 
could be switched on and off at different stages of B cell development, it may be 
possible to study the role of Syk in mature B cells.
There are many different techniques of generating animals with inducible expression of 
genes. One system is the Cre-loxP system. Two loxP site could be introduced within the
183
Syk gene so that after Cre-mediated recombination Syk would be inactivated. This 
choice would allow B cell development to proceed to the mature B cell stage. And one 
could explore the role of Syk in mature B cells. However, the disadvantage of this 
system is that mice with introduced loxP site in the gene of interest need to be crossed to 
mouse lines expressing Cre recombinase in order to obtain Cre-mediated recombination, 
which is not a quick process.
The tetracycline-based inducible system (tet-system) is one option of making an 
inducible and reversible Syk protein. This system uses the reverse transactivator, rtTA, 
which binds to the tetracycline operator tetO, in the presence of the tetracycline derivate 
doxycycline, and induces transcription of the gene of interest, which is placed under the 
control of tetO. In the absence of doxycycline rtTA is not able to bind to tetO, thus the 
gene of interest is not transcribed. The disadvantage of this system is that is slow, 
needing around four days for the protein to be fully switched off and around 24 hours for 
the system to be switched on (Legname et al., 2000).
The system I decided to use was to fuse the ER-HBD (estrogen receptor hormone- 
binding domain) to Syk, thereby rendering Syk hormone-inducible. The advantages of 
this system are reversibility and rapid induction. Unlike the tet-system, it neither 
requires transcription nor translation for induction of activity. To test the function of the 
Syk-ER fusion proteins, I used DT40 cells as an in vitro test system, where the BCR- 
induced calcium flux is completely dependent on Syk. Three different fusion proteins 
(Syk-NER™, Syk-HER™ and Syk-CER™) were expressed in Syk'1' DT40 cells, and 
BCR-induced calcium flux in the presence and absence of 4-OHT was analysed. This 
experiments revealed that both the Syk-NER™ and Syk-HER™ were activated in a
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hormone-dependent manner. Clones expressing the Syk-CER™ fusion protein were 
constitutively active. This might be due to the high expression levels of the Syk-CER™, 
resulting in insufficient amounts of Hsp90 in the cell to keep the fusion protein in an 
inactive state.
Two versions of the ER HBD are available, the ER™ and the newer version ERT2. The 
ERT2 is believed to be lOx more sensitive to tamoxifen than the ER™, which might be 
useful for later studies of Syk-ER in an in vivo mouse model. I therefore made Syk- 
NER12 and tested its homone-inducibility in ‘Syk'1' DT40 cells. Clones expressing Syk- 
NER12, however, were not entirely hormone-dependent, in contrast to clones stably 
expressing Syk-NER™, therefore I decided to proceed with the Syk-ER™ fusion 
protein. Returning to analysis of Syk-NER™, I established the lowest concentration of 
4-OHT (lOOnM) and the shortest incubation time (lOmin) needed to fully activate Syk- 
ER. Furthermore, I found that Syk-ER was indeed reversible; 24 hours after removal of 
4-OHT Syk-ER was inactive.
The exact mechanism of 4-OHT action on these fusion proteins is unknown. One 
possibility is that once 4-OHT binds to the HBD it cannot dissociate anymore. The 
hormone needs to be degraded first, before HBD is accessible for Hsp90 binding. As the 
half-life of 4-OHT is 6 hours (Danielian et al., 1998), it might take 24 hours before the 
cell is hormone-free and the fusion-protein therefore inactivated. Another possibility is 
that the conformational changes caused by hormone-binding are not reversible. Thus to 
eliminate active Syk, the fusion protein would need to be degraded, new fusion protein 
would need to be synthesised, which would now be complexed with Hsp90 and hence 
inactive.
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A knock-in mouse expressing the Syk-ER would enable me to study the role of Syk in 
mature B cells. One could study the role of Syk in TD- and Tl-independent immune 
responses, in plasma cell generation and germinal centre formation. One could monitor 
B cell proliferation after BCR-stimulation as well as B cell persistence in the presence 
and absence of Syk. Finally, one could address the role of Syk in class switch 
recombination and somatic hypermutation, and memory B cell formation and peristance.
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6.7 Overall conclusions
In these studies I have investigated the role of Zap70 in B cell development and 
function. I have shown that Zap70 is expressed in all developing and mature B cell 
subsets. However the highest expression levels were observed in pro-B cells, in which 
Zap70 seems to be able to drive cells through the pre-BCR checkpoint. In terms of the 
involvement of Zap70 in B cell development, I have also shown an increase in MZ and 
B IB  cells in Zap7&~ mice, which seems to be due to the lack of Zap70 in the B cell 
lineage itself. In terms of B cell function, I have explored the role of Zap70 in TD and TI 
immune responses and BCR-induced calcium release. However, Zap7(7'' B cells were 
able to mount responses to both, TD and TI antigens. Furthermore, Zap70-deficient B 
cells had no defect in BCR-induce calcium release.
Using retroviral gene transfer technology I was able to show that Zap70 can compensate 
for the lack of Syk at the pre-BCR and BCR checkpoints and therefore, the complete 
block of Syk'1' B cells at the BCR checkpoint likely due to insufficient amounts of 
Zap70.
Finally, I have also generated an inducible Syk kinase. I confirmed that the Syk-N-ER™ 
works in a hormone-inducible manner and made the first step toward the Syk-ER knock- 
in mouse.
187
7. References
Abbas, A. K. (2000). Cellular and molecular immunology, fourth edn).
Abtahian, F., Guerriero, A., Sebzda, E., Lu, M. M., Zhou, R., Mocsai, A., Myers, E. E., 
Huang, B., Jackson, D. G., Ferrari, V. A., et al. (2003). Regulation of blood and 
lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 299,247- 
251.
Alarid, E. T., Bakopoulos, N., and Solodin, N. (1999). Proteasome-mediated proteolysis 
of estrogen receptor: a novel component in autologous down-regulation. Mol Endocrinol 
13 ,1522-1534.
Allman, D., Li, J., and Hardy, R. R. (1999). Commitment to the B lymphoid lineage 
occurs before DH-JH recombination. J Exp Med 189,735-740.
Allman, D., Lindsley, R. C., DeMuth, W., Rudd, K., Shinton, S. A., and Hardy, R. R. 
(2001). Resolution of three nonproliferative immature splenic B cell subsets reveals 
multiple selection points during peripheral B cell maturation. J Immunol 167, 6834- 
6840.
Arnold, L. W., Pennell, C. A., McCray, S. K., and Clarke, S. H. (1994). Development of 
B-l cells: segregation of phosphatidyl choline-specific B cells to the B-l population 
occurs after immunoglobulin gene expression. J Exp Med 179,1585-1595.
188
Bain, G., Robanus Maandag, E. C., te Riele, H. P., Feeney, A. J., Sheehy, A., Schlissel, 
M., Shinton, S. A., Hardy, R. R., and Murre, C. (1997). Both E12 and E47 allow 
commitment to the B cell lineage. Immunity 6,145-154.
Bannish, G., Fuentes-Panana, E. M., Cambier, J. C., Pear, W. S., and Monroe, J. G.
(2001). Ligand-independent signaling functions for the B lymphocyte antigen receptor 
and their role in positive selection during B lymphopoiesis. J Exp Med 194,1583-1596.
Barkett, M., and Gilmore, T. D. (1999). Control of apoptosis by Rel/NF-kappaB 
transcription factors. Oncogene 18,6910-6924.
Bergman, Y., and Cedar, H. (2004). A stepwise epigenetic process controls 
immunoglobulin allelic exclusion. Nat Rev Immunol 4 ,753-761.
Berland, R., and Wortis, H. H. (2002). Origins and functions of B-l cells with notes on 
the role of CD5. Annu Rev Immunol 20,253-300.
Bikah, G., Carey, J., Ciallella, J. R., Tarakhovsky, A., and Bondada, S. (1996). CD5- 
mediated negative regulation of antigen receptor-induced growth signals in B-l B cells. 
Science 274,1906-1909.
Boyd, A. W., Anderson, K. C., Freedman, A. S., Fisher, D. C., Slaughenhoupt, B., 
Schlossman, S. F., and Nadler, L. M. (1985). Studies of in vitro activation and 
differentiation of human B lymphocytes. I. Phenotypic and functional characterization of 
the B cell population responding to anti-Ig antibody. J Immunol 134,1516-1523.
189
Brazil, D. P., Park, J., and Hemmings, B. A. (2002). PKB binding proteins. Getting in on 
theAkt. Cell 777,293-303.
Brdicka, T., Kadlecek, T. A., Roose, J. P., Pastuszak, A. W., and Weiss, A. (2005). 
Intramolecular regulatory switch in ZAP-70: analogy with receptor tyrosine kinases.
Mol Cell Biol 25,4924-4933.
Burk, O., and Klempnauer, K. H. (1991). Estrogen-dependent alterations in 
differentiation state of myeloid cells caused by a v-myb/estrogen receptor fusion protein. 
Embo J 10, 3713-3719.
Burkhardt, A. L., Brunswick, M., Bolen, J. B., and Mond, J. J. (1991). Anti­
immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine 
kinases. Proc Natl Acad Sci U S A 88,7410-7414.
Calame, K. L., Lin, K. I., and Tunyaplin, C. (2003). Regulatory mechanisms that 
determine the development and function of plasma cells. Annu Rev Immunol 27,205- 
230.
Cariappa, A., Tang, M., Parng, C., Nebelitskiy, E., Carroll, M., Georgopoulos, K., and 
Pillai, S. (2001). The follicular versus marginal zone B lymphocyte cell fate decision is 
regulated by Aiolos, Btk, and CD21. Immunity 14, 603-615.
190
Camero, A., Hudson, J. D., Hannon, G. J., and Beach, D. H. (2000). Loss-of-function 
genetics in mammalian cells: the p53 tumor suppressor model. Nucleic Acids Res 28, 
2234-2241.
Carroll, M. C. (1998). The role of complement and complement receptors in induction 
and regulation of immunity. Annu Rev Immunol 16,545-568.
Carsetti, R., Kohler, G., and Lamers, M. C. (1995). Transitional B cells are the target of 
negative selection in the B cell compartment. J Exp Med 181,2129-2140.
Carter, R. H., Doody, G. M., Bolen, J. B., and Fearon, D. T. (1997). Membrane IgM- 
induced tyrosine phosphorylation of CD 19 requires a CD 19 domain that mediates 
association with components of the B cell antigen receptor complex. J Immunol 158, 
3062-3069.
Casola, S., Otipoby, K. L., Alimzhanov, M., Humme, S., Uyttersprot, N., Kutok, J. L., 
Carroll, M. C., and Rajewsky, K. (2004). B cell receptor signal strength determines B 
cell fate. Nat Immunol 5, 317-327.
Chan, A. C., Iwashima, M., Turck, C. W., and Weiss, A. (1992). ZAP-70: a 70 kd 
protein-tyrosine kinase that associates with the TCR zeta chain. Cell 71,649-662.
Chan, A. C., van Oers, N. S., Tran, A., Turka, L., Law, C. L., Ryan, J. C., Clark, E. A., 
and Weiss, A. (1994). Differential expression of ZAP-70 and Syk protein tyrosine
191
kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J 
Immunol 752,4758-4766.
Chan, V. W., Meng, F., Soriano, P., DeFranco, A. L., and Lowell, C. A. (1997). 
Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of 
Lyn in signal initiation and down-regulation. Immunity 7,69-81.
Chen, L., Apgar, J., Huynh, L., Dicker, F., Giago-McGahan, T., Rassenti, L., Weiss, A., 
and Kipps, T. J. (2005). ZAP-70 directly enhances IgM signaling in chronic lymphocytic 
leukemia. Blood 105,2036-2041.
Chen, L., Widhopf, G., Huynh, L., Rassenti, L., Rai, K. R., Weiss, A., and Kipps, T. J.
(2002). Expression of ZAP-70 is associated with increased B-cell receptor signaling in 
chronic lymphocytic leukemia. Blood 100,4609-4614.
Cheng, A. M., Negishi, I., Anderson, S. J., Chan, A. C., Bolen, J., Loh, D. Y., and 
Pawson, T. (1997). The Syk and ZAP-70 SH2-containing tyrosine kinases are implicated 
in pre-T cell receptor signaling. Proc Natl Acad Sci U S A 94,9797-9801.
Cheng, A. M., Rowley, B., Pao, W., Hayday, A., Bolen, J. B., and Pawson, T. (1995). 
Syk tyrosine kinase required for mouse viability and B-cell development. Nature 378, 
303-306.
192
Chu, D. H., Spits, H., Peyron, J. F., Rowley, R. B., Bolen, J. B., and Weiss, A. (1996). 
The Syk protein tyrosine kinase can function independently of CD45 or Lck in T cell 
antigen receptor signaling. Embo J 75,6251-6261.
Chu, D. H., van Oers, N. S., Malissen, M., Harris, J., Elder, M., and Weiss, A. (1999). 
Pre-T cell receptor signals are responsible for the down-regulation of Syk protein 
tyrosine kinase expression. J Immunol 163,2610-2620.
Chumley, M. J., Dal Porto, J. M., Kawaguchi, S., Cambier, J. C., Nemazee, D., and 
Hardy, R. R. (2000). A VH1IV kappa 9 B cell antigen receptor drives generation of 
CD5+ B cells both in vivo and in vitro. J Immunol 164,4586-4593.
Chung, J. B., Sater, R. A., Fields, M. L., Erikson, J., and Monroe, J. G. (2002). CD23 
defines two distinct subsets of immature B cells which differ in their responses to T cell 
help signals. Int Immunol 1 4 ,157-166.
Chung, J. B., Silverman, M., and Monroe, J. G. (2003). Transitional B cells: step by step 
towards immune competence. Trends Immunol 24, 343-349.
Clayton, E., Bardi, G., Bell, S. E., Chantry, D., Downes, C. P., Gray, A., Humphries, L. 
A., Rawlings, D., Reynolds, H., Vigorito, E., and Turner, M. (2002). A crucial role for 
the pi lOdelta subunit of phosphatidylinositol 3-kinase in B cell development and 
activation. J Exp Med 196,753-763.
193
Colucci, F., Schweighoffer, E., Tomasello, E., Turner, M., Ortaldo, J. R., Vivier, E., 
Tybulewicz, V. L., and Di Santo, J. P. (2002). Natural cytotoxicity uncoupled from the 
Syk and ZAP-70 intracellular kinases. Nat Immunol 3 ,288-294.
Colucci, F., Soudais, C., Rosmaraki, E., Vanes, L., Tybulewicz, V. L., and Di Santo, J.
P. (1999a). Dissecting NK cell development using a novel alymphoid mouse model: 
investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. J 
Immunol 162,2761-2765.
Colucci, F., Turner, M., Schweighoffer, E., Guy-Grand, D., Di Bartolo, V., Salcedo, M., 
Tybulewicz, V. L., and Di Santo, J. P. (1999b). Redundant role of the Syk protein 
tyrosine kinase in mouse NK cell differentiation. J Immunol 163,1769-1774.
Corcoran, A. E. (2005). Immunoglobulin locus silencing and allelic exclusion. Semin 
Immunol 17 ,141-154.
Costello, P. S., Turner, M., Walters, A. E., Cunningham, C. N., Bauer, P. H.,
Downward, J., and Tybulewicz, V. L. (1996). Critical role for the tyrosine kinase Syk in 
signalling through the high affinity IgE receptor of mast cells. Oncogene 13,2595-2605.
Couture, C., Williams, S., Gauthier, N., Tailor, P., and Mustelin, T. (1997). Role of 
Tyr518 and Tyr519 in the regulation of catalytic activity and substrate phosphorylation 
by Syk protein-tyrosine kinase. Eur J Biochem 246,447-451.
194
Crespo, P., Schuebel, K. E., Ostrom, A. A., Gutkind, J. S., and Bustelo, X. R. (1997). 
Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto­
oncogene product. Nature 385,169-172.
Cyster, J. G., and Goodnow, C. C. (1995). Antigen-induced exclusion from follicles and 
anergy are separate and complementary processes that influence peripheral B cell fate. 
Immunity 3 ,691-701.
Cyster, J. G., Healy, J. I., Kishihara, K., Mak, T. W., Thomas, M. L., and Goodnow, C. 
C. (1996). Regulation of B-lymphocyte negative and positive selection by tyrosine 
phosphatase CD45. Nature 381, 325-328.
Dal Porto, J. M., Gauld, S. B., Merrell, K. T., Mills, D., Pugh-Bernard, A. E., and 
Cambier, J. (2004). B cell antigen receptor signaling 101. Mol Immunol 41 ,599-613.
Danielian, P. S., Muccino, D., Rowitch, D. H., Michael, S. K., and McMahon, A. P. 
(1998). Modification of gene activity in mouse embryos in utero by a tamoxifen- 
inducible form of Cre recombinase. Curr Biol 8 ,1323-1326.
Danielian, P. S., White, R., Hoare, S. A., Fawell, S. E., and Parker, M. G. (1993). 
Identification of residues in the estrogen receptor that confer differential sensitivity to 
estrogen and hydroxytamoxifen. Mol Endocrinol 7,232-240.
195
Deckert, M., Elly, C., Altman, A., and Liu, Y. C. (1998). Coordinated regulation of the 
tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases. J Biol Chem 273, 
8867-8874.
Deckert, M., Tartare-Deckert, S., Couture, C., Mustelin, T., and Altman, A. (1996). 
Functional and physical interactions of Syk family kinases with the Vav proto-oncogene 
product. Immunity 5,591-604.
Doody, G. M., Bell, S. E., Vigorito, E., Clayton, E., McAdam, S., Tooze, R., Fernandez, 
C., Lee, I. J., and Turner, M. (2001). Signal transduction through Vav-2 participates in 
humoral immune responses and B cell maturation. Nat Immunol 2,542-547.
Eilers, M., Picard, D., Yamamoto, K. R., and Bishop, J. M. (1989). Chimaeras of myc 
oncoprotein and steroid receptors cause hormone-dependent transformation of cells. 
Nature 340,66-68.
Fagarasan, S., Shinkura, R., Kamata, T., Nogaki, F., Ikuta, K., Tashiro, K., and Honjo, 
T. (2000). Alymphoplasia (aly)-type nuclear factor kappaB-inducing kinase (NIK) 
causes defects in secondary lymphoid tissue chemokine receptor signaling and homing 
of peritoneal cells to the gut-associated lymphatic tissue system. J Exp Med 191,1477- 
1486.
Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Valetto, A., Allen, S. L., Schulman, P., 
Vinciguerra, V. P., Rai, K., Rassenti, L. Z., et al. (1998). Chronic lymphocytic leukemia
196
B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 
102,1515-1525.
Fearon, D. T., and Carter, R. H. (1995). The CD19/CR2/TAPA-1 complex of B 
lymphocytes: linking natural to acquired immunity. Annu Rev Immunol 1 3 ,127-149.
Feil, R., Brocard, J., Mascrez, B., LeMeur, M., Metzger, D., and Chambon, P. (1996). 
Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A 93, 
10887-10890.
Flaishon, L., Hershkoviz, R., Lantner, F., Lider, O., Alon, R., Levo, Y., Flavell, R. A., 
and Shachar, I. (2000). Autocrine secretion of interferon gamma negatively regulates 
homing of immature B cells. J Exp Med 192,1381-1388.
Fu, C., Turck, C. W., Kurosaki, T., and Chan, A. C. (1998). BLNK: a central linker 
protein in B cell activation. Immunity 9,93-103.
Fujimoto, M., Fujimoto, Y., Poe, J. C., Jansen, P. J., Lowell, C. A., DeFranco, A. L., and 
Tedder, T. F. (2000). CD19 regulates Src family protein tyrosine kinase activation in B 
lymphocytes through processive amplification. Immunity 13,47-57.
Fultz, M., Carman, J., Finkelman, F. D., and Mond, J. J. (1989). Neonatal suppression 
with anti-la antibody. III. In vivo responses to the type 2 antigen TNP-Ficoll. J Immunol 
143,403-406.
197
Gay, D., Saunders, T., Camper, S., and Weigert, M. (1993). Receptor editing: an 
approach by autoreactive B cells to escape tolerance. J Exp Med 777,999-1008.
Germain, R. N. (2002). T-cell development and the CD4-CD8 lineage decision. Nat Rev 
Immunol 2, 309-322.
Gevrey, J. C., Isaac, B. M., and Cox, D. (2005). Syk Is Required for 
Monocyte/Macrophage Chemotaxis to CX3CL1 (Fractalkine). J Immunol 775, 3737- 
3745.
Glick, B. (1991). Historical perspective: the bursa of Fabricius and its influence on B- 
cell development, past and present. Vet Immunol Immunopathol 30, 3-12.
Godfrey, D. I., Kennedy, J., Suda, T., and Zlotnik, A. (1993). A developmental pathway 
involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- 
triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J 
Immunol 150,4244-4252.
Gong, Q., White, L., Johnson, R., White, M., Negishi, I., Thomas, M., and Chan, A. C.
(1997). Restoration of thymocyte development and function in zap-70-/- mice by the 
Syk protein tyrosine kinase. Immunity 7,369-377.
Gong, S., and Nussenzweig, M. C. (1996). Regulation of an early developmental 
checkpoint in the B cell pathway by Ig beta. Science 272,411-414.
198
Goodnow, C. C., Crosbie, J., Adelstein, S., Lavoie, T. B., Smith-Gill, S. J., Brink, R. A., 
Pritchard-Briscoe, H., Wotherspoon, J. S., Loblay, R. H., Raphael, K., and et al. (1988). 
Altered immunoglobulin expression and functional silencing of self-reactive B 
lymphocytes in transgenic mice. Nature 334,676-682.
Greenberg, S., Chang, P., Wang, D. C., Xavier, R., and Seed, B. (1996). Clustered syk 
tyrosine kinase domains trigger phagocytosis. Proc Natl Acad Sci U S A 9 3 ,1103-1107.
Gulbranson-Judge, A., Tybulewicz, V. L., Walters, A. E., Toellner, K. M., MacLennan,
I. C., and Turner, M. (1999). Defective immunoglobulin class switching in Vav-deficient 
mice is attributable to compromised T cell help. Eur J Immunol 29,477-487.
Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G., and Stevenson, F. K. (1999). 
Unmutated Ig V(H) genes are associated with a more aggressive form of chronic 
lymphocytic leukemia. Blood 9 4 ,1848-1854.
Hao, Z., and Rajewsky, K. (2001). Homeostasis of peripheral B cells in the absence of B 
cell influx from the bone marrow. J Exp Med 194,1151-1164.
Hardy, R. R. (2003). B-cell commitment: deciding on the players. Curr Opin Immunol 
15 ,158-165.
Hardy, R. R., Carmack, C. E., Li, Y. S., and Hayakawa, K. (1994). Distinctive 
developmental origins and specificities of murine CD5+ B cells. Immunol Rev 137,91- 
118.
199
Hardy, R. R., and Hayakawa, K. (1991). A developmental switch in B lymphopoiesis. 
Proc Natl Acad Sci U S A 8 8 ,11550-11554.
Hardy, R. R., and Hayakawa, K. (2001). B cell development pathways. Annu Rev 
Immunol 79,595-621.
Harnett, M. M., Katz, E., and Ford, C. A. (2005). Differential signalling during B-cell 
maturation. Immunol Lett 98, 33-44.
Hashimoto, S., Iwamatsu, A., Ishiai, M., Okawa, K., Yamadori, T., Matsushita, M., 
Baba, Y., Kishimoto, T., Kurosaki, T., and Tsukada, S. (1999). Identification of the SH2 
domain binding protein of Bruton's tyrosine kinase as BLNK-functional significance of 
Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. Blood 94 ,2357- 
2364.
Haughton, G., Arnold, L. W., Whitmore, A. C., and Clarke, S. H. (1993). B-l cells are 
made, not bom. Immunol Today 14, 84-87; discussion 87-91.
Hayakawa, K., Asano, M., Shinton, S. A., Gui, M., Allman, D., Stewart, C. L., Silver, J., 
and Hardy, R. R. (1999). Positive selection of natural autoreactive B cells. Science 285, 
113-116.
Hendriks, R. W., and Middendorp, S. (2004). The pre-BCR checkpoint as a cell- 
autonomous proliferation switch. Trends Immunol 25,249-256.
200
Herzenberg, L. A. (2000). B-l cells: the lineage question revisited. Immunol Rev 775,9- 
22.
Hibbs, M. L., Tarlinton, D. M., Armes, J., Grail, D., Hodgson, G., Maglitto, R., Stacker, 
S. A., and Dunn, A. R. (1995). Multiple defects in the immune system of Lyn-deficient 
mice, culminating in autoimmune disease. Cell 83, 301-311.
Hong, J. J., Yankee, T. M., Harrison, M. L., and Geahlen, R. L. (2002). Regulation of 
signaling in B cells through the phosphorylation of Syk on linker region tyrosines. A 
mechanism for negative signaling by the Lyn tyrosine kinase. J Biol Chem 277,31703- 
31714.
Hope, T. J., Huang, X. J., McDonald, D., and Parslow, T. G. (1990). Steroid-receptor 
fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic 
functions of the arginine-rich motif. Proc Natl Acad Sci U S A 87,7787-7791.
Inaoki, M., Sato, S., Weintraub, B. C., Goodnow, C. C., and Tedder, T. F. (1997). 
CD19-regulated signaling thresholds control peripheral tolerance and autoantibody 
production in B lymphocytes. J Exp Med 186,1923-1931.
Indik, Z. K., Park, J. G., Hunter, S., and Schreiber, A. D. (1995). The molecular 
dissection of Fc gamma receptor mediated phagocytosis. Blood 86,4389-4399.
Indra, A. K., Warot, X., Brocard, J., Bomert, J. M., Xiao, J. H., Chambon, P., and 
Metzger, D. (1999). Temporally-controlled site-specific mutagenesis in the basal layer
201
of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible 
Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 27,4324-4327.
Inman, J. K. (1975). Thymus-independent antigens: the preparation of covalent, hapten- 
ficoll conjugates. J Immunol 114,704-709.
Jackson, P., Baltimore, D., and Picard, D. (1993). Hormone-conditional transformation 
by fusion proteins of c-Abl and its transforming variants. Embo J 12, 2809-2819.
Jacob, J., Kassir, R., and Kelsoe, G. (1991). In situ studies of the primary immune 
response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of 
responding cell populations. J Exp Med 173,1165-1175.
Jacobs, D. M., and Morrison, D. C. (1975). Stimulation of a T-independent primary anti­
hapten response in vitro by TNP-lipopolysaccharide (TNP-LPS). J Immunol 114, 360- 
364.
Jacobs, H., and Brass, L. (2001). Towards an understanding of somatic hypermutation. 
Curr Opin Immunol 13,208-218.
Janeway, C. A., Jr., Travers P., Walport M., Shlomchik M. (2001). immunobiology, fifth 
edn, Garland publishing).
Kadlecek, T. A., van Oers, N. S., Lefrancois, L., Olson, S., Finlay, D., Chu, D. H., 
Connolly, K., Killeen, N., and Weiss, A. (1998). Differential requirements for ZAP-70 
in TCR signaling and T cell development. J Immunol 161,4688-4694.
202
Kaisho, T., Takeda, K., Tsujimura, T., Kawai, T., Nomura, F., Terada, N., and Akira, S.
(2001). IkappaB kinase alpha is essential for mature B cell development and function. J 
Exp Med 193,417-426.
Kamogawa, Y., Lee, H. J., Johnston, J. A., McMahon, M., O'Garra, A., and Arai, N.
(1998). A conditionally active form of STAT6 can mimic certain effects of IL-4. J 
Immunol 161,1074-1077.
Kantor, A. B., and Herzenberg, L. A. (1993). Origin of murine B cell lineages. Annu 
Rev Immunol 11,501-538.
Karasuyama, H., Rolink, A., and Melchers, F. (1993). A complex of glycoproteins is 
associated with VpreB/lambda 5 surrogate light chain on the surface of mu heavy chain- 
negative early precursor B cell lines. J Exp Med 178,469-478.
Keshvara, L. M., Isaacson, C., Harrison, M. L., and Geahlen, R. L. (1997). Syk 
activation and dissociation from the B-cell antigen receptor is mediated by 
phosphorylation of tyrosine 130. J Biol Chem 272 ,10377-10381.
Khan, W. N., Alt, F. W., Gerstein, R. M., Malynn, B. A., Larsson, I., Rathbun, G., 
Davidson, L., Muller, S., Kantor, A. B., Herzenberg, L. A., and et al. (1995). Defective 
B cell development and function in Btk-deficient mice. Immunity 3 ,283-299.
203
Kiefer, F., Brumell, J., Al-Alawi, N., Latour, S., Cheng, A., Veillette, A., Grinstein, S., 
and Pawson, T. (1998). The Syk protein tyrosine kinase is essential for Fcgamma 
receptor signaling in macrophages and neutrophils. Mol Cell Biol 18,4209-4220.
Kitamura, D., Kudo, A., Schaal, S., Muller, W., Melchers, F., and Rajewsky, K. (1992). 
A critical role of lambda 5 protein in B cell development. Cell 69, 823-831.
Kitamura, D., Roes, J., Kuhn, R., and Rajewsky, K. (1991). A B cell-deficient mouse by 
targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 
350,423-426.
Kolanus, W., Romeo, C., and Seed, B. (1993). T cell activation by clustered tyrosine 
kinases. Cell 74 ,171-183.
Kondo, M., Weissman, I. L., and Akashi, K. (1997). Identification of clonogenic 
common lymphoid progenitors in mouse bone marrow. Cell 91,661-672.
Kong, G. H., Bu, J. Y., Kurosaki, T., Shaw, A. S., and Chan, A. C. (1995). 
Reconstitution of Syk function by the ZAP-70 protein tyrosine kinase. Immunity 2,485- 
492.
Koyasu, S. (2003). The role of PI3K in immune cells. Nat Immunol 4, 313-319.
Kroese, F. G., Ammerlaan, W. A., and Kantor, A. B. (1993). Evidence that intestinal 
IgA plasma cells in mu, kappa transgenic mice are derived from B-l (Ly-1 B) cells. Int 
Immunol 5,1317-1327.
204
Kudo, A., and Melchers, F. (1987). A second gene, VpreB in the lambda 5 locus of the 
mouse, which appears to be selectively expressed in pre-B lymphocytes. Embo J 6, 
2267-2272.
Kurosaki, T., Johnson, S. A., Pao, L., Sada, K., Yamamura, H., and Cambier, J. C. 
(1995). Role of the Syk autophosphorylation site and SH2 domains in B cell antigen 
receptor signaling. J Exp Med 182,1815-1823.
Kurosaki, T., Takata, M., Yamanashi, Y., Inazu, T., Taniguchi, T., Yamamoto, T., and 
Yamamura, H. (1994). Syk activation by the Src-family tyrosine kinase in the B cell 
receptor signaling. J Exp Med 179,1725-1729.
Kurosaki, T., and Tsukada, S. (2000). BLNK: connecting Syk and Btk to calcium 
signals. Immunity 72,1-5.
Lam, K. P., Kuhn, R., and Rajewsky, K. (1997). In vivo ablation of surface 
immunoglobulin on mature B cells by inducible gene targeting results in rapid cell 
death. Cell 9 0 ,1073-1083.
Latour, S., Chow, L. M., and Veillette, A. (1996). Differential intrinsic enzymatic 
activity of Syk and Zap-70 protein-tyrosine kinases. J Biol Chem 271,22782-22790.
Latour, S., Fournel, M., and Veillette, A. (1997). Regulation of T-cell antigen receptor 
signalling by Syk tyrosine protein kinase. Mol Cell Biol 17,4434-4441.
205
Latour, S., Zhang, J., Siraganian, R. P., and Veillette, A. (1998). A unique insert in the 
linker domain of Syk is necessary for its function in immunoreceptor signalling. Embo J 
17,2584-2595.
Law, C. L., Chandran, K. A., Sidorenko, S. P., and Clark, E. A. (1996). Phospholipase 
C-gammal interacts with conserved phosphotyrosyl residues in the linker region of Syk 
and is a substrate for Syk. Mol Cell Biol 1 6 ,1305-1315.
Law, D. A., Nannizzi-Alaimo, L., Ministri, K., Hughes, P. E., Forsyth, J., Turner, M., 
Shattil, S. J., Ginsberg, M. H., Tybulewicz, V. L., and Phillips, D. R. (1999). Genetic 
and pharmacological analyses of Syk function in alphallbbeta3 signaling in platelets. 
Blood 93, 2645-2652.
Lederberg, J. (1959). Genes and antibodies. Science 129,1649-1653.
Legname, G., Seddon, B., Lovatt, M., Tomlinson, P., Samer, N., Tolaini, M., Williams, 
K., Norton, T., Kioussis, D., and Zamoyska, R. (2000). Inducible expression of a 
p56Lck transgene reveals a central role for Lck in the differentiation of CD4 SP 
thymocytes. Immunity 12,537-546.
Lewis, C. M., Broussard, C., Czar, M. J., and Schwartzberg, P. L. (2001). Tec kinases: 
modulators of lymphocyte signaling and development. Curr Opin Immunol 13, 317-325.
206
Li, C., Fox, C. J., Master, S. R., Bindokas, V. P., Chodosh, L. A., and Thompson, C. B. 
(2002). Bcl-X(L) affects Ca(2+) homeostasis by altering expression of inositol 1,4,5- 
trisphosphate receptors. Proc Natl Acad Sci U S A 99,9830-9835.
Li, Y. S., Wasserman, R., Hayakawa, K., and Hardy, R. R. (1996). Identification of the 
earliest B lineage stage in mouse bone marrow. Immunity 5,527-535.
Lin, H., and Grosschedl, R. (1995). Failure of B-cell differentiation in mice lacking the 
transcription factor EBF. Nature 376,263-267.
Lin, S., Cicala, C., Scharenberg, A. M., and Kinet, J. P. (1996). The Fc(epsilon)RIbeta 
subunit functions as an amplifier of Fc(epsilon)RIgamma-mediated cell activation 
signals. Cell 85,985-995.
Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., and Evan, G. I. 
(1995). A modified oestrogen receptor ligand-binding domain as an improved switch for 
the regulation of heterologous proteins. Nucleic Acids Res 2 3 ,1686-1690.
Liu, Y. J. (1997). Sites of B lymphocyte selection, activation, and tolerance in spleen. J 
Exp Med 186,625-629.
Loder, F., Mutschler, B., Ray, R. J., Paige, C. J., Sideras, P., Torres, R., Lamers, M. C., 
and Carsetti, R. (1999). B cell development in the spleen takes place in discrete steps 
and is determined by the quality of B cell receptor-derived signals. J Exp Med 190,75- 
89.
207
Lopes-Carvalho, T., and Keamey, J. F. (2004). Development and selection of marginal 
zone B cells. Immunol Rev 197,192-205.
Lowell, C. A., and Soriano, P. (1996). Knockouts of Src-family kinases: stiff bones, 
wimpy T cells, and bad memories. Genes Dev 1 0 ,1845-1857.
Ludviksson, B. R., Ehrhardt, R. O., and Strober, W. (1997). TGF-beta production 
regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet 
hemocyanin-induced colonic inflammation in IL-2-deficient mice. J Immunol 159, 
3622-3628.
Mallick-Wood, C. A., Pao, W., Cheng, A. M., Lewis, J. M., Kulkarni, S., Bolen, J. B., 
Rowley, B., Tigelaar, R. E., Pawson, T., and Hayday, A. C. (1996). Disruption of 
epithelial gamma delta T cell repertoires by mutation of the Syk tyrosine kinase. Proc 
Natl Acad Sci U S A 93,9704-9709.
Mandik-Nayak, L., Seo, S. J., Sokol, C., Potts, K. M., Bui, A., and Erikson, J. (1999). 
MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular 
exclusion of anti-double-stranded DNA B cells. J Exp Med 189,1799-1814.
Marshall, A. J., Niiro, H., Yun, T. J., and Clark, E. A. (2000). Regulation of B-cell 
activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase 
Cgamma pathway. Immunol Rev 176, 30-46.
208
Martensson, I. L., Rolink, A., Melchers, F., Mundt, C., Licence, S., and Shimizu, T. 
(2002). The pre-B cell receptor and its role in proliferation and Ig heavy chain allelic 
exclusion. Semin Immunol 14,335-342.
Martin, F., and Kearney, J. F. (2000a). B-cell subsets and the mature preimmune 
repertoire. Marginal zone and B IB  cells as part of a "natural immune memory". 
Immunol Rev 775,70-79.
Martin, F., and Kearney, J. F. (2000b). Positive selection from newly formed to marginal 
zone B cells depends on the rate of clonal production, CD 19, and btk. Immunity 72, 39- 
49.
Martin, F., and Kearney, J. F. (2001). B1 cells: similarities and differences with other B 
cell subsets. Curr Opin Immunol 1 3 ,195-201.
Martin, F., and Kearney, J. F. (2002). Marginal-zone B cells. Nat Rev Immunol 2, 323- 
335.
Martin, F., Oliver, A. M., and Kearney, J. F. (2001). Marginal zone and B1 B cells unite 
in the early response against T-independent blood-borne particulate antigens. Immunity 
14,617-629.
Mattioni, T., Louvion, J. F., and Picard, D. (1994). Regulation of protein activities by 
fusion to steroid binding domains. Methods Cell Biol 43 Pt A, 335-352.
209
Max, E. E. (1993). Immunoglobulins: Molecular Genetics. In Fundamental 
Immunology, W. E. Paul, ed. (Raven Press, New York), pp. 315-382.
Meade, J., Tybulewicz, V. L., and Turner, M. (2004). The tyrosine kinase Syk is 
required for light chain isotype exclusion but dispensable for the negative selection of B 
cells. Eur J Immunol 3 4 ,1102-1110.
Medzhitov, R., and Janeway, C. A., Jr. (1997). Innate immunity: impact on the adaptive 
immune response. Curr Opin Immunol 9,4-9.
Meffre, E., Casellas, R., and Nussenzweig, M. C. (2000). Antibody regulation of B cell 
development. Nat Immunol 1, 379-385.
Mizuno, K., Tagawa, Y., Mitomo, K., Arimura, Y., Hatano, N., Katagiri, T., Ogimoto, 
M., and Yakura, H. (2000). Src homology region 2 (SH2) domain-containing 
phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 
65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells. J 
Immunol 165,1344-1351.
Mocsai, A., Humphrey, M. B., Van Ziffle, J. A., Hu, Y., Burghardt, A., Spusta, S. C., 
Majumdar, S., Lanier, L. L., Lowell, C. A., and Nakamura, M. C. (2004). The 
immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) 
regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc 
Natl Acad Sci U S A 101,6158-6163.
210
Mocsai, A., Zhou, M., Meng, F., Tybulewicz, V. L., and Lowell, C. A. (2002). Syk is 
required for integrin signaling in neutrophils. Immunity 16,547-558.
Mombaerts, P., Clarke, A. R., Rudnicki, M. A., Iacomini, J., Itohara, S., Lafaille, J. J., 
Wang, L., Ichikawa, Y., Jaenisch, R., Hooper, M. L., and et al. (1992). Mutations in T- 
cell antigen receptor genes alpha and beta block thymocyte development at different 
stages. Nature 360,225-231.
Morita, S., Kojima, T., and Kitamura, T. (2000). Plat-E: an efficient and stable system 
for transient packaging of retroviruses. Gene Ther 7,1063-1066.
Movilla, N., and Bustelo, X. R. (1999). Biological and regulatory properties of Vav-3, a 
new member of the Vav family of oncoproteins. Mol Cell Biol 19,7870-7885.
Negishi, I., Motoyama, N., Nakayama, K., Senju, S., Hatakeyama, S., Zhang, Q., Chan, 
A. C., and Loh, D. Y. (1995). Essential role for ZAP-70 in both positive and negative 
selection of thymocytes. Nature 376,435-438.
Nemazee, D. A., and Burki, K. (1989). Clonal deletion of B lymphocytes in a transgenic 
mouse bearing anti-MHC class I antibody genes. Nature 337,562-566.
Niiro, H., and Clark, E. A. (2002). Regulation of B-cell fate by antigen-receptor signals. 
Nat Rev Immunol 2,945-956.
211
Nishimura, H., Honjo, T., and Minato, N. (2000). Facilitation of beta selection and 
modification of positive selection in the thymus of PD-1-deficient mice. J Exp Med 191, 
891-898.
Nishizumi, H., Taniuchi, I., Yamanashi, Y., Kitamura, D., Ilic, D., Mori, S., Watanabe, 
T., and Yamamoto, T. (1995). Impaired proliferation of peripheral B cells and indication 
of autoimmune disease in lyn-deficient mice. Immunity 3,549-560.
Nitschke, L., Carsetti, R., Ocker, B., Kohler, G., and Lamers, M. C. (1997). CD22 is a 
negative regulator of B-cell receptor signalling. Curr Biol 7,133-143.
Nolan, G. www.stanford.edu/group/ nolan/retroviral_systems/phx.html.
Nolz, J. C., Tschumper, R. C., Pittner, B. T., Darce, J. R., Kay, N. E., and Jelinek, D. F. 
(2005). ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an 
activated phenotype. Leukemia 79,1018-1024.
Noraz, N., Schwarz, K., Steinberg, M., Dardalhon, V., Rebouissou, C., Hipskind, R., 
Friedrich, W., Yssel, H., Bacon, K., and Taylor, N. (2000). Alternative antigen receptor 
(TCR) signaling in T cells derived from ZAP-70-deficient patients expressing high 
levels of Syk. J Biol Chem 275,15832-15838.
Norvell, A., Mandik, L., and Monroe, J. G. (1995). Engagement of the antigen-receptor 
on immature murine B lymphocytes results in death by apoptosis. J Immunol 154,4404- 
4413.
212
Nutt, S. L., Heavey, B., Rolink, A. G., and Busslinger, M. (1999). Commitment to the B- 
lymphoid lineage depends on the transcription factor Pax5. Nature 401,556-562.
O'Rourke, L. M., Tooze, R., Turner, M., Sandoval, D. M., Carter, R. H., Tybulewicz, V. 
L., and Fearon, D. T. (1998). CD 19 as a membrane-anchored adaptor protein of B 
lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav.
Immunity 8 ,635-645.
Oh-hora, M., Johmura, S., Hashimoto, A., Hikida, M., and Kurosaki, T. (2003). 
Requirement for Ras guanine nucleotide releasing protein 3 in coupling phospholipase 
C-gamma2 to Ras in B cell receptor signaling. J Exp Med 198,1841-1851.
Okkenhaug, K., and Vanhaesebroeck, B. (2003). PI3K in lymphocyte development, 
differentiation and activation. Nat Rev Immunol 3, 317-330.
Oliver, A. M., Martin, F., Gartland, G. L., Carter, R. H., and Kearney, J. F. (1997). 
Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin 
secretory responses. Eur J Immunol 27,2366-2374.
Ollila, J., and Vihinen, M. (2005). B cells. Int J Biochem Cell Biol 37 ,518-523.
Orchard, J. A., Ibbotson, R. E., Davis, Z., Wiestner, A., Rosenwald, A., Thomas, P. W., 
Hamblin, T. J., Staudt, L. M., and Oscier, D. G. (2004). ZAP-70 expression and 
prognosis in chronic lymphocytic leukaemia. Lancet 363 ,105-111.
213
Oscier, D. G., Gardiner, A. C., Mould, S. J., Glide, S., Davis, Z. A., Ibbotson, R. E., 
Corcoran, M. M., Chapman, R. M., Thomas, P. W., Copplestone, J. A., et al. (2002). 
Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational 
status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 
100,1177-1184.
Osmond, D. G. (1993). The turnover of B-cell populations. Immunol Today 14,34-37.
Osmond, D. G., and Everett, N. B. (1964). Radioautographic Studies of Bone Marrow 
Lymphocytes in Vivo and in Diffusion Chamber Cultures. Blood 2 3 ,1-17.
Osmond, D. G., and Nossal, G. J. (1974). Differentiation of lymphocytes in mouse bone 
marrow. I. Quantitative radioautographic studies of antiglobulin binding by lymphocytes 
in bone marrow and lymphoid tissues. Cell Immunol 1 3 ,117-131.
Osmond, D. G., Rolink, A., and Melchers, F. (1998). Murine B lymphopoiesis: towards 
a unified model. Immunol Today 19,65-68.
Pasparakis, M., Schmidt-Supprian, M., and Rajewsky, K. (2002). IkappaB kinase 
signaling is essential for maintenance of mature B cells. J Exp Med 196,743-752.
Pennington, D. J., Silva-Santos, B., and Hayday, A. C. (2005). Gammadelta T cell 
development-having the strength to get there. Curr Opin Immunol 1 7 ,108-115.
Picard, D. (1993). Steroid-binding domains for regulating the functions of heterologous 
proteins in cis. Trends Cell Biol 3 ,278-280.
214
Pike, B. L., Boyd, A. W., and Nossal, G. J. (1982). Clonal anergy: the universally 
anergic B lymphocyte. Proc Natl Acad Sci U S A 79,2013-2017.
Pillai, S., Cariappa, A., and Moran, S. T. (2004). Positive selection and lineage 
commitment during peripheral B-lymphocyte development. Immunol Rev 797,206-218.
Pillai, S., Cariappa, A., and Moran, S. T. (2005). Marginal zone B cells. Annu Rev 
Immunol 2 3 ,161-196.
Poole, A., Gibbins, J. M., Turner, M., van Vugt, M. J., van de Winkel, J. G., Saito, T., 
Tybulewicz, V. L., and Watson, S. P. (1997). The Fc receptor gamma-chain and the 
tyrosine kinase Syk are essential for activation of mouse platelets by collagen. Embo J 
16,2333-2341.
Reichlin, A., Hu, Y., Meffre, E., Nagaoka, H., Gong, S., Kraus, M., Rajewsky, K., and 
Nussenzweig, M. C. (2001). B cell development is arrested at the immature B cell stage 
in mice carrying a mutation in the cytoplasmic domain of immunoglobulin beta. J Exp 
Med 193,13-23.
Reichman-Fried, M., Hardy, R. R., and Bosma, M. J. (1990). Development of B-lineage 
cells in the bone marrow of scid/scid mice following the introduction of functionally 
rearranged immunoglobulin transgenes. Proc Natl Acad Sci U S A 87,2730-2734.
Reth, M. (1989). Antigen receptor tail clue. Nature 338, 383-384.
215
Rickert, R. C., Rajewsky, K., and Roes, J. (1995). Impairment of T-cell-dependent 13- 
cell responses and B-l cell development in CD 19-deficient mice. Nature 376, 352-355.
Robey, E., and Fowlkes, B. J. (1994). Selective events in T cell development. Annu Rev 
Immunol 72,675-705.
Rodriguez, R., Matsuda, M., Perisic, O., Bravo, J., Paul, A., Jones, N. P., Light, Y., 
Swann, K., Williams, R. L., and Katan, M. (2001). Tyrosine residues in phospholipase 
Cgamma 2 essential for the enzyme function in B-cell signaling. J Biol Chem 276, 
47982-47992.
Roemer, K:, and Friedmann, T. (1993). Modulation of cell proliferation and gene 
expression by a p53-estrogen receptor hybrid protein. Proc Natl Acad Sci U S A 90, 
9252-9256.
Rolink, A. G., Winkler, T., Melchers, F., and Andersson, J. (2000). Precursor B cell 
receptor-dependent B cell proliferation and differentiation does not require the bone 
marrow or fetal liver environment. J Exp Med 191,23-32.
Rolli, V., Gallwitz, M., Wossning, T., Flemming, A., Schamel, W. W., Zurn, C., and 
Reth, M. (2002). Amplification of B cell antigen receptor signaling by a Syk/ITAM 
positive feedback loop. Mol Cell 1 0 ,1057-1069.
Rothstein, T. L. (2002). Cutting edge commentary: two B-l or not to be one. J Immunol 
168,4257-4261.
216
Rothstein, T. L., Fischer, G. M., Tanguay, D. A., Pavlovic, S., Colarusso, T. P.,
Gerstein, R. M., Clarke, S. H., and Chiles, T. C. (2000). STAT3 activation, chemokine 
receptor expression, and cyclin-Cdk function in B-l cells. Curr Top Microbiol Immunol 
252,121-130.
Rothstein, T. L., Kolber, D. L., Murphy, T. P., and Cohen, D. P. (1991). Induction of 
phorbol ester responsiveness in conventional B cells after activation via surface Ig. J 
Immunol 147,3728-3735.
Saijo, K., Mecklenbrauker, I., Santana, A., Leitger, M., Schmedt, C., and Tarakhovsky, 
A. (2002). Protein kinase C beta controls nuclear factor kappaB activation in B cells 
through selective regulation of the IkappaB kinase alpha. J Exp Med 795,1647-1652.
Saijo, K., Schmedt, C., Su, I. H., Karasuyama, H., Lowell, C. A., Reth, M., Adachi, T., 
Patke, A., Santana, A., and Tarakhovsky, A. (2003). Essential role of Src-family protein 
tyrosine kinases in NF-kappaB activation during B cell development. Nat Immunol 4 , 
274-279.
Sakaguchi, N., and Melchers, F. (1986). Lambda 5, a new light-chain-related locus 
selectively expressed in pre-B lymphocytes. Nature 324,579-582.
Samardzic, T., Marinkovic, D., Danzer, C. P., Gerlach, J., Nitschke, L., and Wirth, T. 
(2002). Reduction of marginal zone B cells in CD22-deficient mice. Eur J Immunol 32, 
561-567.
217
Samelson, L. E., and Klausner, R. D. (1992). Tyrosine kinases and tyrosine-based 
activation motifs. Current research on activation via the T cell antigen receptor. J Biol 
Chem 2(57,24913-24916.
Samuels, M. L., Weber, M. J., Bishop, J. M., and McMahon, M. (1993). Conditional 
transformation of cells and rapid activation of the mitogen-activated protein kinase 
cascade by an estradiol-dependent human raf-1 protein kinase. Mol Cell Biol 13,6241- 
6252.
Sanchez, M., Misulovin, Z., Burkhardt, A. L., Mahajan, S., Costa, T., Franke, R., Bolen, 
J. B., and Nussenzweig, M. (1993). Signal transduction by immunoglobulin is mediated 
through Ig alpha and Ig beta. J Exp Med 178,1049-1055.
Sandel, P. C., and Monroe, J. G. (1999). Negative selection of immature B cells by 
receptor editing or deletion is determined by site of antigen encounter. Immunity 10, 
289-299.
Sato, S., Ono, N., Steeber, D. A., Pisetsky, D. S., and Tedder, T. F. (1996). CD19 
regulates B lymphocyte signaling thresholds critical for the development of B-l lineage 
cells and autoimmunity. J Immunol 157,4371-4378.
Satterthwaite, A. B., Li, Z., and Witte, O. N. (1998). Btk function in B cell development 
and response. Semin Immunol 10, 309-316.
218
Scharenberg, A. M., and Kinet, J. P. (1998). PtdIns-3,4,5-P3: a regulatory nexus 
between tyrosine kinases and sustained calcium signals. Cell 94,5-8.
Schuebel, K. E., Movilla, N., Rosa, J. L., and Bustelo, X. R. (1998). Phosphorylation- 
dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav- 
2. EmboJ 17,6608-6621.
Schweighoffer, E., Vanes, L., Mathiot, A., Nakamura, T., and Tybulewicz, V. L. (2003). 
Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion. 
Immunity 18,523-533.
Schwenk, F., Kuhn, R., Angrand, P. O., Rajewsky, K., and Stewart, A. F. (1998). 
Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res 26, 
1427-1432.
Scott, E. W., Simon, M. C., Anastasi, J., and Singh, H. (1994). Requirement of 
transcription factor PU.l in the development of multiple hematopoietic lineages. Science 
265, 1573-1577.
Shapiro-Shelef, M., and Calame, K. (2005). Regulation of plasma-cell development. Nat 
Rev Immunol 5,230-242.
Sidman, C. L., Shultz, L. D., Hardy, R. R., Hayakawa, K., and Herzenberg, L. A. (1986). 
Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and 
normal mice. Science 232,1423-1425.
219
Smith, K. G., Hewitson, T. D., Nossal, G. J., and Tarlinton, D. M. (1996). The 
phenotype and fate of the antibody-forming cells of the splenic foci. Eur J Immunol 26, 
444-448.
Spanopoulou, E., Roman, C. A., Corcoran, L. M., Schlissel, M. S., Silver, D. P., 
Nemazee, D., Nussenzweig, M. C., Shinton, S. A., Hardy, R. R., and Baltimore, D. 
(1994). Functional immunoglobulin transgenes guide ordered B-cell differentiation in 
Rag-1-deficient mice. Genes Dev 8 ,1030-1042.
Srivastava, B., Lindsley, R. C., Nikbakht, N., and Allman, D. (2005). Models for 
peripheral B cell development and homeostasis. Semin Immunol 1 7 ,175-182.
Stein, P. L., Lee, H. M., Rich, S., and Soriano, P. (1992). pp59fyn mutant mice display 
differential signaling in thymocytes and peripheral T cells. Cell 70,741-750.
Su, T. T., and Rawlings, D. J. (2002). Transitional B lymphocyte subsets operate as 
distinct checkpoints in murine splenic B cell development. J Immunol 168,2101-2110.
Suzuki, H., Terauchi, Y., Fujiwara, M., Aizawa, S., Yazaki, Y., Kadowaki, T., and 
Koyasu, S. (1999). Xid-like immunodeficiency in mice with disruption of the p85alpha 
subunit of phosphoinositide 3-kinase. Science 283, 390-392.
Takahashi, K., Kozono, Y., Waldschmidt, T. J., Berthiaume, D., Quigg, R. J., Baron, A., 
and Holers, V. M. (1997). Mouse complement receptors type 1 (CR1;CD35) and type 2
220
(CR2;CD21): expression on normal B cell subpopulations and decreased levels during 
the development of autoimmunity in MRL/lpr mice. J Immunol 759,1557-1569.
Takata, M., and Kurosaki, T. (1996). A role for Bruton's tyrosine kinase in B cell 
antigen receptor-mediated activation of phospholipase C-gamma 2. J Exp Med 184,31- 
40.
Takata, M., Sabe, H., Hata, A., Inazu, T., Homma, Y., Nukada, T., Yamamura, H., and 
Kurosaki, T. (1994). Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled 
Ca2+ mobilization through distinct pathways. Embo J 13 ,1341-1349.
Tangye, S. G., Avery, D. T., Deenick, E. K., and Hodgkin, P. D. (2003). Intrinsic 
differences in the proliferation of naive and memory human B cells as a mechanism for 
enhanced secondary immune responses. J Immunol 170, 686-694.
Tarakhovsky, A., Turner, M., Schaal, S., Mee, P. J., Duddy, L. P., Rajewsky, K., and 
Tybulewicz, V. L. (1995). Defective antigen receptor-mediated proliferation of B and T 
cells in the absence of Vav. Nature 374,467-470.
Taylor, J. A., Karas, J. L., Ram, M. K., Green, O. M., and Seidel-Dugan, C. (1995). 
Activation of the high-affinity immunoglobulin E receptor Fc epsilon RI in RBL-2H3 
cells is inhibited by Syk SH2 domains. Mol Cell Biol 75,4149-4157.
221
Tedford, K., Nitschke, L., Girkontaite, I., Charlesworth, A., Chan, G., Sakk, V., 
Barbacid, M., and Fischer, K. D. (2001). Compensation between Vav-1 and Vav-2 in B 
cell development and antigen receptor signaling. Nat Immunol 2,548-555.
Teitelbaum, S. L. (2000). Bone resorption by osteoclasts. Science 289,1504-1508.
Texido, G., Su, I. H., Mecklenbrauker, I., Saijo, K., Malek, S. N., Desiderio, S., 
Rajewsky, K., and Tarakhovsky, A. (2000). The B-cell-specific Src-family kinase Blk is 
dispensable for B-cell development and activation. Mol Cell Biol 20,1227-1233.
Tolias, K. F., Cantley, L. C., and Carpenter, C. L. (1995). Rho family GTPases bind to 
phosphoinositide kinases. J Biol Chem 270,17656-17659.
Torres, R. M., and Hafen, K. (1999). A negative regulatory role for Ig-alpha during B 
cell development. Immunity 77,527-536.
Turner, M., and Billadeau, D. D. (2002). VAV proteins as signal integrators for multi­
subunit immune-recognition receptors. Nat Rev Immunol 2,476-486.
Turner, M., Gulbranson-Judge, A., Quinn, M. E., Walters, A. E., MacLennan, I. C., and 
Tybulewicz, V. L. (1997). Syk tyrosine kinase is required for the positive selection of 
immature B cells into the recirculating B cell pool. J Exp Med 186,2013-2021.
Turner, M., Mee, P. J., Costello, P. S., Williams, O., Price, A. A., Duddy, L. P., Furlong, 
M. T., Geahlen, R. L., and Tybulewicz, V. L. (1995). Perinatal lethality and blocked B- 
cell development in mice lacking the tyrosine kinase Syk. Nature 378,298-302.
222
Turner, M., Schweighoffer, E., Colucci, F., Di Santo, J. P., and Tybulewicz, V. L.
(2000). Tyrosine kinase SYK: essential functions for immunoreceptor signalling. 
Immunol Today 27,148-154.
Tuveson, D. A., Carter, R. H., Soltoff, S. P., and Fearon, D. T. (1993). CD19 of B cells 
as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260, 
986-989.
Walmsley, M. J., Ooi, S. K., Reynolds, L. F., Smith, S. H., Ruf, S., Mathiot, A., Vanes, 
L., Williams, D. A., Cancro, M. P., and Tybulewicz, V. L. (2003). Critical roles for Racl 
and Rac2 GTPases in B cell development and signaling. Science 302,459-462.
Wang, H., and Clarke, S. H. (2003). Evidence for a ligand-mediated positive selection 
signal in differentiation to a mature B cell. J Immunol 777,6381-6388.
Wang, J. H., Avitahl, N., Cariappa, A., Friedrich, C., Ikeda, T., Renold, A., 
Andrikopoulos, K., Liang, L., Pillai, S., Morgan, B. A., and Georgopoulos, K. (1998). 
Aiolos regulates B cell activation and maturation to effector state. Immunity 9, 543-553.
Wang, L. D., and Clark, M. R. (2003). B-cell antigen-receptor signalling in lymphocyte 
development. Immunology 770,411-420.
Wang, Y., Brooks, S. R., Li, X., Anzelon, A. N., Rickert, R. C., and Carter, R. H.
(2002). The physiologic role of CD19 cytoplasmic tyrosines. Immunity 77,501-514.
223
Wasserman, R., Li, Y. S., and Hardy, R. R. (1997). Down-regulation of terminal 
deoxynucleotidyl transferase by Ig heavy chain in B lineage cells. J Immunol 158,1133- 
1138.
Wehr, C., Eibel, H., Masilamani, M., Illges, H., Schlesier, M., Peter, H. H., and 
Warnatz, K. (2004). A new CD211ow B cell population in the peripheral blood of 
patients with SLE. Clin Immunol 113,161-171.
Wen, L., Brill-Dashoff, J., Shinton, S. A., Asano, M., Hardy, R. R., and Hayakawa, K. 
(2005). Evidence of marginal-zone B cell- positive selection in spleen. Immunity 23, 
297-308.
Wiest, D. L., Ashe, J. M., Howcroft, T. K., Lee, H. M., Kemper, D. M., Negishi, I., 
Singer, D. S., Singer, A., and Abe, R. (1997). A spontaneously arising mutation in the 
DLAARN motif of murine ZAP-70 abrogates kinase activity and arrests thymocyte 
development. Immunity 6 ,663-671.
Wiestner, A., Rosenwald, A., Barry, T. S., Wright, G., Davis, R. E., Henrickson, S. E., 
Zhao, H., Ibbotson, R. E., Orchard, J. A., Davis, Z., et al. (2003). ZAP-70 expression 
identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin 
genes, inferior clinical outcome, and distinct gene expression profile. Blood 101,4944- 
4951.
Wilson, J. G., Ratnoff, W. D., Schur, P. H., and Fearon, D. T. (1986). Decreased 
expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B
224
lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. 
Arthritis Rheum 29,739-747.
Witt, C. M., Won, W. J., Hurez, V., and Klug, C. A. (2003). Notch2 haploinsufficiency 
results in diminished B1 B cells and a severe reduction in marginal zone B cells. J 
Immunol 171,2783-2788.
Wortis, H. H., Teutsch, M., Higer, M., Zheng, J., and Parker, D. C. (1995). B-cell 
activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal 
pathways and results in different B-cell phenotypes. Proc Natl Acad Sci U S A 92, 3348- 
3352.
Xu, S., Tan, J. E., Wong, E. P., Manickam, A., Ponniah, S., and Lam, K. P. (2000). B 
cell development and activation defects resulting in xid-like immunodeficiency in 
BLNK/SLP-65-deficient mice. Int Immunol 12, 397-404.
Yang, W. C., Miller, S. C., and Osmond, D. G. (1978). Maturation of bone marrow 
lymphocytes. II. Development of Fc and complement receptors and surface 
immunoglobulin studied by rosetting and radioautography. J Exp Med 148,1251-1270.
Zhang, J., Berenstein, E. H., Evans, R. L., and Siraganian, R. P. (1996). Transfection of 
Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated 
degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J Exp 
Med 184,71-79.
225
Zoller, K. E., MacNeil, I. A., and Brugge, J. S. (1997). Protein tyrosine kinases Syk and 
ZAP-70 display distinct requirements for Src family kinases in immune response 
receptor signal transduction* J Immunol 158,1650-1659.
226
